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SClMftRY
Diabetes mellitus is the most common endocrine disorder 
affecting about one per cent of the population although about the same 
number are still undiagnosed clinically. It is believed that diabetic 
patients are more predisposed to infections than non-diabetic 
individuals and oral candidosis is more common in diabetic patients.
Many local and systemic factors have been claimed to 
predispose an individual to oral candidal infection and the integrity 
of host defence factors seems to be an important determinant in 
mucocutaneous candidosis. Therefore, in Chapter One the local host 
defence factors of known importance, in addition to some general 
factors thought to increase the risk for oral candidosis have been 
reviewed, and particular attention has been directed toward those 
factors that might predispose diabetic patients to oral candidal 
infection.
Since candidal adhesion to host surfaces is recognised as an 
essential prerequisite for colonisation and subsequent infection, 
factors affecting adhesion of candidal species to epithelial cell and 
denture acrylic surfaces, in addition to the possible mechanisms 
involved, were reviewed in Chapter Two.
Although oral candidal carriage and infection in diabetic 
patients has been reported, the various methodologies used have been 
criticised, and consequently the reasons for increased oral candidal 
colonisation have never been clearly defined. Chapter Three of this 
study aimed to study and compare the prevalence of candidal carriage 
and clinical candidal infection in the oral cavity of a group of 
diabetic patients and a matched group of control subjects using
15
current methodology. In addition, the effect if any, of factors such 
as degree of glycaemic control, type and duration of diabetes as well 
as the inherited ability to secrete ABO blood group antigens in 
saliva, on candidal carriage and infection was also evaluated.
Fifty patients with diagnosed diabetes mellitus (19 insulin- 
dependent and 31 non-insulin dependent) and 50 age, gender and denture 
status matched non-diabetic individuals underwent routine oral 
clinical examination where the presence of angular cheilitis or oral 
candidal infection was recorded. Swabs and smears were collected from 
clinically infected mucosa and perioral skin and oral candidal 
carriage was determined using a concentrated oral rinse technique. 
The samples were inoculated on Sabouraud's dextrose agar plates and 
incubated aerobically for 48 hours at 37°C.
Unstimulated mixed saliva (2ml) was collected from each 
subject and assayed for ABO blood group antigen secretor status using 
an agglutination inhibition technique. Each subject had 
haematological and biochemical assessment including corrected whole 
blood folate, ferritin, vitamin B12, haemoglobin and random blood 
glucose. Diabetic patients were also assayed for glycosylated 
haemoglobin concentration.
The rate and quantity of oral candidal isolation was higher 
in diabetic patients compared to non-diabetics although the difference 
was not significant but, diabetic patients had a significantly 
increased incidence of clinical oral candidal infection (p<0.002). 
Candida albicans was by far the most commonly isolated species 
followed by glabrata. Age, gender and denture status had no 
significant relationship to either rate or quantity of candidal 
isolation but, diabetic patients who wore dentures continuously (day
16
and night) had a significantly increased rate of candidal isolation 
(p<0.05) and clinical candidal infection (p<0.0005) over those who 
wore dentures during the day only.
Haamatinic status had no significant effect cm oral candidal 
isolation. Factors such as blood glucose level, glycosylated 
haemoglobin, type and duration of diabetes also had no significant 
relationship to oral candidal isolation in diabetic patients. The 
ability to secrete ABO blood group antigens in saliva was not 
different between diabetic patients and control subjects nor between 
diabetic patients in relation to type of diabetes. However, diabetic 
patients who were non-seeretors had a significantly increased rate of 
oral candidal isolation compared to secretors (p<0.05).
Candidal adhesion to mucosal surfaces was recognised as an 
essential first step in the process of candidal colonisation and 
infection. In view of the results obtained and described in Chapter 
Three, the objectives of the study described in Chapter Four were to 
investigate and compare adhesion of C. albicans to buccal epithelial 
cells (BEC) in a group of diabetic patients and a closely matched 
group of non-diabetic individuals to determine whether a relationship 
existed between the in vitro candidal adhesion to BEC and the 
increased predisposition to clinical oral candidal colonisation and 
infection.
The Candida albicans strain CDS 88 used throughout this study 
was originally isolated from the oral cavity of an asymptomatic 
carrier. For candidal adhesion assay in vitro, equal volumes (0.5ml) 
of a standardised suspension of candidal cells and BEC were incubated 
in an orbital shaker for one hour and then the cells were harvested on 
*\2im pore-size filter and washed with phosphate buffered saline (PBS).
17
The BEC and the adherent candidal cells were Gram-stained and the 
number of C. albicans blastospores adherent to 100 individual BEC in 
randomly selected fields were counted microscopically.
Mean candidal adhesion (MCA) in the diabetic patients was 
significantly higher than in the control group (p<0.001) and 
correlated inversely with age (p<0.05). In control subjects, a higher 
MCA was observed in females than males (p<0.02) and also in continuous 
denture wearers compared to those who wore dentures during the day 
only (p<0.05). In both groups, no significant correlation was 
observed between MCA and smoking or alcohol drinking habits, 
symptomatic xerostomia, or haematinic status. Nevertheless, a 
significant correlation was observed between MCA and haemoglobin 
concentration in control subjects (p<0.05). Neither type of diabetes 
nor blood glucose concentration had a relationship to MCA but, MCA was 
higher in patients with duration of diabetes less than five years 
compared with those who had the disease for more than five years 
(p<0.05) and, in patients who had glycosylated haemoglobin higher than 
12% compared with those below 12% (p= 0.05). The relationship between 
in vitro candidal adhesion and oral candidal colonisation and 
infection was not significant in either group and, MCA was not 
significantly different between secretors and non-secretors.
In the light of the results of Chapter Four and the reports 
that pretreatment of acrylic strips with chlorhexidine gluconate 
reduced adherence of Candida species, the objective of Chapter Five 
was to investigate whether mouth rinsing with 0.2% chlorhexidine would 
similarly reduce candidal adhesion to BEC comparably in diabetic 
patients and non-diabetic individuals. Twelve diabetic patients and 
12 closely-matched control subjects participated in the study.
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Initially, BEC were obtained from each individual and subjected to 
10ml of 0.2% chlorhexidine gluconate in vitro for one minute, then 
assayed for candidal adhesion as described previously. In the second 
part of the experiment, each subject was required to rinse the mouth 
throughly with 10ml chlorhexidine gluconate mouth rinse for one minute 
and then BEC were assayed for candidal adhesion. The same subjects 
participated in both parts of the experiment which was repeated twice 
with a two week interval between visits. BEC collected from each 
subject prior to exposure to chlorhexidine were also assayed for 
candidal adhesion and used as control cells.
Exposure of BEC to 0.2% chlorhexidine gluconate, both in 
vitro and in vivo, for one minute resulted in a significant reduction 
in candidal adhesion to BEC both in diabetic patients and control 
subjects. The reduction in adhesion was more marked in control 
subjects than in diabetic patients and, more pronounced in vitro than 
in vivo in both groups but not significantly so (p>0.05). The 
reduction in mean candidal adhesion was comparable between secretors 
and non-secretors in both groups.
The antifungal agent nystatin is widely prescribed for the 
treatment of oral candidosis and well known for its potent fungicidal 
activity. Previous reports have shown pretreatment of acrylic strips 
with nystatin to result in a significant reduction in candidal 
adhesion. The main aim of Chapter Six was to investigate whether 
nystatin, in therapeutic doses, would reduce candidal adhesion to 
buccal epithelial cells and whether any differences were discemable 
between diabetic patients and non-diabetic individuals.
Twelve diabetic patients and 12 closely-matched control 
subjects participated in this part of the study. Initially, BEC were
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obtained from each subj ect and exposed in vitro to 1 ml of nystatin 
solution (100,000iu) for ten minutes and then assayed for candidal 
adhesion. Subsequently, each subject was asked to dissolve a nystatin 
pastille (100,000iu) in the mouth and then BEC were collected and 
assayed for candidal adhesion. Each experiment was repeated twice 
with each subject with a two week interval between experiments. BEC 
collected from each subject before exposure to nystatin were assayed 
for candidal adhesion and used as control cells. Pretreatment of BEC 
for ten minutes with nystatin (100,000iu) in vitro resulted in a 
significant reduction in candidal adhesion both to BEC from diabetic 
patients and control subjects (p<0.002). However, the effect of 
dissolution of one nystatin pastille (100,000) did not affect candidal 
adhesion to BEC significantly in either group. The effect of nystatin 
pretreatment on candidal adhesion was not sigificantly different 
between secretors and non-secretors.
Thus this study has shown that patients with diabetes 
mellitus are more prone than normal to develop oral candidosis. 
Factors such as type of diabetes, duration or quality of glycaemic 
control seems to have no significant effect on this susceptibility. 
Hcwever, the significantly increased candidal adhesion to buccal 
epithelial cells of diabetic subjects compared to controls may 
partially explain the increased incidence of oral candidosis. 
Nevertheless, as to why only a limited number of diabetic patients 
develop oral candidosis while the majority remain free of infection is 
still far from clear.
The aetiological factors in oral candidosis are often 
described as multifactorial and are probably increasingly complex in 
diabetic subjects. Unfortunately, many of the previous studies
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undertaken on this topic have been cross-sectional in design and have 
thus yielded limited informations. What is undoubtedly required are 
carefully designed longitudinal studies, monitoring oral candidal 
status in diabetic patients and testing candidal adhesion to oral 
epithelial cells in different states of glycaemic control. These 
studies should also take into account other factors that might affect 
candidal colonisation and adhesion in these patients such as salivary 
glucose level and the influence of oral commensal bacterial flora. 
Obviously, standardised oral candidal sampling methods and candidal 
adhesion assay would be needed to allow comparison of results between 
different research centres. In that regard, the widespread 
application of the concentrated oral rinse technique for oral 
microbial sampling described previously and used in the present study 
would be .aficial.
Should the present finding of increased candidal adhesion in 
vitro to buccal epithelial cells of diabetic subjects be confirmed in 
the future, the detailed study of other factors involved in adhesion 
could be pursued such as analysis of epithelial cell surface lectins.
If one minute oral rinse with 0.2% chlorhexidine gluconate 
was shown to reduce candidal adhesion to epithelial cells in vitro, 
more studies are required to define the effect of this oral rinsing on 
reducing the incidence of oral candidosis in population generally and 
in diabetic subjects in particular. Topical nystatin therapy must 
continue for at least three to four weeks befor resolution of oral 
candidal infection. The effect of nystatin pastilles intake over a 
prolonged period of time on candidal adhesion warrants study.
21
CHAPTER ONE
EKEDISPOSING EACDCRS PGR ORAL CAMHDOSIS: REVIEW CF UTERATURE
1.1 nm raxxjproN
Candidal infection has been frequently reported in the oral 
cavity of compromised patients such as those with diabetes mellitus, 
haematological malignancy and patients infected with the human 
immunodeficiency virus. Candida species are commensal inhabitants of 
the oral cavity of about 40 per cent of normal individuals (Arendorf & 
Walker, 1980) but, the eventual outcome of the balance between the 
efficiency of the host defence mechanisms and the pathogenicity of the 
candidal organisms determines whether clinical disease occurs. This 
balance between the host defence factors and the virulence of Candida 
species appears to be surprisingly even so Candida may be able to 
provoke infection whenever a breakdown of host resistance occurs. 
Candida albicans is considered the most pathogenic of the medically 
important Candida species since it is isolated most commonly from 
cases of oral candidosis. Whilist being potentially capable of 
causing infection, the virulence of Candida seems to be insufficient 
to establish clinical infection in an entirely uncompromised host. 
Therefore, the integrity of local and systemic host defence mechanisms 
seems to be of prime importance in determining pathogenicity.
The following discussion of the factors predisposing to oral 
candidosis deliberately emphasises the most important factors rather 
than being an exhaustive account of all known or possible predisposing 
factors.
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1.2 HOST FACTORS IN CRAL CANDIDAL INFECTION
1 .2.1 Epithelial Barrier
The continuous desquamation of the epithelial cells lining 
the oral cavity constitutes an important factor in limiting candidal 
colonisation of the oral mucosa. In addition, certain proteins 
present on the mucosal cells may retard candidal invasion as recent 
studies have shown that proteins isolated from the rat epidermis 
exhibit candidacidal activity (Kashima et al., 1989).
Local traumatic factor in denture wearers have been 
postulated as contributing to chronic atrophic candidosis (Turrell, 
1966). A recent animal experimental study showed that inoculation of 
C. albicans per se did not lead to candidal invasion or tissues 
changes in the rat palate, except in areas where ulceration of the 
surface epithelium occurred due to the presence of a prosthesis 
(Jennings, 1988). In angular cheilitis, the folds at the comers of 
the mouth may, in some cases, be related to an overdosed bite leading 
to increased maceration of the mucosa, and the continuous bathing of 
saliva may facilitate candidal infection (Cawson, 1963).
1.2.2 Salivary Flow
Ihe flushing effect of salivary flow dislodges yeasts from 
the surface of the oral mucosa, and helps limit oral candidal 
colonisation. Low salivary output appears to be associated with 
higher rates of candidal recovery (Parvinen & Larmas, 1981). Oral 
candidosis has been reported in patients with xerostomia (MacFarlane & 
Mason, 1974) and animals with reduced salivary flow rate (Olsen & 
Haanaes, 1977).
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1 .2.3 Salivary Hydrogen Ion Cbnoentration (pH)
The possible relationship between increased yeast isolation 
and low pH in the oral cavity has been reiterated by several authors 
(Young, Resca, Sullivan, 1951; Shipman, 1979; Arendorf & Walker, 
1980).
The low pH medium could activate extracellular candidal 
phospholipase (Samaranayake, Raeside, MacFarlane, 1984) and acid 
proteinases production (Samaranayake, Hughes, MacFarlane, 1984) which 
are of potential importance in relation to the virulence of candidal 
species.
Candidal adhesion to epithelial cells is increased at low pH 
(Samaranayake & MacFarlane, 1982a). In addition, the aciduric and 
acidophilic nature of Candida species enables it to thrive in a low pH 
milieu in contrast to other components of the oral flora which may not 
survive in such conditions (Odds & Abbott, 1984).
1.2.4 Salivary Glucose Concentration
The study of Knight and Fletcher (1971) showed inhibition of 
candidal growth when cultured in saliva of normal subjects but this 
could be reversed by the addition of glucose. In another study, 
candidal growth was significantly increased in glucose-supplemented 
saliva when compared with glucose-free saliva (Samaranayake et al., 
1986a). In addition, a diet rich in glucose may enhance candidal 
adhesion to epithelial cells (Samaranayake & MacFarlane, 1982b) and 
acrylic denture surfaces (Samaranayake & MacFarlane, 1980).
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1.2.5 Salivary Iactoferrin
Salivary Iactoferrin, the exocrine gland equivalent of 
transferrin, is an iron-binding glycoprotein synthesised by serous 
epithelial cells and neutrophils (Arnold, Brewer, Gauthier, 1980). 
Lactoferrin has been shown to be an active antifungal agent 
(Kirkpatrick et al., 1971; Arnold et al., 1980). Iron-unsaturated 
lactoferrin has an iron binding capacity sufficient to inhibit optimal 
grcwth of albicans but, it loses this capability in an iron- 
saturated environment (Kirkpatrick et al., 1971).
The immune function of lactoferrin in candidal infection is 
not clear. Lactoferrin concentration in parotid saliva from patients 
with chronic mucocutaneous candidosis has been reported to be 
comparable to that in control subjects (Kirkpatrick et al., 1971).
1 .2.6 Salivary Lysozyme
Lysozyme is a low molecular weight protein originating in the 
oral cavity from saliva, gingival crevicular fluid and 
polymorphonuclear leucocytes (Fukui, Fukui, Mbriyama, 1981). It has 
a growth inhibitory effect on several Candida species (Tobgi, 
Samaranayake, MacFarlane, 1988) and has the ability to potentiate the 
antifungal effect of amphotericin B (Collins & Pappagianis, 1974). 
Ultrastructural studies have shown lysozyme to alter Candida cell 
membrane permeability (Marquis et al., 1982).
1.2.7 Salivary Histidine-Rich Polypeptides
The initial findings of an in vitro study showed that human 
parotid salivary histidine-rich polypeptides had fungistatic and 
fungicidal activity towards C;_ albicans at very low concentrations
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(Pollock et al., 1984). However, the antifungal activity observed was 
strain-dependent.
1 .2.8 Salivary Tmmunoglchnlin A (IgA)
It has been estimated that about 100mg of salivary IgA is 
secreted daily in saliva, along with relatively smaller amounts of IgG 
and IgM (Roitt & Lehner, 1983). As salivary IgA is more resistant to 
proteolytic degradation by bacterial hydrolases than other 
iriinunoglobulins, this renders it capable of continuing function on the 
oral mucous membranes(Jeganathan et al., 1987).Therefore, salivary IgA 
is quantitatively and qualitatively the most important immunoglobulin 
secreted in saliva. Accumulating evidence suggests that dimeric 
salivary IgA is produced locally in the salivary glands by plasma 
cells and is different than monomeric IgA produced in the serum (Dolby 
et al., 1 981 ).
Titers of salivary anticandidal IgA have been shown to 
correlate with isolation of candidal species from the oral cavity 
(Jeganathan et al., 1987). Thus titres were low in non-carriers and 
high in clinically infected subjects (Lehner, 1965), while 
asymptomatic Candida carriers had anticandidal IgA levels intermediate 
between those of non-carriers and candidosis patients (Epstein et al., 
1982). Two subclasses of IgA (IgA1 and IgA2) exist in approximately 
equal proportion in oral secretions but, a recent study has shown 
salivary IgA1 subclass antibodies are produced selectively in response 
to clinical candidal infection (Jeganathan et al., 1987).
Studies on the significance of salivary IgA defence against 
candidal infection have yielded conflicting results. Reduced
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concentrations of salivary IgA anticandidal antibodies have been 
reported in patients with chronic mucocutaneous candidosis (Chilgren 
et al., 1967; Lehner, Wilton, Ivanyi, 1972). Secretory IgA has been 
shown to inhibit the adhesion of albicans to epithelial cells 
(Vudhichamnong, Walker, Ryley, 1982). Since newborn infants lack 
salivary IgA, it is believed that the secretory IgA content of human 
breast milk may be responsible in part for the lower incidence of 
thrush in breast-fed infants, compared with that in bottle-fed 
neonates (Ludlam & Henderson, 1 942). On the other hand, oral 
candidosis often persists in spite of a locally detectable salivary 
IgA response (Epstein et al., 1982), and recurrent candidal infections 
may develop in the presence of specific IgA in secretions (Gough et 
al., 1984). These studies suggest that salivary IgA alone lacks the 
ability to eliminate the yeast, although its presence may limit the 
development of infection (Lehner et al., 1972). The susceptibility of 
salivary IgA molecules to degradation by proteinases produced by 
Candida species may partly explain the inability of salivary IgA to 
protect against oral candidosis (Reinholdt, Krogh, Holmstrup, 1987).
1.2.9 Salivary Blood Group Antigens
It has been realised that ABO blood group antigens are not 
confined to the red blood cells but are secreted in body fluids and 
other secretions particularly saliva (Ferguson, 1975). The inherited 
inability to secrete blood group substances has been linked with 
susceptibility to several infections including candidosis (Blackwell, 
1989). Buccal epithelial cells of secretors have been shown to bind 
Candida blastospores in lesser numbers than non-secretors (May, 
Blackwell, Weir, 1986). An increased incidence of non-secretors has
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been reported in asymptomatic oral Candida carriers (Burford-Mason, 
Weber, Willoughby, 1988) and in patients with candidal infection (May 
et al., 1 986).
It has been shown that the ability to secrete blood group 
substances is inherited in a Mendelian fashion controlled by a pair of 
allelomorphic genes, Se and se with Se dominant over se (Ferguson, 
1975). As a consequence, individuals who are either homozygous 
(SeSe) or heterozygous (Sese) are secretors, while homozygous (sese) 
individuals are non-secretors.
1.2.10 Phagocytosis
Polymorphonuclear leucocytes and monocytes can phagocytose 
and kill Candida even in the absence of the specific opsonising 
antibodies and the mechanism of killing is mediated principally by 
myeloperoxidase and hydrogen peroxide (Lehrer, 1978). Therefore, 
defective polymorphs or monocytes predispose to candidosis. This is 
apparent in patients with primary immunodeficiency who usually have a 
qualitative rather than a quantitative defect in polymorph or 
macrophage function. Secondary immunodeficiency, such as that 
resulting from some advanced malignancies or their treatment may also 
affect phagocytosis as will be discussed later. However, current 
evidence points to phagocytic cells as major components of defence 
against deep-seated rather than superficial candidosis (Hurtrel, 
Lagrange, Michel, 1980).
1.2.11 Specific Immunity
Mcst of the specific antibodies to Candida in the serum are 
of the IgG class (Roitt & Lehner, 1983). Antibody and complement
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cannot kill candidal organisms directly but can enhance phagocytosis 
by polymorphs and macrophages (Lehrer, 1978).
Impairment of T-cell mediated delayed hypersensitivity in 
response to Candida is probably the basic defect in patients with 
mucocutaneous candidosis (Kirkpatrick, 1984). In AIDS patients, the 
T-cell mediated immunity is deficient due to selective reduction in 
the number of T-helper cells which are infected with the Human 
Immunodeficiency Virus (HIV). In these patients oral candidosis is a 
common manifestation and may affect up to 50 per cent of such patients 
(Klein et al., 1984). This may be the only specific oral finding in 
HIV infected patients (Chandrasekar & Molinari, 1985). The frequency 
of candidal isolation and oral candidosis has been shown to correlate 
with a reversed T-helper / T-suppresssor cell ratio (Korting et al.,
1988).
1.2.12 Interaction with Other Oral Commensal Organisms
In vitro, lactobacilli have been claimed both to enhance 
(Isenberg, Berkman, Carito, 1960) and to inhibit (Young, Krasner, 
Yudofsky, 1956) candidal growth. In vivo there was a reported 
correlation between salivary lactobacilli levels and candidal count 
(Parvinen & Larmas, 1981) but this relationship was not found in 
preschool young children (Glass, 1951).
C. albicans can colonise the mucous membranes of gnotobiotic 
animals in higher numbers than conventional animals (Phillips & 
Balish, 1366). Moreover, bacterial constituents of the human oral 
flora can suppress colonisation of albicans in gnotobiotic mice 
(Liljemark & Gibbons, 1973).
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In theory, some organisms may compete with Candida species 
for available nutrients (Knight & Fletcher, 1971) or binding sites on 
the host surface (Liljemark & Gibbons, 1973). The latter mechanism 
may explain in part why Streptococcus salivarius and mitior, which 
have been shown to adhere well to mucosal surfaces, were able to 
suppress oral candidal growth, whereas Strep, mutans which is known to 
adhere poorly to oral epithelium had little inhibitory effect (Gibbons 
& van Houte, 1975; Samaranayake & MacFarlane, 1982a). Other studies 
have suggested that some bacterial constituents of the oral microbial 
flora may secrete substances which are toxic or inhibitory to Candida 
species (Kennedy, 1 981).
1 .3 RISK FACTORS IN CRAL CANDIDAL INFECTION
1.3.1 Iren Deficiency
Cawson (1963) was the first to draw attention to the 
relationship between iron deficiency and oral candidosis when he 
reported two cases of chronic atrophic candidosis associated with iron 
deficiency anaemia which resolved after iron replacement therapy 
alone. Thereafter many investigators reported an association between 
iron deficiency (although not necessarily anaemia) and chronic 
mucocutaneous candidosis (Higgs & Wells, 1972), atrophic glossitis and 
angular cheilitis (Fletcher et al., 1975) and chronic atrophic 
candidosis (Rose, 1968). Challacombe (1986) reported sideropenia as 
being detected in 30 per cent of patients with oral candidosis. 
However, this has not been the opinion of other investigators (Jenkins
et al., 1977; Samaranayake & MacFarlane, 1981a). Experimental animal
model studies have indicated that iron deficient animals were less
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able to eliminate Candida from their oral tissues compared to 
haematologically normal animals (Rennie et al., 1983).
Iron plays a modulating role in the activity of both lysozyme 
and lactoferrin (Kirkpatrick et al., 1971), so iron deficiency may 
canprcmise these local host defence factors. Iron deficiency may 
produce an impairment of iron dependent enzyme systems which in turn 
may affect the metabolism and hence the kinetics of rapidly dividing 
oral epithelium (Rennie, MacDonald, Dagg, 1984). The hyperkeratosis 
and atrophy of the epithelium reported in iron deficient individuals 
(Rennie et al., 1984) and in experimental animals (Rennie & MacDonald,
1982) may provide a suitable environment for candidal infestation.
Cell-mediated immunity has been reported as being depressed 
in iron deficiency. Impairment of lymphocyte transformation and 
migration inhibition factor production in response to stimulation with 
candidal antigen in iron-deficient individuals has been reported both 
in vivo and in vitro (Joyson et al., 1972). This immune impairment 
was restored after iron therapy (Joysen et al., 1972; Fletcher et al., 
1975). Decreased peripheral blood lymphocyte count (Fletcher et al.,
1975), impaired phagocytosis and antibody production (Samaranayake, 
1986) have also been reported in association with iron deficiency but, 
low peripheral blood lymphocyte count may respond to iron therapy 
(Fletcher et al., 1975).
1.3.2 Vitamin Deficiency
Jenkins et al. (1977) studied the haematological status of 25 
patients with chronic hyperplastic candidosis and found seven patients 
who were folic acid deficient compared to a single patient in 25
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control subjects. Subsequent studies have shown chronic atrophic 
candidosis to occur in a significant number of patients with folate 
deficiency (Samaranayake & MacFarlane, 1981a; Challacombe, 1986). 
However, in one study folic acid replacement alone was not able to 
resolve the candidal infection (Samaranayake & MacFarlane, 1981a).
Hypovitaminosis A was detected in seven of 12 patients with 
mucocutaneous candidosis (Montes, Krumdieck, Cornwell, 1973). Animal 
experiments revealed that mice treated with vitamin A (Cohen & Elin, 
1974) or vitamin C (Rogers & Balish, 1980) showed increased resistance 
to candidal infection. However, these studies have not been 
substantiated as yet.
1 .3.3 Carbohydrate-Rich Diet
Chronic atrophic candidosis and angular cheilitis were 
reported in four patients consuming a high carbohydrate diet 
(Shuttleworth & Gibbs, 1960). Repeated oral sucrose rinsing can 
initiate chronic atrophic candidosis in healthy denture wearers and 
aggravate preexisting lesions in patients with chronic atrophic 
candidosis (Olsen & Birkeland, 1976). The in vitro study of Knight 
and Fletcher (1971) demonstrated that the growth of C. albicans in 
saliva was accelerated when supplemented with either glucose or 
sucrose. Sucrose and glucose may facilitate candidal adhesion to 
acrylic denture surfaces (Samaranayake, McGourtie, MacFarlane, 1980) 
and oral epithelium generally (Samaranayake & MacFarlane, 1982b). 
Recently, it has been shown that high concentrations of glucose can 
augment the iC3b receptors on C. albicans and increase resistance of 
the organism to phagocytosis (Gilmore et al., 1988).
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1.3.4 Denture-itelated Factors
Denture wearers have been reported to have a qualitative and 
quantitative increase in oral candidal isolation compared with dentate 
individuals (Parvinen, 1984). Candidal species had a propensity to 
proliferate on the fitting surface of the upper denture rather than 
the adjacent mucosa (Davenport, 1970). In edentulous subjects, 
Candida species were recovered in higher rates from the oral cavity of 
denture wearers than from edentulous non-denture wearers 
(Vandenbussche & Swinne, 1984). The importance of denture wearing in 
chronic atrophic candidosis was proven indirectly by Turrell (1966) 
who demonstrated that non-wearing of the dentures for a two week 
period was associated with resolution of the infection. The 
prevalence of denture stomatitis in selected poulations has been shown 
to vary from 27 per cent (Nyquist, 1952) to 67 per cent (Budtz- 
Jorgensen, 1981).
Traumatised soft tissues of denture bearing areas resulting 
from ill-fitting dentures may reduce tissue resistance against 
infection, and increase the permeability of the palatal epithelium to 
soluble candidal antigens and toxins (Budtz-Jorgensen, 1 978). 
Moreover, continuous wearing of the denture may keep Candida species 
in contact with the palatal mucosa for a long enough period to permit 
microbial metabolic products to cause inflammation (Bartels, 1965). 
Also, a close fitting denture may restrict the cleansing effect of the 
tongue and the free flow of saliva to the palatal mucosa, in addition 
to depriving the tissues of anticandidal salivary constituents (Budtz- 
Jorgensen, 1974). Thus, continuous wearing of the dentures has been 
reported to increase the prevalence of chronic atrophic candidosis 
(Budtz-Jorgensen, 1974).
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1 .3.5 Anti bacterial Antibiotics
Antibiotic therapy has been reported to increase oral 
candidal carriage in terms of frequency of isolation and density of 
growth (Johnston et al., 1967; Barlow & Chattaway, 1969; Odds & Evans, 
1980).
Early observations (Tomaszewski, 1951) reported cases of oral 
candidosis following therapeutic use of systemic penicillin, 
aureanycin and chloramphenicol. Repeated topical application of 
tetracycline has also been reported as capable of inducing oral 
candidosis in up to 67 per cent of patients (Lehner & Ward, 1970). 
Achrcmycin or terramycin, but not bacitracin, incorporated in 
periodontal packs have also been associated with the development of 
oral candidosis (Romanow, 1964). However, the latter antibiotic was 
only found to increase oral candidal isolation and not clinical 
infection.
In contrast, McKendrick, Wilson and Main (1967) investigated 
the oral flora of two groups of subjects with chronic bronchitis. The 
subjects of one group were treated with systemic tetracycline, while 
the other group received placebo for a period of six months and there 
were no significant differences in oral candidal isolation between the 
two groups. As a consequence, McKendrick (1968) concluded the lack of 
a relationship between the administration of tetracycline and 
occurrence of oral candidosis. However, the control group subjects 
also recieved tetracycline for acute exacerbations of their 
bronchitis. Nevertheless, it is worth mentioning that apart from the 
studies of McKendrick et al. (1967) and McKendrick (1968), the effect 
of antibiotic treatment on oral candidal colonisation has been
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compared with healthy control group subjects, who were medically 
different from the treated subjects. Therefore, such treated subjects 
may have been debilitated by illness prior to commencing antibiotic 
therapy.
Theoretically, when oral microbial flora has been exposed to 
an antibacterial antibiotic, sensitive organisms are suppressed or 
eliminated, whereas resistant organisms like yeasts may grow in 
abundance (Seelig, 1966). Therefore, candidal growth may be enhanced 
due to suppression of host bacteria competing with yeasts for 
nutrients (Knight & Fletcher, 1971) and attachment sites on the 
epithelial cells (Samaranayake & MacFarlane, 1982a).
Early studies proposed a direct stimulatory effect of 
antibiotics on candidal growth but this hypothesis is no longer 
accepted (Knight & Fletcher, 1971). Another possible mechanism is 
that some antibiotics may depress the host resistance to Candida. 
Aminoglycoside antibiotics have been reported to inhibit anticandidal 
activity of human neutrophil leucocytes in vitro (Ferrari et al., 
1980). On the other hand, the capacity of human serum to inhibit the 
growth of albicans was not affected by the systemic administration 
of therapeutic doses of tetracycline (Roth & Goldstein, 1961 ). The 
experimental study of Domer and Hector (1987) demonstrated that 
therapeutic doses of some antibiotics had no adverse effect on the 
systemic immune response to Candida. However, patients receiving 
prolonged broad spectrum antibiotics may already have depressed 
antimicrobial defenses due to their illness.
For a time it was suggested that alterations in vitamin 
biosynthesis and vitamin B deficiency in patients receiving antibiotic 
therapy may be factors in lowering host resistance, and predisposing
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to oral candidosis (Harris, 1950). However, the beneficial effect of 
vitamin replacement therapy in these cases was not consistent and 
appeared to have varying success (Tomaszewski, 1951; Romanow, 1964). 
In conclusion, more than one mechanism may operate in individuals 
receiving antibiotic therapy and predispose them to higher levels of 
oral candidal growth and infection. In addition, not all antibiotics 
have the same potential to predispose to secondary oral candidosis 
(Odds, 1988).
1.3.6 Gbrticostecoid Therapy
Patients receiving systemic corticosteroid therapy have been 
reported as having an increased prevalence of oral candidal carriage 
(Johnston et al., 1967; Odds & Evans, 1980; Thompson et al., 1986), 
and an increased predisposition to local and systemic candidosis (Folb 
& Trounce, 1970). Topical steroid application has also been 
implicated in the development of oral candidosis in man (Lehner & 
WSard, 1970; Epstein, Komiyama, Duncan, 1986) and in experimental 
animals (Budtz-Jorgensen, 1975). The use of inhaled steroids has also 
been reported to increase the incidence of oral candidosis (Milne & 
Crompton, 1974; Sahay, Chatterjee, Stanbridge, 1979). However, other 
studies have reported no effect of inhaled steroid therapy on oral 
rand-i dal carriage in asthmatic children (Godfrey, Hambleton, Konig, 
1974).
Not all steroids appear to have the same potential for 
predisposing to the development of secondary candidosis. long acting, 
but not short acting, steroids were associated with an increased 
incidence of candidal infection (Hurley, Balow, Fauci, 1975). Oral
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thrush developed after topical application of betamethasone valerate 
and triamcinolone acetonide, while hydrocortisone hemisuccinate or 
betamethasone sodium phosphate did not produce this side effect 
(Lehner & Ward, 1970; Sahay et al., 1979). It seems that the rate of 
absorption of the various topical steroids has an effect on the 
ability to develop secondary candidosis (Lehner & Ward, 1970) and the 
local effect to be dose-related (Sahay et al., 1979). Thus the 
incidence of oral candidosis secondary to topical oral use of steroid 
medications may be expected to be greater than that associated with 
the use of inhaled aerosols due to longer contact time in the oral 
cavity (Epstein et al., 1986). However, a simple mouth wash procedure 
after aerosol inhalation had no prophylactic benefit in reducing the 
incidence of oral candidosis (Sahay et al., 1979).
The mechanisms responsible for the development of secondary 
candidosis in association with the use of topical steroid medications 
are uncertain. This predisposition towards candidal infection appears 
not to be due to enhancement of candidal growth, as the steroids per 
se had no effect on the growth of albicans in vitro (Milne & 
Granpton, 1974). Knight and Fletcher (1971) have shown that patients 
who received corticosteroid therapy had a higher level of salivary 
glucose which may promote candidal growth. Steroid therapy can impair 
cell-mediated immunity (Budtz-Jorgensen, 1 975). Lymphocyte 
transformation in response to antigenic stimulation by Candida was 
depressed in a group of patients treated with high doses of 
corticosteroids (Folb & Trounce, 1970). Chemotaxis of polymorphs 
(Ward, 1966) and phagocytosis of C. albicans (Pallister & Wamock,
1989) were also adversely affected. Nevertheless, antibody production 
was not impaired by steroid therapy (Folb & Trounce, 1970; Budtz-
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Jorgensen, 1975). A recent in vitro study has shown dexaraethasone and 
triamcinolone acetonide to promote candidal adhesion to epithelial 
cells (Ghannoum & Abu Elteen, 1987).
Topical antifungal agents have proved effective in 
controlling secondary oral candidosis in steroid-treated patients, and 
may be prescribed prophylactically in conjunction with steroids until 
caipletion of therapy (Lehner & Ward, 1970; Epstein et al., 1986).
1 .3.7 Antineoplastic Chemotherapy and Irradiation
The oral carriage rate and quantity of candidal growth are 
increased in patients receiving antineoplstic chemotherapy compared to 
a healthy population (Samaranayake et al., 1984). Fungi such as 
Saccharcrnyces cerevisiae, which are generally considered non- 
pathogenic, may cause disease in such compromised patients (Kostiala,
1986). Trauma and drug-induced epithelial desquamation and ulceration 
in these patients may lead to haematogenous dissemination of Candida 
species (Dreizen et al., 1982). In contrast to these reports, Shipman 
(1979) found no relationship between oral candidal isolation and the 
administration of antineoplastic chemotherapy. The discrepancy 
between results of various studies may be partly due to differences in 
type, dose and duration of chemotherapy administered. In addition, 
not all the studies used similar microbial isolation techniques.
It is not clear whether this increased candidal infection was 
due to the underlying disease itself or was a result of the 
chemotherapy. Corticosteroids and antibiotics are frequently 
administered in addition to antineoplastic chemotherapy which adds to 
the confusion. However, a recent study has shown the use of
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antibiotics in various combinations with antineoplastic and 
corticosteroid drugs had no additional impairing effect on phagocytic 
cell function against C^_ albicans over that resulting from the 
antineoplastic chemotherapy alone (Pallister & Warnock, 1989). In 
haematological malignancies and lymphomas, neutropenia resulting from 
cytotoxic chemotherapy, bone marrow infiltration by lymphomatous cells 
and impaired B and T-cell function may be factors predisposing to 
candidosis (Dreizen et al., 1982). Neutrophils from leukaemic 
patients exhibit impaired phagocytosis and intracellular killing of 
C. albicans (Rosner et al., 1970).
In patients receiving radiotherapy, Candida species are 
recovered in higher numbers from the oral cavity, during and after 
completion of treatment than prior to commencement of therapy (Martin, 
Al-Tikriti, Bramley, 1981; Rossie et al., 1987). Patients who were 
originally free of Candida may acquire these organisms postirradiation 
and the density of growth seems to be dose-dependent (Rossie et al.,
1987). Therefore, some researchers considered that radiotherapy 
treatment is associated with a higher incidence of oral fungal 
infection (Schumacher, Ginns, Warren, 1964) whilst others were not of 
this opinion (Shipman, 1979).
The precise reasons for this increased candidal growth and 
infection have never been identified. Alterations in major and minor 
salivary gland function, structural changes in the oral mucosa, with 
increased keratinisation and atrophy as a result of irradiation have 
all been reported as being of significance (Robinson, 1976).
39
1.4 EACDCRS EREDISPOSINS DIABETIC PATI0WS TO INFECTIONS
1.4.1 Introduction
It is generally believed that there is an increased 
susceptibility to infections in patients with diabetes mellitus. 
Although the question of the prevalence of infections in diabetic 
patients is controversial, some infections are believed to occur with 
increased frequency in diabetic patients such as urinary tract 
infection, tuberculosis and superficial staphylococcal skin infections 
(Wheat, 1980). However, the reasons for this increased frequency of a 
variety of infections are likely to be complex and are not completely 
understood.
It is well known that severe infection can disturb 
carbohydrate, mineral and other aspects of metabolism in man (Rayfield 
et al., 1982). In diabetic patients particularly, this may render the 
control of diabetes more difficult and in some circumstances can be 
life threatening. Acute infections can adversely affect carbohydrate 
metabolism principally in two main ways; either directly by 
destruction of pancreatic islet cells by an infectious agent, or 
indirectly through antagonism of insulin action by certain hormones 
secreted in excess during infection such as growth hormone, glucagon 
or cortisol (Baird, 1987). Therefore, minor infections which may pass 
virtually unnoticed clinically in non-diabetics, may lead to serious 
sequalae in diabetic patients (Larkin, Frier, Ireland, 1985).
Although a significant correlation between the overall 
prevalence of infections and high plasma glucose level in diabetic 
patients has been described (Rayfield et al., 1982; Larkin et al.,
1985), this does not alone identify the reason of the claimed lower
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resistance to infection associated with poor glycaemic control , 
although several mechanisms are possible.
Since diabetics usually have normal serum levels of 
antibodies (Rayfield et al., 1982), much interest has been directed 
toward the function of polymorphonuclear leucocytes and cell-mediated 
immunity in diabetic patients. Impairment of various aspects of 
neutrophil function in diabetic patients have been described (Wilson,
1986) but their significance remain questionable.
1.4.2 Impaired Granulocyte Adherence
Granulocyte adherence to vascular endothelium is an important 
early event in the normal inflammatory response. Studies have shown 
this adherence to be defective in diabetic patients (Mowat & Baum, 
1971 ). This functional abnormality has been reported to correlate 
inversely with the fasting plasma glucose level and to be corrected by 
insulin treatment (Bagdade, Stewart, Walters, 1978). However, the 
role of impaired granulocyte adherence in candidal infection has not 
been determined.
1 .4.3 Abnormal Leucocyte Biociiemistry
Although glucose transport across the neutrophil cell 
membrane is independent of insulin (Wilson, 1986), neutrophils from 
diabetic patients have reduced glucose uptake, and low levels of 
lactate production (lactate is considered important for neutrophil 
function). This glucose uptake defect could be corrected by insulin 
in certain concentrations (Esmann, 1963). Polymorphs from diabetic 
patients exhibit a significant decrease in stimulated glucose
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oxidation and activity of the myeloperoxidase and hydrogen peroxide 
system (Qvist & Larkins, 1981) which may further affect the 
intracellular killing ability of these cells.
1 .4.4 Impaired Chemotaxis
Impaired chemotaxis of polymorphs has been reported in 
patients with diabetes mellitus (Mowat & Baum, 1971; Miller & Baker, 
1972) both in insulin-dependent and non-insulin dependent patients 
(Molenaar et al., 1976), as well as in rats rendered diabetic by 
alloxan therapy (Pereira, Sannomiya, Leme, 1987). Serum from diabetic 
patients may contain substances which could inhibit neutrophil 
chemotaxis, and insulin administration appears crucial for correction 
of this defect (Mowat & Baum, 1971; Pereira et al., 1987).
Impaired chemotaxis in diabetic patients may be an inherited 
defect in leucocyte function (Molenaar et al., 1976). However, this 
defective chemotaxis could also be the result of impaired granulocyte 
adherence reported in other studies (Bagdade et al., 1978).
1 .4.5 Tjqpaired Phagocytosis
Impaired polymorph phagocytic activity has been reported in 
diabetic patients with ketoacidosis (Bybee & Rogers, 1964), in poorly 
controlled diabetics without ketoacidosis (Bagdade, Root, Bulger, 
1974; Tan et al., 1975) and in mice with experimentally-induced 
diabetes (Saiki et al., 1980). In some of these studies the defect 
was restored after the correction of the metabolic state of the 
patients (Bagdade et al., 1974; Tan et al., 1975).
Experimental studies have shown that mouse macrophages 
recognise and bind microorganisms by means of "lectin-like" surface
42
receptors that interact with microbial cell wall sugars. In diabetes 
mellitus, the raised level of glucose in the tissue fluids may block 
the sugar specific "lectin-like" phagocyte receptors, leading to 
reduced binding of organisms to phagocytes with consequent reduced 
elimination of the potential pathogenic organisms (Weir, Blackwell, 
McLean, 1 981).
1.4.6 IDqpaired Intracellular Killing
In well controlled diabetic patients, the intracellular 
killing capacity of neutrophils to Staphylococcus aureus was 
comparable to that from control subjects (Repine, Clawson, Goetz, 
1980). Neutrophils from poorly controlled diabetics showed reduced 
intracellular killing capacity towards that organism (Tan et al., 
1975; Nolan, Beaty, Bagdade, 1978; Repine et al., 1980). This 
functional impairment has also been observed towards Escherichia coli 
(Rayfield et al., 1982).
In acute bacterial infections, neutrophils from diabetic 
patients, particularly those with poor diabetic control, fail to 
stimulate their bactericidal activity, although this does happen in 
neutrophils from non-diabetics (Repine et al., 1980). Although this 
functional neutrophil impairment was claimed to be corrected after 
institution of better glycaemic control and insulin therapy (Nolan et 
al., 1978; Repine et al., 1980), this finding does not have universal 
acceptance (Tan et al., 1975).
Recent studies have shown the intracellular killing capacity 
of neutrophils from diabetic patients to C. albicans to be impaired 
under conditions of hyperglycaemia and ketoacidosis (Wilson & Reeves,
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1986; Wilson, Tomlinson, Reeves, 1987). The proposed explanation was 
that, in diabetics, conversion of glucose to sorbitol reduced the 
available concentration of NADPH leading to inhibition of the 
oxidative killing mechanisms of neutrophils; this was normal in well 
controlled diabetic patients (Davies & Denning, 1972).
1 .4.7 Tiqpaired Cell-Mediated Immunity
A reduced cell-mediated immune response has been reported in 
diabetic patients to staphylococcal antigens (Casey, Heeter, 
Klyshevich, 1 977) and to tubercle bacillus in mice with 
experimentally-induced diabetes (Saiki et al., 1980). This immune 
defect probably resides in lymphocytes rather than in serum (Casey et 
al., 1977). Peripheral blood lymphocyte transformation in response to 
phytohaemgglutinin was depressed in diabetic patients and directly 
proportional to the severity of diabetes (Delespesse et al., 1974). 
The effect of insulin therapy on the lymphocytic response remains 
controversial (Mahmoud etal., 1975).
In contrast, peripheral blood lymphocyte transformation in 
well controlled diabetic patients in response to phytohaemagglutinin 
(Casey et al., 1977) and to C^ albicans antigens (Ragab, Hazlett, 
Cbwan, 1972) was comparable to that of non-diabetic subjects and no 
relationship between serum glucose level and degree of immunological 
response was noted (Ragab et al., 1972).
1.4.8 Salivary Antimicrobial Factors
Reduced lysozyme activity has been observed in the saliva of 
diabetic patients (Velikov et al., 1985). In hamsters rendered 
diabetic with streptozotocin, salivary lysozyme and peroxidase
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activity was reduced but, insulin treatment was able to restore these 
functions to normal (Muratsu & Morioka, 1985).
Some researchers have claimed that there was a significant 
increase in the proportion of non-secretors of the blood group 
antigens among insulin-dependent diabetic patients compared to non­
insulin dependent diabetics (Blackwell et al., 1987). Inability to 
secrete these antigens was postulated as being responsible for an 
increased incidence of candidal infection (Blackwell, 1989).
1 .4.9 High Tissue and Salivary Glucose levels
Diabetic patients have a higher level of cutaneous glucose 
and lower level of lactic acid than non-diabetics (Kandhari et al., 
1969). These may be factors predisposing diabetic patients to more 
candidal skin infection than non-diabetic individuals.
Knight and Fletcher (1971) reported a significant correlation 
between salivary glucose and candidal growth in vitro in patients with 
diabetes mellitus. They concluded that the increased incidence of 
oral candidosis in diabetic patients could be attributed to higher 
levels of glucose in their saliva.
1.4.10 Miscellaneous Factors
The fourth complement component (C4), which is important in 
virus neutralisation, has been reported as being quantitatively and 
qualitatively deficient in insulin-dependent diabetics (Senaldi et 
al., 1988). Vascular insufficiency of small and medium-sized blood 
vessels in diabetic patients may compromise the host defences by 
reducing tissue blood flow and consequently decrease oxygen
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concentration of these tissues which in turn may promote the growth of 
microaerophilic and anaerobic organisms (Rayfield et al., 1982). The 
increase of the oral capillary basement membrane thickness in diabetic 
patients (Keene, 1975) may further impede leucocyte migration and 
prevent adequate diffusion of insulin and glucose to extravascular 
leucocytes at the site of microbial invasion.
Sensory neuropathy contributes to the development of 
neuropathic ulcers which may subsequently predispose to infection. 
Autonanic neuropathy affecting the bladder may result in urine 
retention and stasis which may predispose to bacteruria (Rayfield et 
aim, 1982). Therefore, both sensory and autonomic neuropathy may play 
an indirect role in promoting candidal infection in diabetic subjects.
1 .5 CRAL CANDIDAL OCBXNISATICN IN DIABETIC PATEHWS
Whether the prevalence of oral candidal carriage in patients 
with diabetes mellitus is higher than that in non-diabetic individuals 
has not been clearly defined. Substantial evidence points towards a 
greater prevalence among diabetics (Weinstein et al., 1960; Bhatt, 
Doshi, Bilimoria, 1983; Bartholomew, Rodu, Bell, 1987; Lamey et al., 
1988) where a rate of oral candidal carriage between 30 per cent 
(Johnston et al., 1967) and 80 per cent (Weinstein et al., 1960) has 
been reported. Among Candida carriers, diabetic patients were shown 
to have a higher density of oral candidal colonisation than non­
diabetics (Tapper-Jones et al., 1981; Agarunowa et al., 1986). On the 
other hand, some early studies did not find a relationship between 
diabetes mellitus and oral candidal colonisation (Mehnert & Mehnert, 
1958; Peters, Bahn, Barens, 1966). Variations in candidal isolation 
and culturing techniques used by different researchers (Table 1.1), in
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addition, to variations in clinical status of the subjects studied 
probably led to conflicting results which make comparison of data 
difficult and confusing.
Study
Yeast
isolation
(%)
Sampling
technique
Mehnert & Mehnert (1958) 50 Whole saliva
Weinstein et al. (1960) 80 Whole saliva
Peters et al. (1966) 46 Oral swabs
Johnston et al. (1967) 38 Sabouraud mouth 
rinse
Bar lew & Chattaway (1969) 62.5 Oral swabs
Farrnan and Nutt (1976) 46.2 Oral swabs
Odds et al. (1978) 41 Mouth wash
Tapper-Jones et al. (1981) 60 Imprint culture
Bhatt et al. (1983) 58 Oral swabs
Bartholomew et al. (1987) 75 Cytology
Banoczy et al. (1987) 34.5 Special diagnostic 
kit
Fisher et al. (1987) 51 Concentrated rinse
Lamey et al. (1988) 57 Concentrated rinse
Pohjamo et al. (1988) 56.8 Special diagnostic 
kit
Hill et al. (1989) 50 Oral swabs
1 .1 Candidal isolation rates from the oral cavity of diabetic 
patients and isolation techniques used in different 
studies.
47
The contention that poor glycaemic control in diabetic 
patients is associated with increased oral candidal colonisation is 
controversial. Odds, Evan and Taylor (1978) and Hill et al. (1989) 
related quantitatively the extent of oral candidal colonisation to the 
quality of glycaemic control, while other studies showed oral candidal 
carriage to decrease after improvement of glycaemic control in 
diabetic patients (Odds & Evans, 1 980). However, recent 
investigations have emphasised the lack of a relationship between oral 
candidal carriage and quality of diabetic control (Bartholomew et al., 
1987; Lamey et al., 1988; Fohjamo et al., 1988). Furthermore, factors 
such as type of diabetes mellitus or method of glycaemic control 
(Tapper-Jones et al., 1981; Lamey et al., 1 988) as well as the 
presence of complications, such as diabetic retinopathy (Bartholomew 
et al., 1987), seem to bear no relationship to oral candidal carriage.
1.6 CANDIDAL INFECTION OF THE ORO-FACIAL REGION IN DIABETIC
PATI0WS
The conclusive evidence that diabetes per se increases 
susceptibility to candidal infection derived from experiments on 
animals rendered diabetic by alloxan treatment (Hurley, 1966). These 
animals were more susceptible to cutaneous or systemic candidosis. 
Unfortunately, because of the time at which these studies were 
undertaken no detailed analysis of the immunological status was 
performed.
1.6.1 Median Rhanboid Glossitis
Median rhomboid glossitis, or central papillary atrophy of 
the tongue, was previously considered to be a developmental anomaly,
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caused by a retention of the tuberculum impar (small median elevation 
of the tongue which arises between the distal and lateral lingual 
region) during embryonic development (Martin & Howe, 1983). Cooke 
(1975) had previously commented on the possibility of median rhomboid 
glossitis being a form of oral candidosis.
Additional evidence for the role of candidal species in 
median rhomboid glossitis was provided by the demonstration of a 
correlation between the incidence of central papillary atrophy in 
diabetics and the finding of C. albicans mycelia in smears from the 
lesions (Farman, 1976; Farman & Nutt, 1976; Farman, 1977). In 
relation to this, rats rendered diabetic by streptozotocin developed 
median rhomboid glossitis-like lesions after intraoral inoculation of 
C. albicans while similarly inoculated control animals did not develop 
oral candidosis (Dourov & Coremans-Pelseneer, 1987).
The prevalence of central papillary atrophy in diabetic 
patients has been reported to be between 14.2 and 17.7 per cent, 
whilst the prevalence was between 0.22 and 2.56 per cent in the 
general population (Farman & Nutt, 1976). As species morphologically 
identical to Candida mycelia were found in only 24 per cent of cases 
of central papillary atrophy (Farman, 1976), it appeared that the 
condition may not have been caused in all cases by Candida species, 
and a cause and effect relationship was considered unproven. In 
addition, the prevalence of the lesion could not be related either to 
diabetic treatment or to the degree of glycaemic control (Farman,
1976).
Thickening of the basement membrane and proliferation of the 
endothelial lining of the oral vasculature in diabetic patients have 
been reported as being part of generalised phenomenon (Keene, 1975).
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Histological examination of biopsy specimens from diabetic patients 
with central papillary atrophy revealed thickening of the capillary 
walls within the lamina propria (Farman & Nutt, 1976). This may 
impair the blood supply, and then the decreased local tissue 
resistance could predispose to candidosis.
Due to the rarity of central papillary atrophy in the general 
population and its high frequency of occurrence in diabetic patients, 
Farman (1976) suggested that patients with this lesion should be 
screened for possible diabetes mellitus. However, the author admitted 
that central papillary atrophy was a clinical rather than a 
pathological entity, and that other conditions such as geographic 
tongue could not be excluded from the differential diagnosis.
1.6.2 Chronic Atrophic Candidosis
The aetiology of chronic atrophic candidosis is 
multifactorial but, infection by Candida species has been shown to be 
of significance (Budtz-Jorgensen, 1974). It has been proposed that 
diabetes mellitus promotes the growth of Candida species in the oral 
cavity (Knight & Fletcher, 1971) and this was a systemic predisposing 
factor encouraging the alteration of C^ albicans from commensalism to 
parasitism and subsequent initiation of chronic atrophic candidosis in 
denture wearers (Budtz-Jorgensen, 1981). Denture wearing has been 
associated with a substantial increase in the frequency of oral 
candidal isolation in patients with diabetes mellitus (Tapper-Jones et 
al., 1981; Fisher et al., 1987).
A literature search revealed only occasional reports linking 
chronic atrophic candidosis and diabetes mellitus. Cawson (1965)
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reported a case of chronic atrophic candidosis in a patient with 
poorly controlled diabetes mellitus. The prevalence of this condition 
has been shown generally to be higher in diabetics over that in 
denture status matched non-diabetic individuals (Lamey et al., 1988). 
In contrast, other studies could not demonstrate this association 
(Peters et al., 1966; Phelan & Levin, 1986).
1.6.3 Angular Cheilitis
C. albicans is the organism most commonly isolated from the 
lesions of angular cheilitis (MacFarlane & Helnarska, 1976). The 
observation that angular cheilitis lesions underwent resolution after 
local antifungal treatment of the intraoral infection alone (Cawson, 
1963) has led to the suggestion that oral candidal colonisation is an 
aetiologic factor in the development of angular cheilitis. In the 
light of the substantial increase in the oral candidal colonisation in 
diabetic patients (Bartholomew et al., 1987), a higher incidence of 
angular cheilitis in diabetic patients could be expected.
Burman, Bartels and Bailey (1 956) reported a case of 
persistent angular cheilitis in an undiagnosed diabetic patient. The 
lesion was dramatically improved after correction of the 
hyperglycaemic state. Exacerbation and remission of the lesion was 
noticed to be associated with the rise and fall in the patient's blood 
glucose in spite of antifungal therapy.
1.6.4 Chronic Candidosis
Chronic mucocutaneous candidosis is a group of conditions 
characterised by chronic candidal infection, usually affecting skin 
and nails as well as mucous membranes of the mouth and vagina (Odds,
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1988). The wide clinical variation seen in affected cases has allowed 
differentiation to be made between those patients with and without 
detectable endocrine disease (Kirkpatrick, 1984).
The association of chronic mucocutaneous candidosis with one 
or more endocrinopathies constitutes what is known as the Candida 
endocrinopathy syndrome (Odds, 1988). Diabetes mellitus is one of the 
associated endocrinopathies (Kirkpatrick & Bennett, 1971 ), although 
diabetes mellitus arising from non-autoimmune mechanism is believed 
not to be associated (Porter & Scully, 1986).
Chronic mucocutaneous candidosis is a rare form of candidal 
infection. However, according to Lehrer (1966) oral candidosis is 
generally classified into acute (acute pseudomembranous candidosis and 
acute atrophic candidosis) and chronic (chronic atrophic candidosis 
"denture stomatitis" and chronic hyperplastic candidosis) forms. 
Although this classification is far from ideal, it is nevertheless 
widely accepted clinically. Denture stomatitis is further classified 
into Type 1 which is a simple localised inflammation of the denture 
bearing mucosa, Type 2 a generalised simple inflammation, and Type 3 a 
granular type commonly involving the central part of hard palate 
(Newton, 1962).
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CHAPTER TWO
ADHESION OF CANDIDA SPECIES TO EPITHELIAL AND ACRYLIC SURFACES:
REVIEW CF LTIEUmJKE
2.1 INTRODUCTION
It is generally accepted that microbial adhesion to host 
surfaces is an essential first step in the process of colonisation and 
subsequent infection (Gibbons & van Houte, 1975). During the past 
decade extensive research have been undertaken to elucidate the 
mechanisms of bacterial adhesion to host cells and surfaces but, the 
knowledge gained has been rarely translated into approaches for 
modification or prevention of infection.
Candida species, particularly albicans have been shown to 
adhere in vitro to a variety of body cells and surfaces including 
buccal epithelium (Kimura & Pearsall, 1978), vaginal epithelium (Sobel 
et al., 1981), urinary epithelium (Centeno et al., 1983), and to a 
fibrin platelet matrix (Samaranayake, McLaughlin, MacFarlane, 1988) as 
well as to dental resin materials (Samaranayake et al., 1980). 
Candidal adhesion to the aforementioned cells and surfaces have been 
studied to determine factors relevant to the pathogenesis of candidal 
infections. At present, the importance of candidal adhesion in 
pathogenesis is only partially defined and the contention that 
virulence of Candida depends on adhesion is based only on association 
(McCourtie & Douglas, 1984; Ghannoum & Abu Elteen, 1986). Whether or 
not a particular form of adhesion observed jln vitro plays a role in 
colonisation or infection in vivo is a matter of debate. Initial 
studies (McCourtie & Douglas, 1984; Barrett-Bee et al., 1985)
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suggested a correlation between candidal adhesion and virulence. If 
so, factors or mediators that affect the adhesion in vitro should be 
evaluated in vivo.
2.2 YEAST CEUj FACTORS AFFECTING CANDIDAL ADHESION TO EPITHELIAL
SURFACES
2.2.1 Candida Species and Strain Variations
C. albicans has been reported to adhere in vitro to 
epithelial cells in greater numbers than do other Candida species 
(King, Lee, Morris, 1980; Sobel et al., 1981; Ray, Digre, Payne, 
1984). Some species like stellatoidea and Ct_ tropicalis showed 
inconsistent and lesser degrees of adherence capability (King et al., 
1980; Ray et al., 1984), whereas C. parapsilosis, C. guilliermondii, 
C. krusei and (L_ pseudotropicalis have been reported to show little or 
no adhesion capability (King et al., 1980; Ray et al., 1984). After 
growing different candidal species in sugar-rich medium, only C. 
albicans exhibited marked increase in adhesion to epithelial cells 
compared with the same organisms grown in a medium of relatively low 
sugar content, while C. guilliermondii and C. pseudotropicalis did 
not show any enhanced adhesion (Critchley & Douglas, 1985).
Differences in adhesion capability between strains of the 
same species were less obvious. Strains of albicans isolated from 
patients with candidosis showed increased adhesion in vitro over those 
from asymptomatic carriers (Kearns, Davies, Smith, 1983; Segal, 
Soroka, Schechter, 1984). However, this was not the case in all the 
strains studied (Kearns et al., 1983). McCourtie and Douglas (1984)
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found C;_ albicans strains isolated from patients with candidal 
infections were able to show enhanced adhesion after being grown in a 
sugar-rich media, while strains isolated from asymptomatic carriers 
did not show enhanced adhesion. Recently, it was reported that some 
pathogenic strains of C. albicans were capable of switching reversibly 
between two general phenotypes (white or opaque). White cells were 
found to be significantly more adhesive to epithelial cells in vitro 
when compared with the opaque cells (Kennedy et al., 1988).
2.2.2 Candida Cell Viability
Although yeast cell viability is not essential for adhesion 
(Lee & King, 1983), viable candidal cells adhere in vitro in higher 
numbers to buccal epithelial cells (Kimura & Pearsall, 1978). Non- 
viable CL_ albicans with germ tubes showed no better adhesion than non- 
viable blastospores (Sobel et al., 1981). The non-viable candidal 
cells may be able to form a loose association with an epithelial cell 
but, viability is perhaps necessary for a stable adhesion 
(Vudhichamnong et al., 1982).
2.2.3 Candida Cell Concentration
Candidal adhesion to epithelial cells in vitro is dependent 
upon and correlates with yeast cell concentration in the incubation 
medium (Kimura & Pearsall, 1978; King et al., 1980; Samaranayake & 
MacFarlane, 1981b).
One explanation for the reported variations in the rate of 
candidal adhesion to epithelial cells in different studies is the 
inconsistency in concentration of the yeast to epithelial cells ratio 
used in different adhesion assays. This ratio varied considerably
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from 25:1 (Sobel et al., 1981) up to 1000:1 (King et al., 1980). 
However, using a very high concentration of candidal cells may lead to 
yeast co-adherence and clumping resulting in misleading results (Cox,
1983).
2.2.4 Candida Growth Phase and Temperature of Growth
C. albicans blastospores grown in stationary phase were found 
to adhere more than those grown in logarithmic phase (King et al., 
1980). Yeast cells harvested from cultures grown at 25°C adhered 
significantly greater than those harvested at 37°C (Lee & King, 1983; 
Kennedy & Sandin, 1988). At lower temperature the yeast cells produce 
short germ tube-like structures which might be responsible for the 
increased adhesion at that temperature (Kennedy & Sandin, 1988).
2.2.5 Candida Cell Morphology
Germ tube formation is repeatedly reported as being 
associated with significantly increased adhesiveness of albicans to 
epithelial cells (Kimura & Pearsall, 1978; Sobel et al., 1981; 
Samaranayake & MacFarlane, 1982a; Kennedy & Sandin, 1988). C. 
tropicalis and stellatoidea induced to form germ tubes in tissue
culture medium showed enhanced adhesion to epithelial cells when 
compared with the parent blastospore, while partial inhibition of 
germ tube formation by the enzyme cystein resulted in inhibition of 
yeast adhesion (Kimura & Pearsall, 1980).
Factors contributing to enhanced adhesion of Candida forming 
germ tube are not clearly understood. Ultrastructure studies have 
shown the germ tube region to adhere more frequently than do other 
portions of the fungi (Kimura & Pearsall, 1980). In addition, major
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differences in the cell wall structure at the site of germ tube 
formation have been reported (Kennedy & Sandin, 1988). Thus current 
evidence has indicated that the chemical entity on the yeast cell 
responsible for adhesion may be concentrated on the germ tube surface 
(Sandin et al., 1982). Moreover, there is evidence of specific 
antigens synthesised during germ tube formation which are not found on 
the yeast form (Casanova et al., 1989). Others have suggested that 
there are increased numbers of adhesion sites present on filamentous 
yeast surfaces, or alternatively increased surface area of yeast 
exposed to epithelial cells may be factors responsible for enhanced 
adhesion (Sobel et al., 1981).
2.3 EPTTHRTiTRL (SL FACTORS AETBCDNG CAMUDAL AEBESTON TO
EPITHELIAL SURFACES
C. albicans adhere readily to a variety of epithelial cells 
but, several in vitro studies have shown differential susceptibility 
of candidal adhesion to epithelial cells obtained from different 
sources (Sandin et al., 1987a).
2.3.1 Vciriaticns in Cell Type
Studies investigating adhesion of albicans to different 
types of epithelial cells have shown inconsistent results. Candida 
species have been shown to adhere more to buccal epithelial cells than 
to vaginal epithelial cells (Sobel et al., 1981; Sandin et al., 
1987a), urinary urothelial cells (Centeno et al., 1983; Sandin et al., 
1987a) and corneocytes (Collins-Lech et al., 1984). Whether these 
variations indicate differences in receptivity of epithelial cells 
obtained from different tissues has yet to be determined.
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2.3.2 Epithelial Op.ll Viability
Epithelial cell viability appears not to be necessary for
adhesion of C. albicans (Sandin et al., 1987b) which have been shown 
to adhere equally well to viable and non-viable buccal epithelial 
cells (Vudhichamnong et al., 1982). However, non-viable HeLa cells 
permitted adhesion of C. albicans in greater numbers than did viable 
cells (Samaranayake & MacFarlane, 1981b).
2.3.3 Circadian and Donor to Donor Variations
Epithelial cells obtained from different donors have shown 
considerable variations in adhesion values (King et al., 1980; Sobel 
et al., 1981; Collins-Lech et al., 1984; Sandin et al., 1987a). In 
addition, cells from the same donor show different adhesion values 
from day to day (King et al., 1980; Kearns et al., 1983; Sandin et 
al., 1987a). In general, these differences may reflect variations in 
the number or nature of the available surface receptors on the 
epithelial cells between donors and from day to day. Therefore, a 
constant collection time for epithelial cells is essential if the 
results of adhesion is to be compared between individuals.
2.4 QWUKXmnAL FACTORS AFEBCFING CANDIDAL ADHESION TO
EPITHELIAL SERFAGES
2.4.1 Temperature and Time of Contact
Candidal adhesion in vitro is time and temperature-dependent 
(Kimura & Pearsall, 1978). However, the effect of these factors may 
vary according to the media used for the adhesion assay (Kennedy & 
Sandin, 1988). There is evidence that candidal cells adhere optimally
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at a temperature of 37 C (Kimura & Pearsall, 1978; King et al., 1980). 
However, others have reported that yeast incubated at 28° C adhered 
better than those at 37°C (Segal, Lehrer, Ofek, 1982).
Although candidal adhesion to epithelial cells can be 
detected after only five minutes of incubation, it seems to be optimal 
after 60 minutes (King et al., 1980).
2.4.2 pH of the Incubation Mediim
The degree of adhesion of 0_ albicans to epithelial cells has 
been shown to vary with pH. Generally, it is enhanced under acidic 
than alkaline conditions (Samaranayake & MacFarlane, 1982a), probably 
due to enhanced germ tube formation in the acidic condition over that 
in an alkaline one (Sobel et al., 1981). In contrast, Cox (1983) 
found no significant change in adhesion when the pH was increased from 
4 to 11. However, the reported optimal candidal adhesion to 
epithelial cells at low pH in vitro may be relevant to the in vivo 
data showing oral candidal colonisation to be higher in acidic saliva 
(Young et al., 1 951 ).
Mammalian cells are endowed with a net negative surface 
potential resulting largely from ionisation of sialic acid residues of 
the glycocalyx (Gasic, Berwick, Sorentino, 1968). The cell surface of 
candidal species is likewise negatively charged. It is possible that 
the enhanced candidal adhesion observed under low pH conditions may 
be, in part, due to protonation of exposed cell surface functional 
groups which results in a reduction in surface electronegativity on 
the yeast and epithelial cells (Samaranayake & MacFarlane, 1982a).
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2.4.3 Saliva
Kimura and Pearsall (1978) used whole human saliva as an 
adhesion medium and reported increased candidal adhesion to buccal 
epithelial cells over that in phosphate buffered saline. Thereafter, 
Samaranayake and Macfarlane (1982a) reported increased candidal 
adhesion to epithelial cells monolayer pretreated with whole saliva.
2.4.4 Serum
Preincubation of epithelial cells with human serum resulted 
in a slight, but significant, reduction in the adhesion of albicans 
(Samaranayake & MacFarlane, 1982a). In addition, when fresh human 
serum was added to the assay medium, candidal adhesion to comeocytes 
was inhibited by 25 to 50 per cent (Ray et al., 1984). Nevertheless, 
heat inactivated serum in the assay medium showed no inhibition and 
possibly slight enhancement of adhesion, which may have been due to 
nutritional factors provided by serum (Ray et al., 1984).
The cell wall of candidal species can activate serum 
complement through the alternative pathway. Ray et al. (1984) 
proposed that the deposition of complement from fresh serum onto the 
yeast cell surface may cause alterations of the physical properties of 
the cell wall surface which alters their adhesion to epithelial cells.
2.4.5 Dietary Carbohydrates
Several reports have described increased adhesion of Candida 
species grown in media containing high concentrations of certain 
sugars (Samaranayake & MacFarlane, 1982b; Critchley & Douglas, 1985). 
Addition of glucose to the incubation mixture of C^_ albicans and 
vaginal epithelial cells increased candidal adhesion (Sobel et al.,
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1981) • Sucrose at very low concentrations enhanced significantly the 
adhesion of C._ albicans to epithelial cells in a concentration- 
dependent manner (Samaranayake & MacFarlane, 1982b).
After incubation of albicans in a defined concentration of 
different sugars, maltose was the most effective sugar, while glucose 
was the least effective in enhancing adhesion (Samaranayake & 
MacFarlane, 1982b). However, this enhancement seemed to be strain- 
dependent (McCourtie & Douglas, 1984) and may differ in different 
Candida species, or strains of the same species, incubated in the same 
sugar concentration (Critchley & Douglas, 1985).
Samaranayake and MacFarlane (1982b) proposed that the ability 
of the yeasts to produce extracellular metabolic product after 
incubation in sucrose-rich medium was responsible for enhanced 
adhesion of the organisms. That is presumably why lactose, which is 
not metabolised by Ct_ albicans, exhibited no influence on candidal 
adhesion to epithelial cells (Samaranayake & MacFarlane, 1981b). 
However, the enhanced candidal adhesion after incubation in sugar-rich 
medium appears to be associated with the ability of the organism to 
produce an additional fibrillar surface layer (McCourtie & Douglas, 
1981).
2.4.6 Salivary Immunoglobulins
Several studies have shown that salivary IgA (Kimura & 
Pearsall, 1978; Epstein et al., 1982) and secretory IgA isolated from 
human breast milk (Vudhichamnong et al., 1982) can inhibit adhesion of 
C. albicans to human oral epithelium in vitro. Salivary antibodies 
specific for C. albicans may be of several classes (IgA, IgG and IgM)
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but, only salivary IgA anticandidal antibodies have the ability to 
inhibit candidal adhesion to buccal cell significantly and in a 
concentration-dependent manner CEpstein et al., 1982).
The reported Inhibitory effect of secretory IgA is 
independent of its agglutination effect, as reduced randidal adhesion 
was shown with a subagglutination concentration of secretory IgA 
(Vudhichamnoog et al., 1982). The effectiveness of salivary IgA as an 
adhesion inhibitor when used within the physiological range of 
concentration requires to be studied.
2.4.7 Oral Obnoeesal Microflora
The experimental observation that albicans colonised 
epithelial cells from conventional rats in lower numbers than from 
gem-free rats (Liljemark & Gibbons, 1973), drew attention, to the fact 
that indigenous oral bacteria may interfere with candidal adhesion and 
colonisation of oral tissues.
Liljemark and Gibbons (1973) reported that secondary 
inoculation of Strep, salivarius and Strep, mitior, but not Strep, 
mntains, inhibited intraoral candidal colonisation in gem—free rats. 
Similarly in vitro, candidal adhesion was significantly reduced to 
cells previously exposed to Strep, salivarius and Strep, mitior 
(Samaranayake & MaeKarlane, 1982a) while strains of Strep, sanguis and 
Strep, mil lerj have shown little effect on yeast attachment (Makrides 
& MacEarlane, 1982). Adhesion of vaginal isolates of lactobacilli to 
vaginal epithelial cells reduced the subsequent adhesion of 
albicans to these cells (Sobel et al., 1981). Cox (1983) noticed 
reduced candidal adhesion to buccal epithelial cells which were 
already colonised with bacteria, and that the number of adherent
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candidal cells correlated inversely with the number of adherent 
bacteria. In contrast, preincubation of epithelial cells with 
piliated strains of Escherichia coli and Klebsiella pneumoniae 
resulted in a significantly increased subsequent 0_ albicans adhesion 
(Centeno et al., 1983; Makrides & MacFarlane, 1983).
The mechanisms by which some bacteria inhibit, and others 
promote, candidal adhesion to epithelial cells is not clear. Candidal 
adhesion is probably influenced by competition for mucosal receptors 
on epithelial cells with host bacteria (Samaranayake & MacFarlane, 
1982a). The fact that Strep, mutans, an organism with a relatively 
low affinity for epithelial cell receptors, did not significantly 
affect candidal adhesion (Liljemark & Gibbons, 1973; Samaranayake & 
MacFarlane, 1982a) supports this contention. On the other hand, pili 
of E. coli and K. pneumoniae could act as a bridging mechanism between 
epithelial cells and C. albicans, thus increasing candidal adhesion 
(Centeno et al., 1983; Makrides & MacFarlane, 1983).
2.5 ADHESION OF CMPIDA SPECIES TO ACRYLIC SURFACES
2.5.1 Introduction
Infection of the palatal mucosa with candidal species is 
generally accepted as a prominent aetiological factor in chronic 
atrophic candidosis (Budtz-Jorgensen, 1974) the commonest form of oral 
candidosis (Odds, 1988). The fact that Candida species are recovered 
more frequently and in higher counts from the fitting surface of the 
upper denture than from the palatal mucosa (Davenport, 1970) lends 
support to the theory that acrylic dentures may act as a reservoir of 
infection.
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There are few studies which have investigated the adhesion of 
yeasts to acrylic surfaces. The study of Samaranayake and MacFarlane 
(1980) was the first to give informations in that field. Although 
many factors affect candidal adhesion to acrylic surfaces in vitro 
(Samaranayake et al., 1980), the significance of these factors in vivo 
is uncertain.
2.5.2 Effect of Dietary Carbohydrates
Candida species grown in media containing dietary sugars 
showed significantly increased adhesion to acrylic surfaces, in a 
concentration-dependent manner, than those grown in media devoid of 
these sugars (Samaranayake & MacFarlane, 1980; McCourtie & Douglas, 
1981). However, not all sugars have had the same influence on 
adhesion. Galactose and sucrose were able to induce maximal 
enhancement (McCourtie & Douglas, 1981) while lactose and xylitol had 
a negligible effect on candidal adhesion (Samaranayake et al., 1980). 
Candida grown in media containing a high concentration of certain 
sugars undergoes changes in cell surface composition which may 
facilitate adhesion to acrylic surfaces (McCourtie & Douglas, 1981). 
Ultrastructural studies have revealed the presence of an additional 
fibrillar floccular layer, probably an extracellular metabolic 
product, when yeasts are grown in a high sugar concentration media 
(Samaranayake & MacFarlane, 1980; McCourtie & Douglas, 1981).
In the light of these findings one may expect denture wearers 
who frequently have a carbohydrate-rich diet to have a high candidal 
colonisation to their dentures. This is relevant to the observation 
of Olsen and Birkeland (1976) that a sucrose rinse initiated or 
aggravated denture stomatitis in a group of denture wearers.
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2.5.3 Effect of Saliva
Incubation of cold-cured acrylic resin in whole saliva for 30 
minutes inhibited adhesion of albicans (Samaranayake et al., 1980; 
McCourtie & Douglas, 1981; McCourtie, MacFarlane, Samaranayake, 
1986a). At the same time, saliva coating of heat-cured acrylic resin 
was found to increase adhesion of C«_ albicans and to decrease adhesion 
of C. tropicalis (Minagi et al., 1986). Discrepancies in methodology, 
Candida species and strains and adhesion surfaces employed may explain 
these apparent contradictions.
r^ ie .ill vitro inhibitory effect of salivary pellicle on 
candidal adhesion may be paralleled by the clinical observations of 
increased yeast colonisation of the upper acrylic plates fitted to 
monkeys with reduced salivary flow (Olsen & Haanaes, 1977).
2.5.4 Effect of Serum
C. albicans exhibited enhanced adhesion to acrylic surfaces 
preincubated in human serum (Samaranayake et al., 1980; McCourtie et 
al., 1986a). The conclusion of Nyquist (1952) that trauma is an 
aetiological factor in chronic atrophic candidosis is relevant to 
these findings, where the inflammatory exudate coating the surface of 
the denture could enhance candidal adhesion and colonisation of the 
denture.
2.5.5 Effect of Oral Cbmnensal Microflora
The role played by oral bacteria in affecting candidal 
adhesion to acrylic denture surfaces has been little studied and the 
results are conflicting. Samaranayake et al. (1980) reported a 
significant reduction in the number of yeast cells which adhered to
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acrylic strips precoated with Strep, salivarius. In that study the 
bacterial adhesion was scanty and the yeast cells adhered to areas 
free from streptococci. In contrast, Verran and Motteram (1987) 
reported a significant positive correlation between the number of 
adherent Strep, sanguis and Strep, salivarius on acrylic surfaces and 
the number of adherent C. albicans. Yeast cells tended to adhere to 
the already adherent streptococci, which appeared to provide a 
suitable surface for adhesion of C. albicans. Moreover, C. albicans 
adhered more firmly to acrylic surfaces when the yeast was incubated 
simultaneously with Strep, mutans in sucrose-containing incubation 
medium (Branting, Sund, Linder, 1989). The same authors also showed 
that yeasts incubated alone with acrylic surfaces in the same medium 
showed only loose adhesion. Interestingly, albicans when 
preincubated with a culture supernatant of Strep, salivarius showed a 
significant increase in adhesion to acrylic surfaces (Samaranayake et 
al., 1980).
2.6 EFFECT OF SPECIFIC ANTIFUNGAL AGENTS AND CHLORHEXIDINE
GLOOONME ON CANDIDAL ADHESION TO EPITHELIAL AND ACRYLIC
SURFACES
2.6.1 Effect of Specific Antifungal Agents
The evidence available for the effect of antifungal drugs on 
candidal adhesion to host surfaces are inconclusive. Pretreating 
denture acrylic with nystatin and amphotericin B in therapeutic 
concentrations has been shown to inhibit candidal adhesion for 48 and 
24 hours respectively and the extent of inhibition seemed to be dose-
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dependent (McCourtie, MacFarlane, Samaranayake, 1986b). On the other 
hand, albicans blastospores pretreated with subminimal inhibitory 
concentrations of amphotericin B (Brenciaglia et al., 1 986), 
ketoconazole (Sobel & Obedeanu, 1983; Shibl, 1985), nystatin and 
miconazole (Shibl, 1985) showed significantly reduced adhesion to 
epithelial cells. In addition, pretreatment of albicans with 
suJsninimal inhibitiory concentrations of amphotericin B resulted in 
reduced adhesion of this organism to plastic surfaces and fibrin 
matrices in vitro (Nugent & Couchot, 1986). In contrast, Odds and 
Webster (1988) found that clotrimazole, itraconazole or ketoconazole 
had no effect on candidal adhesion to vaginal epithelial cells 
regardless of whether the drugs were used to pretreat the fungi or the 
vaginal epithelial cells.
Pretreatment of albicans with subminimal inhibitory 
concentrations of the aforementioned antifungal agents was associated 
with inhibition of germ tube formation (Shibl, 1985; Brenciaglia et 
al., 1986; Nugent & Couchot, 1986). Other researchers have reported 
that growth of G;_ albicans in the presence of subminimal inhibitory 
concentrations of amphotericin B reduced synthesis of surface mannan 
(Al-Bassam et al., 1985). This cell wall component is known to be 
important in mediating candidal adhesion to epithelial surfaces 
(Critchley & Douglas, 1987a).
2.6.2 Effect of CMxatheaddine Gluconate
Pretreating acrylic surfaces with chlorhexidine in a two per 
cent concentration for 15 seconds inhibited adhesion of C^_ albicans 
(Samaranayake et al., 1980; McCourtie, MacFarlane, Samaranayake,
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et al., 1985). The adhesion was most inhibited when the organisms 
were grown in conditions known to promote adhesion such as sugar-rich 
media (McCourtie et al., 1985), or when adhesion was tested in the 
stationary growth phase (McCourtie et al., 1986b). a_ albicans 
strains isolated from active infections were more sensitive to the 
inhibitory effect than those isolated from carriers whilst other 
species such as C^ glabrata, C. parapsilosis, and C^ _ krusei were not 
affected (McCourtie et al., 1985).
Although saliva and serum are known to reduce the fungicidal 
activity of chlorhexidine, they do not affect the ability of 
chlorhexidine gluconate to inhibit candidal adhesion to acrylic 
surfaces (McCourtie et al., 1986a).
The ability of chlorhexidine to reduce candidal adhesion to 
acrylic surfaces is independent of its fungicidal effect since 
candidal species exposed to sublethal concentration of chlorhexidine 
showed reduced ability to adhere to acryic (McCourtie et al., 1986b). 
However, this treatment has been shown to have other adverse effects 
on Candida causing changes in the cell wall surface leading to loss of 
cytoplasmic components and coagulation of the nucleoproteins, in 
addition to inhibition of the budding process (Bobichon & Bouchet, 
1987).
A recent report has shown mouth rinsing with chlorhexidine in 
concentrations of 0.2 or 0.002 per cent reduced candidal adhesion to 
buccal epithelial cells both in vitro and in vivo (Tobgi, 
Samaranayake, MacFarlane, 1987).
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2.7 MECHANISMS CF ADHESION
Specific adhesion involves interaction of macromolecules on 
the surface of the microorganism and macromolecules on the surface of 
the substratum, while non-specific adhesion involves hydrophobic and 
electrostatic forces which hold the organism in contact with the 
substratum (Kennedy, 1988). A clear understanding of the mechanisms 
of candidal adhesion is necessary for successful prevention of 
candidal adhesion to surfaces in vivo.
Candidal cell walls are composed of three main 
polysaccharides; mannan, glucan and chi tin in addition to proteins and 
lipids (Sandin et al., 1982). The recent experimental evidence has 
indicated a role for mannoproteins in mediating yeast adhesion to 
epithelial cells (Sandin et al., 1982; Critchley & Douglas, 1987a) and 
suggested that the protein portion of the mannoprotein adhesin is more 
important than the carbohydrate moiety in mediating adhesion to 
epithelial surfaces (Critchley & Douglas, 1987a). Chitin, a candidal 
cell wall component which was thought to be concentrated on the inner 
layer of the candidal cell wall, was proposed to mediate yeast 
adhesion to epithelial cells (Segal et al., 1982). However, more than 
a single surface component may function in the process of adhesion 
(Kennedy, 1988) as additional studies have suggested that at least two 
morphologic classes of candidal adhesin exist; floccular and fibrillar 
adhesins. Tronchin, Poulain and Vemes (1984) noticed that adherent 
Candida cells tended to have a fibrillar cell wall coat of thin 
filaments arranged perpendicular to the cell surface composed mainly 
of mannoprotein, while non-adherent cells were devoid of this layer.
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In addition to variations in candidal cell wall biochemistry, 
the identity of the epithelial cell receptors also remains complex. 
Sugars including L-fucose (Sobel et al., 1981), D-mannose (Sandin et 
al., 1982), aminosugars, mannosamine, glucosamine and galactosamine 
(Collins-Lech et al., 1984) in addition to the saccharide-like cyclic 
alcohol-inositol (Ghannoum et al., 1986) have all been considered as 
likely candidal adhesion receptors determinants. Current evidence 
indicates that glycoprotien receptors may be most commonly involved in 
C. albicans adhesion (Critchley & Douglas, 1987b) and proposed that 
fibronectin, the cell surface glycoprotein, functions as a receptor 
(Skerl et al., 1984). According to recent research, the carbohydrate 
moiety of the epithelial cell surface glycoprotein is more important 
in mediating candidal adhesion (Critchley & Dougals, 1987b). However, 
more than one surface component on epithelial cells may serve a 
receptor function (Kennedy, 1988).
The mechanisms by which yeasts adhere to acrylic surfaces are 
not clearly identified. Some investigators implicated cell surface 
canponents (McCourtie & Douglas, 1981), whereas others have suggested 
non-specific Candida surface interactions such as cell surface 
hydrophobicity and elecrostatic forces may mediate or participate in 
adhesion (Koltz, Drutz, Zajic, 1985; Miyake et al., 1986). It was 
found that hydrophobic yeasts adhere to hydrophobic surfaces mainly by 
hydrophobic interactions, whereas in less hydrophobic yeasts 
electrostatic interactions seemed to play a more important role in 
adherence to solid surfaces (Nikawa et al., 1989). However, both 
hydrophobic and electrostatic forces, in addition to adhesion-receptor 
interactions, may operate in concert to achieve irreversible adhesion 
either to epithelial or non-bio logical surfaces (Kennedy, 1988).
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2.8 RELATIONSHIP CF ADHESION TO PA!3HX£NICTIY
Microbial adhesion to epithelial cells is recognised to be 
the initial step in the process of colonisation of the mucosal 
surfaces (Gibbons & van Houte, 1975). This adhesion enables the 
microorganism to resist elimination by the mucosal secretions/ and to 
proliferate under existing conditions. Epithelial cells with adherent 
organisms, as any other epithelial cells, exhibit a continuous 
desquamation process. Thus the progeny of these organisms must adhere 
to newly exposed cells if colonisation is to be maintained.
The ability of different Candida species to adhere to the 
epithelial cells (Kimura & Pearsall, 1980) may explain its ability to 
colonise the mucosal surfaces. Consequently, variation in adhesion 
capability between different species may partly explain why some 
species are recovered more often from the mucosal surfaces than 
others. This is well illustrated by C^_ albicans which adheres to 
buccal and vaginal epithelial cells to a much higher degree than the 
other Candida species (King et al., 1980), and at the same time is the 
species most commonly isolated from these sites as a commensal and 
pathogen (Odds, 1988). King et al. (1980) proposed a relationship 
between the relative ability of candidal species to adhere and their 
ability to colonise and subsequently infect mucosal surfaces.
C. albicans and stellatoidea both exhibit marked adhesion 
to epithelial cells and were found as cutaneous pathogens in a rodent 
model while non-adherent species were non-pathogenic (Ray et al., 
1984). The strains of C. albicans that showed greatest adhesion to 
epithelial cells in vitro were the most virulent to mice in vivo 
(McCourtie & Douglas, 1984). In contrast, strains with reduced 
ability to adhere in vitro to fibrin platelet matrix were relatively
avirulent in a rabbit endocarditis model (Calderone et al., 1985). A 
mutant strain of C. albicans# which adhered less readily in vitro to 
vaginal epithelial cells than the parent strain was less virulent in 
an animal model of vaginal candidosis (Lehrer et al., 1986). In this 
context, albicans strains isolated from active infections gave 
greater adhesion values than those isolated from commensal carriers 
(McCourtie & Douglas, 1984; Segal et al., 1984).
Under conditions conducive to germ tube formation, C. 
albicans which produced germ tubes adhered better to vaginal 
epithelial cells in vitro, and were more virulent in a rat vaginal 
candidosis model than the strain which failed to produce germ tubes 
(Sobel et al., 1981). Candidal adhesion to cell surface is critical 
for mycelial penetration of the epithelial cell surfaces (Howlett & 
Squier, 1980). Furthermore, candidal adhesion to epithelial cells may 
provide a stimulus for mycelial transformation (Ray et al., 1984).
Among different Candida species, a correlation between some 
proposed virulence parameters such as phospholipase activity (Barrett- 
Bee et al., 1985), proteinase production (Ghannoum & Abu Elteen, 1986) 
on one side and pathogenicity and adhesion to epithelial cells on the 
other side has been presented. These results further emphasise the 
role played by adhesion mechanisms of Candida in the pathogenesis of 
human candidosis.
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CHAPTER THRT?K
DIABETES MHLETOS, CRAL CANDIDAL CARRIAGE AND CANDIDAL INFECTION
3.1 INTOODOCriCN AND AIMS QF THE STDCY
Whether the prevalence of oral candidal carriage in patients 
with diabetes mellitus is higher than in non-diabetic individuals is 
still a matter of debate. Several studies have shown the rate of oral 
candidal carriage as being greater among diabetics (Johnston et al., 
1967; Tapper-Jones et al., 1981; Bhatt et al., 1983) and some studies 
have stated the oral candidal carriage rate as high as 80 per cent in 
these patients (Weinstein et al., 1960). Quantitatively oral candidal 
grcwth has also been claimed to be greater in diabetic patients than 
in non-diabetic individuals (Tapper-Jones et al., 1981; Agarunowa et 
al., 1986). However, others have not found a relationship between 
diabetes mellitus and oral candidal colonisation in terms of rate of 
carriage or quantity of growth (Mehnert & Mehnert, 1958; Peters et 
al., 1966).
As opposed to oral candidal carriage or quantitative candidal 
isolation, the incidence of oral candidal infection has been recently 
reported to be higher in diabetic patients than in a normal population 
(Lamey et al., 1988). Historically however, opinions still differ in 
this regard (Peters et al., 1966; Phelan & Levin, 1986). Furthermore, 
the genetically determined inability to secrete the water soluble 
glycoprotein forms of the ABO blood group antigens in saliva have been 
described in association with increased rate of oral candidal carriage 
(Burford-Mason et al., 1988) and candidal infection (May et al., 1986) 
in studies of non-diabetic subjects. However, the relationship
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between oral candidal colonisation and secretor status in diabetic 
patients does not appear to have been established.
Therefore, the aims of this study were to investigate and 
compare the rate of oral candidal carriage, clinical candidal 
infection and quantity of candidal growth, in a group of patients with 
diabetes mellitus and a group of age, sex and denture status matched 
non-diabetic individuals. In addition, the possible effects of 
parameters such as blood glucose level, quality of glycaemic control 
and glycosylated haemoglobin levels on candidal colonisation were 
studied. Finally, the relationship between oral candidal colonisation 
and secretor status was also evaluated.
3.2 MATERIALS AND METHODS
3.2.1 Patients Selection
Patients with diagnosed diabetes mellitus attending the 
Diabetic Clinic at Glasgow Royal Infirmary were asked if they would 
like to participate in this investigation. The first 50 patients who 
agreed to participate, comprised the study group. The control group 
comprised 50 non-diabetic individuals who were recruited from either 
the Oral Medicine Unit at their first attendence to a "Migraine 
Clinic" or from patients attending the Department of Prosthodontics,
Glasgow Dental Hospital. The latter subjects were attending for
denture review assessment. The subjects of both study and control 
group were matched as closely as possible for age, sex and denture 
status. All subjects gave informed consent to participate in the 
study which was approved in full by the local Ethics Committee.
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3.2.2 Clinical History and Oral Examination
The clinical history of each diabetic patient and control 
subject was recorded on a special proforma (Figure 3.1 ). The 
possession of a dental prosthesis and the patients denture wearing 
patterns were also noted. In the case of diabetic patients, the type 
of diabetes mellitus and diabetic treatment as well as the duration of 
the metabolic disease were recorded.
The medical and drug history, other than those used for 
glycaemic control, were matched in both groups as closely as possible. 
No individual in either group had received antibiotic or steroid 
therapy or had used an antiseptic mouth wash for at least three months 
prior to the study. Tobacco smoking and alcohol drinking habits were 
also matched as possible between individuals of both groups. A 
participant who smoked cigarettes daily at the time of sampling was 
classified as a smoker and who consumed alcohol on daily basis was 
classified as a drinker. Those individuals were considered to be non- 
smokers if they had never smoked, or had stopped smoking over at least 
the preceding six months.
Each diabetic patient and control subject underwent a routine 
oral clinical examination. The presence of signs of angular cheilitis 
or intraoral candidal infection was recorded. Patients with clinical 
signs of chronic atrophic candidosis had the extent of their disease 
classified according to Newton's classification (Newton, 1962).
3.2.3 Routine Rlnnfl Investigations
Each diabetic patient and control subject had haematological 
and biochemical assessment including corrected whole blood folate, 
ferritin, vitamin B12, haemoglobin (Hb) and a random blood glucose
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estimation. For assay of corrected whole blood folate and 
haemoglobin, 4ml of venous blood were collected in a tube containing 
potassium EDTA (Sherwood Medical Industries Ltd., Crawley, West 
Sussex, England) while for serum vitamin B12 and ferritin estimation, 
10ml blood were collected in a plain glass tube (Sherwood Medical 
Industries Ltd., Crawley West Sussex, England). For blood glucose 
determination, 2.5ml of blood were collected in a fluoride bottle 
(Sherwood Medical Industreis Ltd., Crawley, West Sussex, England). 
Corrected whole blood folate and serum vitamin B1 2 concentrations 
were determined radiometrically using SimulTRAC radioassay kit (Becton 
Dickinson Immunodiagnostics, Orangeburg, New York, USA) while serum 
ferritin level was determined immunoradiometrically using Ferritin MAb 
Solid Phase Component System (Becton Dikinson and Co., Orangeburg, New 
York, USA). Blood haemoglobin and glucose concentrations were 
determined by Cyanmethaemoglobin and, Glucose oxidase method on 
Beckman Autoanalyser respectively.
Each diabetic patient also had a blood sample assayed for 
glycosylated haemoglobin concentation (HbA1) by Corning method, an 
investigation which reflects the degree of glycaemic control during 
the preceding two months (Nathan et al., 1984). On the basis of 
latter results the quality of diabetic control of each patient was 
designated as "good" when the glycosylated haemoglobin level was less 
than 10 per cent, "fair" between 10 and 12 per cent or "poor" when it 
was greater than 12 per cent. This designation is somewhat arbitrary 
but, nevertheless, is widely used clinically (Lamey et al., 1988).
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CANDIE&-DTAKRTRS STUDY
NAME: DOB: SEX: M/F
UNIT NO: DURATION OF DIABETES: STUDY NO:
DIABETES TREATMENT: Insulin / OHA / Diet 
PMH:
DRUGS: DOSE:
PDH:
BLOOG GLUCOSE: HBA1 :
FERRITIN: FOLATE:
DENTURES: Y/N CU: Y/N CL: Y/N
WEARING: DAY- U/L/Both DAY & NIGHT- U/L/Both
SMOKING: Y/N Cigarettes/Cigar/Pipe
ALCOHOL: Y/N
CLINICAL FINDINGS:
SAMPLING:
Beer/Spirits/Others
Denture Stomatitis: Y/N 
Tongue:
Soft Palate:
Others:
Symptomatic Xerostomia: Y/N
Oral Rinse: Y/N
Swab & Smear: Y/N
Saliva: Y/N
Buccal Scrabing: Y/N
Hb:
VITAMIN B12:
PU: Y/N PL: Y/N
NEVER- U/L/Both 
QUANTITY: 
QUANTITY:
Type:
am/pm/both
RESULTS: Candidal Isolation: Rinse:
Swab :
Smear:
Secretor Status: Y/N Specify:
Mean Candidal Adhesion: Yeast/100 BEC
Figure 3.1: Proforma used for recording the clinical and medical
history of the study subjects.
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3.2.4 Microbiological Investigations
Swabs and smears were collected from areas of clinically 
infected mucosa and skin from the angles of the mouth. A plain cotton 
swab (Exogen Ltd., Clydebank, Scotland) was moistened in tap water and 
rubbed against the clinically infected tissue surface and returned 
immediately to its sterile tube. In cases of chronic atrophic 
candidosis, swabs and smears were obtained from the palatal mucosa and 
the fitting surface of the upper denture. The smear was taken using a 
sterile plastic instrument onto a microscope glass slide with the 
specimen then being left to air-dry.
The concentrated oral rinse technique (Samaranayake et al., 
1986b) was used for oral yeast isolation. Each subject was supplied 
with 10ml of sterile phosphate buffered saline and requested to rinse 
thoroughly, following denture removal if appropriate. Although 
rinsing with the dentures in place was considered, it was decided to 
take the dentures out before rinsing according to the technique 
described by Samaranayake et al. (1986b). The period of rinsing was 
standardised at 60 seconds at which time the rinse was expectorated 
into the container and left on crushed ice until processed. The rinse 
container was then centrifuged at 1700g for 15 minutes and the 
supernatant discarded. The deposit was mixed with 1ml of sterile PBS 
and agitated on a bench vibrator for 30 seconds for disaggregation of 
microorganisms. A spiral plater model D (Spiral System Marketing 
Ltd., Maryland, USA) shown in figure 3.2 was used to dispense 50/iL of 
the deposit onto a Sabouraud's dextrose agar plate (Gibco, Paisley, 
Scotland) and the swabs were streaked on similar plates. The culture 
plates were incubated aerobically at 37° C for 48 hours and the smears
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semi{/vuto»
Figure 3.2 The spiral plater model D.
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were Gram stained. All clinical ©xamination and sampling took place 
between 1400 and 1600 hours.
3.2.5 Yeast Identification
Yeast growth on the culture plates (Figure 3.3) was confirmed 
microscopically by observing the blastospore phase in a direct wet 
film under a x40 objective (Olympus Ltd., London, England). Gram- 
stained smears were examined microscopically using oil immersion (BDH 
Chemicals Ltd., Poole, England) under x100 objective for the presence 
of yeast blastospores or hyphae. Candida albicans and other Candida 
species were identified by serum germ tube test (MacKenzie, 1962) and 
by using the yeast identification system API 20 C AUX (API Products 
Ltd., Basingstoke, Hampshire, England) as shown in Figure 3.4.
3.2.6 Quantification of Candidal Growth
The yeast colonies on each culture plate obtained from oral 
rinse were enumerated and multiplied by the 20 to calculate the 
initial number of colony fanning units per 1ml of rinse (cfu/ml). The 
yeast growth obtained from a swab was semi-quantitatively estimated as 
a light growth when it was 10cfu or less, a growth between 11 and 
50cfu was described as a moderate growth, while a growth of over 50cfu 
was described as a heavy growth.
3.2.7 Collection ami Preparation of Saliva for Secretor Status 
Determination
Each subject was asked to collect about 2ml of unstimulated 
whole mixed saliva into a sterile universal container which was kept 
on crushed ice at the time of collection until processed.
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Figure 3.3 Candidal growth on the culture plate inoculated by the 
spiral plater.
Figure 3.4 The yeast identification system API 20 C AUX.
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Sa.li.va. samples were collected while patients were in a 
resting position* after denture removal* if appropriate. Saliva 
samples were prepared according to the standard techniques (Periera* 
Dodd* Marchant* 1969). Briefly* each sample was decanted into a 
sterile glass tube with an equal volume of normal saline. The tube 
was closed with non-absorbant cotton wool and placed in a boiling 
water bath for ten minutes to inactivate enzymes that may destroy 
secreted blood group antigens. The sample was then centrifuged at 
1700g for 15 minutes to remove particulate matter and the supernatant 
was dispensed into a sterile bijou container (Sterilin Ltd., Feltham, 
England). The sample was either analysed immediately or stored frozen 
at a temperature of -20° C until analysis.
3.2.8 Agglutination Inhibition Technique
Secretor status was determined by the agglutination 
inhibition technique described by Periera et al. (1969). The anti A 
and anti B sera (American Hospital Supplies, Compton, England) were 
used at a dilution of 1/16 and 1/256 respectively. Anti H(O) serum 
(Ian McCombe Laboratories Supplies, Bellshill* Scotland) was used at a 
dilution of 1 /4. These dilutions were determined after titration of 
the antisera with the corresponding red blood cells (Blood Transfusion 
Service, Glasgow) in 96 U-microwell titration plates (Gibco, Paisley, 
Scotland). The antisera were diluted in six per cent bovine albumin 
saline (Ortho Diagnostic, High Wycombe, England).
For secretor status determination the antisera were mixed 
with equal volumes (20/zl) of saliva, diluted in two fold series in six 
per cent v/v bovine albumin saline up to 1/512 using a 96 U-microwell 
titration plate and incubated at room temperature (approximately 24° C)
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for 30 minutes. Subsequently, a 20fjtl suspension of two per cent v/v 
in normal saline of corresponding red blood cells (five per cent of 
group 0 cells) were added, and the final mixture was incubated for a 
further two hours at room temperature. The stocks of the red blood 
cells were washed every other day in 10ml normal saline by 
centrifuging at 1700g for 20 minutes and stored at 4°C.
3.2.9 Defining Secretor Status
The individual was considered as a secretor of blood group 
specific antigen if his, or her, saliva inhibited agglutination of the 
corresponding blood cells. The titre was expressed as the reciprocal 
of the highest dilution of saliva showing macroscopic inhibition of 
agglutination. Individuals whose saliva inhibited blood cell 
agglutination at a titre of 1/16 or less were considered as non- 
secretors. Only those in whom the agglutination titre was 1/32 or 
more were considered as secretors (Periera et al., 1969).
3.2.10 Statistical Analysis
The proportion of subjects from whom yeasts were isolated in 
either group and the proportion of secretors were compared by means of 
the chi square test. In those instances in which the sample size gave 
rise to expected frequencies of less than five, Fisher's exact 
probability test was employed. Since the number of cfu/ml obtained 
from subjects of both groups were not normally distributed as 
determined graphically, a Mann Whitney U test was used to compare 
quantitative candidal isolation from each group. The quantity of 
candidal isolation in the groups was presented as the median of the
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number of cfu/ml isolated and the the spread of data was presented by 
the interquartiles range (Q1, Q3). Pearson's correlation test was 
used to correlate candidal count to various parameters. Probabilities 
of less than five per cent were taken to be statistically significant.
The number of diabetic patients with clinical oral candidosis 
were included together with the Candida carriers when comparing oral 
candidal isolation rates between different groups. On the other hand, 
only quantity of candidal isolation from Candida carriers was compared 
between different groups.
3.3 KBSULTS
3.3.1 Subjects of the Study
As shown in Table 3.1 the diabetic patients and control 
subjects were closely matched for age, sex and smoking habit as well 
as for denture status and denture wearing patterns.
The diabetic group comprised 19 (38%) insulin-dependent and 
31 (62%) non-insulin dependent patients with a mean disease duration 
of 6.7 years (range four months and 32 years). For diabetic control, 
19 (38%) patients were on insulin injection, six (12%) on diet control 
alone and 25 (50%) on a combination of diet control and oral 
hypoglycaemic agents.
According to the percentage of blood glycosylated haemoglobin 
the quality of diabetic control was designated as "good" in 25 (59.5%) 
patients, "fair" in 13 (31%) and "poor" in four (9.5%) patients. 
However, blood samples could not be obtained from eight diabetic 
patients. None of the control subjects were discovered to be diabetic 
or showed abnormally high blood glucose concentrations.
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Diabetics (it= 50) Controls (n?= 50)
Male 27 (54%) 23 (46%)
Female 23 (46%) 27 (54%)
Mean age (years) 53.7 (SD 14.9) 56.3 (SD
Age range (years) 17 - 81 20 - 84
Denture wearers 36 (72%) 36 (72%)
Partial denture 12 (33%) 10 (28%)
Ccmplate denture 24 (67%) 26 (72%)
Denture wearing patterns
Day and night 13 (36%) 14 (39%)
Day only 23 (64%) 22 (61%)
Dentate 14 (28%) 14 (28%)
Smoker 16 (32%) 14 (28%)
Alcohol drinker 7 (14%) 2 ( 4%)
Symptomatic xerostomia 15 (30%) 8 (16%)
Am 4 (27%) 0 ( 0%)
Rn 5 (33%) 1 (12%)
Both 6 (40%) 7 (87%)
SD: Standard deviation of the mean.
’Eabie 3.1 Clinical status of the study subjects.
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3.3.2 Oral Candidal Carriage
Oral candidal carriage was defined as a positive oral 
candidal isolation but in the absence of any mucosal reaction 
suggestive of clinically apparent candidosis.
Twenty one (42%) diabetic patients and 20 (40%) control 
subjects were Candida carriers. The difference between the two groups 
was not significant (p>0.05). Altogether, Candida species were 
isolated from 27 (54%) diabetic patients (21 carriers and six patients 
with oral candidosis). However, this candidal isolation rate was not 
significantly different than that in control subjects (p>0.05). One 
diabetic patient and a control subject harboured more than a single 
Candida species; C. albicans was the most frequent species isolated 
from both groups, followed by C  ^glabrata (Table 3.2).
3.3.3 Oral Candidal Infection
Diabetic patients had a significantly higher incidence of 
oral candidal infection than control subjects (p<0.02). Indeed, six 
(12%) of the diabetic patients had clinical and microbiological 
evidence of oral candidosis compared to none of the control subjects. 
Table 3.3 summarises the various types of oral candidosis diagnosed in 
the diabetic patients.
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Frequency of isolation
Candida species Diabetics Controls
C. albicans 21 (75.0%) 14 (66.7%)
C. crlabrata 4 (14.3%) 3 (14.2%)
C. krusei 1 ( 3.6%) 1 ( 4.8%)
C. stellatoidea 1 ( 3.6%) 1 ( 4.8%)
C. pseudotropicalis 1 ( 3.6%) 1 ( 4.8%)
Multiple yeasts
(C* albicans + C. glabrata) 1 ( 3.6%) 1 ( 4.8%)
Thble 3*2 Candida species isolated from the oral cavity of the
diabetic patients and the control subjects.
Case
no.
Chronic atrophic 
Type 1 Type 2 Type 3
Angular
A d U H a
Acute atrophic
14 + +
19 +
24 +
38 +
41 +
46 +
Table 3*3 Type of oral candidosis diagnosed in the diabetic patients*
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3.3.4 Quantity of Oral Candidal Isolaticxi
Diabetic patients with oral candidosis had a significantly 
increased quantity of oral candidal isolation compared to the carriers 
(p<0.01; Table 3.4). Quantity of candidal isolation was not 
significantly different between diabetic patients and control subjects 
who were carriers (p>0.05), however, diabetic patients more frequently 
had a higher count of candidal isolation (Figure 3.5). In cases of 
chronic atrophic candidosis, swab cultures obtained from the fitting 
surface of upper dentures yielded a heavy candidal growth, whereas 
those obtained from clinically infected palatal mucosa or angles of 
the mouth (in cases of angular cheilitis) yielded a moderate to heavy 
grcwth.
3.3.5 Relationship of Oral Candidal Isolation to Gender
Statistical analysis of data from both diabetic and control 
group showed no significant difference between males and females in 
either rate or quantity of candidal isolation (ps*).05; Table 3.5).
3.3.6 Relationship of Oral Candidal Isolation to Age
The subjects of both groups were divided into ten year age 
groups and the number of individuals in each group who had Candida 
isolated from the oral cavity was analysed (Table 3.6). Chi square 
test showed no significant difference in the rate of candidal 
isolation between different age groups in either diabetic patients or 
control subjects (p>0.05). No significant correlation was found 
between age and the quantity of candidal isolation in diabetic 
patients (r= -0.05) and control subjects (r= 0.23) as shown in Tables
3.7 and 3.8 respectively.
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Diabetics Controls
Carriers (n= 21) Infected (n= 6) Carriers (n= 20)
cfu/ml cfu/ml cfu/ml
64842 93345 62418
5280 17120 32118
3300 9120 18080
3000 6880 11040
2700 3300 2000
2200 1000 1800
1460 1280
1300 920
1140 500
800 340
500 280
500 220
240 136
180 120
160 120
140 120
140 40
100 40
100 40
80 20
40
Median 500a 8000b 310C
Q1, Q3 140, 2450 2725, 36176 120, 1950
a vs b (p<0.01)? a vs c (p>0.05); b vs c (p<0.05)
Table 3,4 Quantity of oral candidal isolation in the diabetic
patients and the control subjects.
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% of subjects 
60
50 -
Diabetics
Control
40 -
30 -
20 -
10 -
<100 100-400 >400
Colony Forming Unit/ml
Figure 3.5 Frequency of quantitative oral candidal isolation fran 
Candida carriers.
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Canriirtel Quantity of isolation
Group Gender isolation (%) cfu/ml (Q1, Q3)
Diabetics Male
Female
14 (51.8%) 
p>0.05 
13 (56.5%)
500 (100, 1300) 
p>0.05
980 (155, 2775)
Controls Male
Female
8 (34.8%) 
p>0.05 
12 (44.4%)
250 (120, 815) 
p>0.05
810 ( 60, 16320)
Table 3.5 Relationship of oral candidal isolation to gender.
Diabetics ( i 50) Controls (n= 50)
Age group 
(year)
No. of 
subjects
Candidal 
isolation (%)
No. of Candidal 
subjects isolation (%)
11 - 20 1 0 ( 0%) 1 1 (100%)
21 - 30 4 2 ( 50%) 3 0 ( 0%)
31 - 40 5 3 ( 60%) 10 3 ( 30%)
41 - 50 9 4 ( 44%) 2 2 (100%)
51 - 60 15 6 ( 40%) 6 3 ( 50%)
61 - 70 11 8 ( 73%) 18 8 ( 44%)
71 - 80 4 4 ( 75%) 9 3 ( 33%)
81 - 90 1 1 (100%) 1 0 ( 0%)
Total 50 27 (100%) 50 20 (100%)
3.6 Relationship of oral candidal isolation to age.
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3-3.7 Relationship of Oral Candidal Isolation to Denture Status and
Denture Wearing Patterns
The relationship of oral candidal isolation to denture status 
in both groups is presented in Table 3.9. Candida species were 
isolated at a higher rate from denture wearers compared to dentate 
subjects in both groups although the difference was not significant 
either in diabetic patients or control subjects (p>0.05). The 
difference in quantity of candidal isolation also was not significant 
between denture wearers and dentate subjects either in diabetic 
patients or control subjects (p>0.05).
The six diabetic patients with oral candidosis were 
exclusively denture wearers, with a significantly increased incidence 
of oral candidosis among diabetic patients who were denture wearers 
compared to dentate diabetic patients (p<0.05).
As shown in Table 3.9, the rate of candidal isolation from 
diabetic patients who wore dentures continuously (day and night) was 
significantly higher than that from those who wore dentures during the 
day only (p<0.02). This relationship was not significant in the 
control group (p>0.05).
The quantity of candidal isolation was significantly higher 
in control subjects who wore dentures continuously over those who wore 
dentures during the day only (p<0.05). This relationship, however, 
was not significant among the diabetic patients (p>0.05).
Statistical analysis showed that diabetic patients who wore 
dentures continuously had a significantly increased incidence of oral 
candidosis compared with those who wore dentures during the day only 
(p<0.0005).
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Group
Candidal
isolation
(%)
Quantity of 
isolation 
cfu/ml (Q1, 03)
DIABETICS Denture wearers 22 (63%) 650 (165, 2015)
Dentate 5 (36%) 140 (120, 4140)
D & N 12 (92%) 210 ( 95, 1275)
D 10 (43%) 1120 (415, 2475)
CONTROLS Denture wearers 16 (44%) 280 (120, 11040)
Dentate 4 (29%) 890 (155, 1820)
D & N 8 (57%) 6420 (250, 28608)
D 8 (36%) 120 ( 40, 280)
D & N : Day and night denture wearing.
D : Day only denture wearing.
T M t* 3.9 Relationship of oral candidal isolation to denture status 
and denture wearing patterns.
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3.3.8 Relationship of Oral Candidal Isolation to Haematological
Status
In diabetic patients and control subjects no significant 
correlation was detected between quantity of candidal isolation and 
values of corrected whole blood folate (r= -0.1 and -0.3 
respectively), ferritin (r= -0.1 and -0.2 respectively), vitamin B12 
(r= 0.06 and -0.1 respectively) or haemoglobin (r= -0.08 and -0.3 
respectively) as presented in Tables 3.7 and 3.8 respectively.
Sixteen (39%) of the diabetic patients were iron-deficient 
(ferritin <12ng/ml), 26 patients had ferritin values within normal 
range (12 - 300ng/ml) while ferritin estimation could not be 
determined in eight diabetic patients. Candida species were isolated 
from seven (43.7%) of the iron-deficient patients (median= 1420cfu/ml; 
Q1, Q3= 95, 18461 ) ) and from 15 (57.7%) of those with a normal 
ferritin concentration (median= 500cfu/ml; Q1, Q3= 160, 1460) without 
a significant difference in either rate or quantity of candidal 
isolation (p>0.05).
Three (7.1%) of the diabetic patients had low haemoglobin 
concentrations (<12g/dl for females and <12.5g/dl for males). Thirty 
nine patients had normal haemoglobin concentrations while haemoglobin 
level could not be determined in eight patients. Candida species were 
isolated from only one (33.3%) patient with a low haemoglobin 
concentration and from 21 (53.8%) patients with normal haemoglobin 
concentrations. The difference in rate of candidal isolation was not 
significant (p>0.05).
All diabetic patients had normal level of blood folate (75 - 
400ng/ml) and vitamin B12 (175 - 800pg/ml). Table 3.7 presents the 
oral candidal isolation data and values of corrected whole blood
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folate, ferritin, vitamin B12 and haemoglobin in diabetic patients.
In control subjects, four individuals (8.7%) had low ferritin 
levels, 42 subjects had normal ferritin concentrations while ferritin 
level could not be determined in four subjects. Candida species were 
isolated from three (75%) of the ferritin-deficient subjects (median= 
1280cfu/ml; Q1, Q3= 120, 18080)) and from 14 (33.3%) of the subjects 
with normal ferritin levels (median= 178cfu/ml; Q1, Q3= 40, 3450). 
The difference was not significant in either rate or quantity of 
candidal isolation between subjects with low ferritin ot those with 
normal levels (p>0.05).
Three (6.5%) of the control subjects had a low haemoglobin 
concentration, 43 had normal haemoglobin levels while haemoglobin 
level could not be estimated for technical reason in four subjects. 
Candida species were isolated from two (66.7%) of the subjects with 
low haemoglobin concentrations and from 15 (34.9%) of the subjects 
with normal haemoglobin levels. No significant difference was 
detected in rate of candidal isolation between subjects who were low 
in haemoglobin and those with normal levels (p>0.05). Due to the 
small sample size, the quantity of candidal isolation could not be 
compared statistically between the two groups. None of the control 
subjects was folate deficient but four subjects were vitamin B1 2 
deficient and Candida was isolated from only one of the subjects. 
Table 3.8 presents data of candidal isolation and values of corrected 
whole blood folate, ferritin, vitamin B12 and haemoglobin in control 
subjects.
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3*3*9 Relationship of Oral Candidal Isolation to Symptomatic
Xerostomia
Table 3*10 presents the relationship of oral candidal 
isolation and symptomatic xerostomia* Although a higher rate of 
candidal isolation was noticed in association with symptomatic 
xerostomia, neither the rate nor quantity of candidal isolation was 
significantly different between subjects with symptomatic xerostomia 
and those who were free of this complaint. This finding pertained 
both to diabetic patients and control subjects. In diabetic patients 
oral candidosis was diagnosed in three (20%) patients with symptomatic 
xerostomia and in another three (8.6%) patients who were free of this 
symptom but, there was no significant difference between the two 
groups (p>0.05).
Group
Synptomatic
xerostomia
Candidal
isolation
(%)
Quantity of 
isolation 
cfu/ml (Q1, Q3)
DIABETICS Yes (n= 15) 10 (66.7%) 800 (140, 3000)
p>0.05 p>0.05
No (n= 35) 17 (48.6%) 500 (100, 1770)
CONTROLS Yes (n= 8) 5 (62.5%) 920 (238, 1540)
p>0.05 p>0.05
No (n= 42) 15 (35.7%) 220 (40, 2200)
Thble 3.10 Relationship of oral candidal isolation to symptomatic 
xerostomia.
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3.3.10 Relationship of Oral Candidal Isolation to Type of Diabetes
Candida species were isolated from 11 (58%) diabetic patients 
with insulin-dependent diabetes mellitus (median= 800cfu/ml; Q1, Q3= 
100, 2380)) and from 16 (52%) non-insulin dependent diabetic patients 
(median= 500cfu/ml; Q1, Q3= 165, 2575). Statistical analysis showed 
no significant difference either in rate (p>0.05) or quantity (p>0.05) 
of candidal isolation between patients of either type of diabetes 
mellitus.
Oral candidosis was diagnosed in four (13%) non-insulin 
dependent and two (10.5%) insulin-dependent diabetic patients but, 
statistical analysis showed no significant difference in the incidence 
of oral candidosis between patients of either type of diabetes 
mellitus (p>0.05).
3.3.11 Relationship of Oral Candidal Isolation to Duration of
Diabetes
Statistical analysis showed no significant correlation 
between quantity of candidal isolation and duration of diabetes 
mellitus (r= -0.1; Table 3.7). Diabetic patients were subdivided 
according to the duration of diabetes into groups of five year 
intervals (Table 3.11). Chi square test showed no significant 
difference in the rate of candidal isolation between the subgroups 
(p>0.05). However, quantity of candidal isolation was significantly 
higher in patients who had had diabetes for less the five years 
compared with those who had the disease for more than five years 
(p<0.05).
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Duration of
diabetes
(years)
Nunter
of
patients
Cinriidal
isolation
(%)
Quantity of 
isolation 
cfu/ml (Q1 / Q3)
< 5 26 13 (50%) 1460* (340, 3000)
> 5 24 14 (58%) 140* ( 90, 1220)
5-10 16 9 (56%) 120 ( 70, 1180)
11 - 15 4 3 (75%) 120 (100, 1250)
16 - 20 2 1 (50%) 3300
>20 2 1 (50%) 3300
*: p<0.05.
TaKle 3.11 Relationship of oral candidal isolation to duration of 
diabetes.
102
3.3*12 Relationship of Oral Candidal Isolation to Blood Glucose Level
No significant correlation was detected between quantity of 
candidal isolation and blood glucose concentration either in diabetic 
patients (r= 0.05) or control group subjects (r= 0.005) as shown in 
Table 3.7 and 3.8 respectively.
Diabetic patients were divided into subgroups according to 
blood glucose concentration. Sixteen diabetic patients had blood 
glucose concentrations less than 8mmol/l and Candida species were 
isolated from seven (43.7%) patients (median= 650cfu/ml; Q1, Q3= 205, 
1650) and nine diabetic patients had blood glucose concentration 
between 8-10mmol/l and Candida species were isolated from six (66.6%) 
patients (median= 980cfu/ml; Q1, Q3= 245, 48997). Blood glucose 
concentration was above 10mmol/l in 25 patients and Candida species 
were isolated from 14 (56%) patients (median= 180cfu/ml; Q1, Q3= 100, 
3000). The difference was not significant either in rate (p>0.05) or 
quantity (p>0.05) of candidal isolation between the subgroups.
Since results of blood glucose concentration of control 
subjects were within the normal range (<6mmol/l), no attempt was 
undertaken to assess the correlation between rate of candidal 
isolaticxi and blood glucose concentration.
3.3.13 Relationship of Oral c*ndidal Isolation to Overall Quality of
Glycaemic Gbntrol
Candida species were isolated from 13 of 24 (54%) diabetic 
patients with good glycaemic control (median= 21 Ocfu/ml; Q1, Q3= 100, 
1050), from six of 13 (46%) patients with fair control (median= 
2070cfu/ml; Q1, Q3= 885, 3225) and from three of four (75%) patients 
with poor glycaemic control (median= 1460cfu/ml; Q1, Q3= 140, 5280).
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Statistical analysis showed no significant difference in either rate 
(p>0.05) or quantity of candidal isolation (p>0.05) between diabetic 
patients with good, fair or poor overall glycaemic control. Analysis 
of the correlation between quantity of candidal isolation and 
percentage of glycosylated haemoglobin was also not significant (r= 
0.006; Table 3.7).
3.3.14 Distribution of Seeretors in Diabetic Patients and Control 
Subjects
Saliva sample analysis showed that 31 (64.6%) of the diabetic 
patients and 31 (62%) of the control subjects were secretors of the 
corresponding blood group antigens without a significant difference in 
proportion of secretors between the two groups (p= 0.9; Table 3.12). 
However, two diabetic patients could not provide sufficient quantity 
of saliva for analysis.
3.3.15 Relationship of Seczetor Status to Type of Diabetes
Seven (36.8%) of the insulin-dependent and 10 (34.5%) of the 
non-insulin dependent diabetic patients were non-secretors. The 
proportion of non-secretors did not differ significantly between 
patients of either type of diabetes (p>0.05). In addition, there was 
no significant difference in the proportion of non-secretors between 
either insulin-dependent and non-insulin dependent diabetic patients 
compared with the controls (p>0.05).
3.3.16 Relationship of Oral fianrHdal Isolation to Secretar Status
In diabetic patients, Candida species were isolated from 13 
(41.9%) of the secretors (median= 1220cfu/ml; Q1, Q3= 220, 2775) and
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from 13 (76.5%) of the non-secretors (median= 1320cfu/ml; Q1, Q3= 100, 
2750). The non-secretors had a significantly increased rate of 
candidal isolation over secretors (p<0.05)• However, the quantity of 
candidal isolation was not significantly different between secretors 
and non-secretors (p>0.05).
Clinical and microbiological evidence of oral candidosis was 
observed in three (9.7%) of the diabetic patients who were secretors 
(median= 6880cfu/ml; Q1, Q3= 3300, 17120)) and in three (17.6%) of 
those who were non-secretors (median= 9120cfu/ml; Q1, Q3= 1000, 
93345). The proportion of patients with oral candidal infection 
between secretors and non-secretors was not significantly different 
(p>0.05) nor was there a difference in the quantity of candidal 
isolation (p>0.05).
In control subjects, Candida species were isolated from ten 
(32.2%) of the secretors (medians 280cfu/ml; Q1, Q3= 100, 5870) and 
from ten (52.6%) of the non-secretors (medians 390cfu/ml; Q1, Q3s 100, 
4260). No significant difference was detected in either rate (p>0.05)
or quantity of candidal 
secretors.
isolation (p>0.05) between secretors and non-
Blood group antigen
Group Secretors A B AB 0
Diabetics
Controls
31 (64.6%) 
31 (62.0%)
14 (45%) 2 
10 (32%) 7
( 6%) 
(23%)
3 (10%) 
0 ( 0%)
12 (39%) 
14 (45%)
liable 3.12 Distribution of secretors in the diabetic patients and the 
control subjects.
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3.4 DISCUSSION AND CONCLUSIONS
Cartiida species, particularly C. albicans are common human 
oral commensals present in three to 47 per cent of a healthy adult 
population (Odds, 1988). The present finding of 40 per cent positive 
candidal isolates amongst the non-diabetic individuals is within this 
range.
The identity and frequency of Candida species isolated were 
comparable in the diabetic patients and control subjects. albicans 
was the predominant isolate followed by glabrata. This is relevant 
to the repeatedly reported finding that C;_ albicans is the most 
frequently isolated species in health and disease (Odds, 1988). 
Multiple yeast isolation was observed in only one diabetic patient 
(3.4%) and one non-diabetic subject (4.7%). This is lower than the 
multiple yeast carriage rate of 9.1 per cent in healthy individuals 
reported by Yamane and Saitoh (1985). In that study a discriminatory 
selective medium, Pagano-Levin agar, was used for isolation of 
multiple yeasts from the clinical specimens. That particular medium 
was not used in the present study because tetrazolium chloride 
incorporated into the medium can suppress candidal growth (Stedham, 
Kelley, Coles, 1966).
The finding of the present study that Candida species were 
isolated from 54 per cent of the diabetic patients compared to 40 per 
cent of the age, sex and denture status matched non-diabetic control 
subjects lends further support to the previous findings that Candida 
species are more prevalent in the oral cavity of diabetic patients 
compared to healthy individuals (Weinstein et al., 1960; Johnston et 
al., 1967; Barlow and Chattaway, 1969; Tapper-Jones et al., 1981; 
Lamey et al., 1988). As some of the studies selected diabetic
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patients free from clinical candidal infection (Odds et al., 1978), 
the present study with a randomly selected patients population may 
present the oral clinical and microbiological state of a diabetic 
population more comprehensively. The present results in addition to 
those reported recently by Lamey et al. (1988) and Thorstensson et al. 
(1989) were unable to confirm the claim that diabetic patients had a 
quantitative increase in oral candidal carriage (Tapper-Jones et al., 
1981 ).
The present finding of 54 per cent candidal isolation among 
diabetic patients using the concentrated oral rinse technique for 
candidal isolation is similar to the candidal isolation rate reported 
by Fisher et al. (1987) and Lamey et al. (1988) who used the same 
method of isolation. In those studies, Candida species were recovered 
from 51 and 57 per cent of the diabetic patients respectively. The 
concentrated oral rinse technique is known for its higher sensitivity 
in candidal isolation when compared with other isolation techniques 
such as imprint sampling and conventional swabing (Samaranayake et 
al., 1986b).
A higher candidal isolation rate from diabetic patients (75%) 
was recently reported by Bartholomew et al. (1987) using exfoliative 
cytology of swabs taken from the tongue and buccal mucosa, rather than 
by culture. This high isolation rate may be related to the fact that, 
the diabetic patients were hospital in-patients and the prevalence of 
oral yeasts is thought to be higher among such patients (Odds & Evans, 
1980). In addition, the majority of patients studied (39 of 60) were 
poorly controlled diabetics and some with infections, for which they 
were on antibiotic therapy which in turn may encourage candidal growth
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(Johnston et al., 1 967). Banoczy et al. (1 987) reported no 
significant increase in candidal isolation rate from a group of 
insulin-dependent diabetic women compared with age and sex matched 
control subjects. These authors used a special diagnostic kit for 
candidal isolation with a lower sensitivity limit whereby only 
individuals who had more than 10OOcfu/ml were distinguished as 
carriers. In addition, the majority of subjects in the latter study 
were young and therefore unlikely to be wearing dentures.
To compare candidal isolation rates from different studies is 
fraught with a number of difficulties such as the apparent variations 
in candidal isolation and culture techniques used (see Table 1.1). 
Even those studies which had used identical candidal isolation 
procedures and culturing methods still have inter study variations in 
local factors such as age, sex, denture wearing patterns and smoking; 
all factors which have been suggested as influencing oral candidal 
colonisation (Arendorf & Walker, 1979; 1980). Similarly, the lack of 
matching in these factors between diabetic patients and control 
subjects may be a reason why some researchers failed to record a 
difference in candidal isolation between the two groups (Mehnert & 
Mehnert, 1958; Peters et al., 1966).
Other reasons for the discrepancies in candidal isolation 
rates reported in different studies may be variations in the 
sensitivity of methods for candidal isolation and culturing 
techniques. In that regard, Peters et al. (1966) swabbed the teeth, 
gingiva, mucobuccal and mucolingual folds of 400 diabetic patients and 
200 control subjects and reported no difference in candidal isolation 
rate between the two groups. Nevertheless, their isolation technique 
may not represent the entire oral cavity (eg. the tongue) so the
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carriage rate may be under estimated.
However, in the present study the quantity of oral candidal 
isolation as presented by the cfu/ml may be an under estimation of the 
real intraoral candidal load. The salivary IgA secreted in higher 
concentration in saliva of subjects colonised with Candida (Jeganathan 
et al., 1987) may result in agglutination of candidal cells in the 
oral cavity (Lehner, 1965; Epstein et al., 1982). Accordingly, after 
rinsing the mouth, several agglutinated candidal blastospores in the 
rinse could grow and be counted as a single candidal colony.
In the present study, factors such as age, sex, type and 
duration of diabetes mellitus seem to bear no relationship to oral 
candidal isolation in diabetic patients. This conclusion was also 
reported by other workers in this field (Odds et al., 1978; Tapper- 
Jones et al., 1981; Bartholomew et al., 1987; Fisher et al., 1987; 
Lamey et al., 1988). However, the observed higher rate and quantity 
of candidal isolation, although not significant, among the female non­
diabetic subjects compared to males may support the suggestion that 
hormonal factors may influence oral candidal colonisation (Arendorf & 
Walker, 1980).
Diabetes mellitus is known to predispose to many infections 
(Wheat, 1980) and candidosis is no exception. Genital candidal 
infections are more common and florid in diabetic patients (Sonck & 
Somersalo, 1963) and diabetes mellitus has been implicated as a factor 
in approximately five to 15 per cent of reported cases of systemic 
candidosis (Odds, 1988). Previously the author and other workers 
reported on the significantly increased prevalence of oral candidosis
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among diabetic patients (Lamey et al., 1988) and the present study is 
a further confirmation. Other investigators have found more atrophic 
lesions of the tongue associated with Candida among diabetic patients 
(Farman & Nutt, 1976; Farman, 1977) while Phelan and Levin (1986) 
found the prevalence of denture stomatitis to be similar in diabetic 
and non-diabetic subjects. However, the diabetic group in the latter 
study included subjects with increased plasma glucose levels who were 
not necessarily diabetic but may have had glucose intolerance.
The pathogenicity of Candida has been reported to depend in 
part upon the number of organisms present (Wain, Price, Cawson, 1976). 
Hcwever, this does not seem the case in diabetic patients of this 
study, as these patients had a significantly increased incidence of 
oral candidosis over the matched non-diabetic individuals despite the 
comparable quantity of candidal growth in both groups. In an animal 
model of diabetes mellitus, Hurley (1966) presented evidence that 
diabetes mellitus decreased host resistance and predisposed to 
candidal infection. Later, Dourov and Coremans-Pelseneer (1987) 
showed that experimental oral candidosis was successfully induced in 
rats rendered diabetic by streptozotocin but not in healthy animals 
when challanged with a similar yeast inoculum. Therefore, the disease 
outcome may depend more on host health than on the yeast load.
Precisely why diabetes mellitus increases susceptibility of 
an individual to oral candidosis is not clear. Knight and Fletcher 
(1971) noticed increased in vitro candidal growth in saliva from 
diabetic patients compared to that in saliva from non-diabetic 
individuals. The authors proposed that a higher glucose level in the 
saliva of diabetics may be one factor responsible for enhancing 
candidal growth. However, C^_ albicans cultured in saliva from
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diabetic patients and healthy individuals has shown comparable 
percentages of germ tube formation (Kumar et al., 1 982). The 
relationship between salivary glucose concentration and in vivo oral 
candidal colonisation in diabetic patients has not been studied, as 
yet, and is an area worthy of investigation.
The oral microbial flora is proposed as a factor influencing 
candidal colonisation. Mixed aerobic microflora has been shown to 
inhibit oral candidal colonisation in gnotobiotic mice (Liljemark & 
Gibbons, 1973), and anaerobic oral flora to inhibit candidal growth 
(Kennedy, 1981). On the other hand, components of the oral flora like 
E. coli and Kj_ aerogenes have promoted oral candidal colonisation 
(Makrides & MacFarlane, 1982). A prospective comprehensive study 
investigating the possible differences in oral microflora in diabetic 
patients, in relation to possibly enhanced candidal colonisation seems 
worthwhile.
Whether the salivary antimicrobial factors are altered in 
patients with diabetes mellitus is debatable (Tenovuo et al., 1986). 
Sane investigators have reported reduced salivary lysozyme activity in 
diabetic patients (Velikov et at., 1985) and in experimental animals 
rendered diabetic by alloxan treatment (Muratsu & Morioka, 1985). 
Recent research has indicated that lysozyme in vitro has potent 
anticandidal activity (Tobgi et al., 1988), therefore, the increased 
oral colonisation with Candida species observed in patients with 
diabetes mellitus could be, in part, due to concomitant reduction in 
salivary lysozyme.
Several aspects of neutrophil function has been reported as 
being impaired in patients with diabetes mellitus (Wilson, 1986).
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Intracellular candidacidal capacity of neutrophils from diabetic 
patients has been shown to be particularly impaired (Wilson & Reeves, 
1986; Wilson et al., 1987) and this may further predispose to candidal 
infection.
It is of interest in the present study to note that all the 
diabetic patients with oral candidosis were denture wearers who wore 
their dentures continuously. Although the control individuals were 
closely matched for denture status and wearing patterns, none of the 
latter group had clinical oral candidosis. This tends to emphasise 
the role of an interaction between diabetes mellitus and local factors 
such as the presence of dentures, particularly when worn continuously, 
in promoting candidal colonisation of the mouth. However, the 
increased rate and quantity of candidal isolation among denture 
wearers, particularly those who wear dentures continuously, is 
consistent with that reported for denture wearers generally (Arendorf 
& Walker, 1979).
It is of importance to note that the control subjects of this 
study were recruited from individuals attending a dental hospital for 
treatment of non-mucosal problems and for denture assessment. This 
method of patient selection may not be ideal, but due to the 
difficulty of obtaining the required number of healthy control 
subjects this method was felt appropriate for the purpose of this 
study.
In the present study, The lack of cases of denture stomatitis 
among the control subjects who were denture wearers could be 
attributed, in part, to the fact that those subjects were recruited 
from a prosthodontic clinic. Such subjects may be more careful about
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their denture hygiene than other denture wearers who were receiving 
the attention from a dentist. On the other hand, the diagnosis of 
denture stomatitis in about 20 per cent of the denture wearers of the 
diabetic subjects is relatively comparable to that reported in general 
population of denture wearers (Nyquist, 1952).
In the present study, more diabetic patients had a low blood 
ferritin concentration than control subjects. Although a relationship 
was suggested between the latter parameter and oral candidosis 
(Fletcher et al., 1975), the higher rate of candidal isolation and 
infection observed among diabetic patients was felt unlikely to be due 
to the direct effect of reduced ferritin, as no correlation was noted 
between haematological parameters and oral candidal status. This 
observation is consistent with the findings of other workers among 
non-diabetic individuals (Jenkins et al., 1977).
Interestingly, the concentration of blood ferritin was 
significantly higher in the control group when compared with that in 
the diabetic group generally. The precise reason(s) for this 
observation is not apparent at present, but could be of clinical 
interest. In that regard, the control subjects who harboured Candida 
intraorally have shown significantly lower blood ferritin 
concentration (though not below the lower limit of normal) than those 
who were Candida free in the same group. However, the relationship 
between blood ferritin level and oral candidal colonisation needs 
further clarification.
Although it is widely reported that poor glycaemic control 
predisposes to infections generally in diabetic patients (Rayfield et 
al., 1982), the relationship between oral candidal carriage, candidal
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infection and glycaemic control is controversial. In order to 
investigate the association between glycaemic control and oral 
candidal colonisation in the diabetic patients of this study, random 
blood glucose (which reflects the degree of glycaemic control at one 
point in time) and glycosylated haemoglobin concentration (which 
reflects the degree of glycaemic control during the preceding two 
months) were compared between diabetics with and without positive 
candidal isolation. The degree of glycaemic control as assessed by 
either blood glucose or glycosylated haemoglobin was unrelated to rate 
or quantity of candidal isolation a finding which is in accordance 
with previous reports (Barlow & Chattaway, 1969; Tapper-Jones et al., 
1981; Bartholomew et al., 1987; Fisher et al., 1987; Lamey et al., 
1988). Therefore, the present results do not confirm other reports 
that patients with poorly controlled diabetes have a higher candidal 
isolation rate than those in whom the disease is well controlled (Odds 
et al., 1978; Hill et al., 1989).
In the study of Odds et al. (1978), glycaemic control was 
assessed by a scoring system including random blood glucose and the 
degree of fasting glucosuria. Both parameters are poor indices of 
glycaemic control since blood glucose concentration fluctuates from 
one day to another and levels of glucosuria is subjected to individual 
variations in renal threshold for glucose (Baird, 1987). In addition, 
the patients with poor glycaemic control included hospitalised in­
patients who may have received antibiotics or other medications that 
may have enhanced candidal colonisation. However, the present 
investigation included only four patients with poor glycaemic control 
with the majority of patients having good control. Further studies
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with more equal distribution of patients in different categories of 
diabetic control/ are warranted for further investigation and 
statistical analysis.
Salivary analysis for ABO(H) secretor status determination 
has shown that 38 per cent of the non-diabetic subjects were non- 
secretors. This proportion is somewhat higher than the 29.4 per cent 
reported for other areas in Scotland (Lincoln & Dodd, 1972). The 
relatively small number of subjects investigated in the present study 
in addition to the strict definition of secretors may partly explain 
this discrepancy. However, this does not exclude the possibility of 
regional variations in the inherited ability to secrete blood group 
substances. For instance, Lincoln and Dodd (1972) noticed significant 
differences in the proportion of non-secretors between different 
regions in the British Isles and found the Scottish population to be 
among the highest in relation to non-secretor status. However, the 
present proportion of non-secretors is not far from the 36 per cent 
and 37 per cent of non-secretors reported by Macafee (1964) and 
Denborough, Downing and McCrea (1967) respectively.
The lack of a difference in the proportion of secretors 
between the diabetic patients and non-diabetic individuals observed in 
the present study supports the previous report of Doll, Drane and 
Newell (1961) and Macafee (1964) who reported that the occurrence of 
diabetes mellitus was independent of secretor status.
Whether patients with insulin-dependent diabetes mellitus 
have a higher proportion of non-secretors than patients with non- 
insulin-dependent diabetes (Blackwell et al., 1987) or not (Peters & 
Gohler, 1986) is unclear. However, the present results could not 
detect a difference in the proportion of non-secretors when patients
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with either type of diabetes were compared with each other or when 
compared with the non-diabetic subjects.
The genetically determined inability to secrete the blood 
group specific antigens into body fluids has been described in 
association with several systemic infections (Blackwell, 1989). 
Recently Bur ford- Mason et al. (1988) reported an increased proportion 
of non-secretors among healthy subjects who were Candida carriers. In 
the present study, the observed significantly increased rate of 
positive candidal isolation among non-secretors than among secretors, 
in patients with diabetes mellitus, tends to support and extend these 
findings. A similar trend was observed among the non-diabetic 
individuals of the study although the difference in candidal carriage 
rate between secretors and non-secretors was not statistically 
significant.
The lack of a significant relationship between secretor 
status and presence of oral candidosis among the diabetic patients is 
consistent with that reported by Lamey et al. (1 988) but contrary to 
the increased proportion of non-secretors among non-diabetic patients 
with oral candidal infections reported by Thom et al. (1989). Others 
too, have been unable to establish a relationship between secretor 
status and infections such as gonorrhoea (Kinane et al., 1983) and 
periodontal disease (Pradhan et al., 1971). However, the present 
study comprised a limited number of diabetic patients with clinical 
candidal infection, so a larger scale investigation may be required to 
investigate such an association between secretor status and candidal 
infection in these patients.
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It has been theorised that, the blood group substances in 
secretions may possess the ability to occupy or interfere with binding 
sites present either on the surface of microorganism or on the 
epithelial cell surface, and retard microbial colonisation of mucosal 
surfaces (Blackwell, 1989), Hence the relationship between the 
ability to secrete these substances in saliva and candidal adhesion to 
oral epithelial cells warranted further investigation. In addition, 
salivary IgA, which has been shown to inhibit candidal colonisation to 
mucosal surfaces (Epstein et al., 1982), may be secreted in lower 
concentration in mixed saliva from non-secretors compared to secretors 
(Waissbluth & Langman, 1 971 ).
In conclusion, candidal isolation rate and oral candidosis 
were found to be more common in patients with diabetes mellitus than 
in healthy individuals for reasons as yet unclear. Furthermore, all 
the investigations undertaken on these aspects have been so far cross- 
sectional in nature thus yielding limited information. The question 
to why a diabetic patient becomes a carrier of Candida species or 
develops oral candidosis while another may not is still without a 
convincing answer. Differences in virulence factors between different 
Candida species and strains may be a part of the answer while the 
other may be the intrinsic differences in susceptibility among 
individuals. Carefully designed longitudinal studies, monitoring oral 
candidal status in diabetic patients in different states of diabetic 
control and over a prolonged period of time, are required to answer 
these questions.
In diabetic patients, the lower proportion of secretors with 
positive candidal isolation suggests that the ability to secrete the 
ABO antigens may play a role in the innate defences of the host
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against these opportunistic organisms. Further work in the area 
should include investigating other immunosuppressed patients such as 
those receiving chemotherapy or radiotherapy to determine if secretion 
of the blood group antigens plays a role in prevention of candidal 
infection. Conceivably, patients with HTV infection who develop oral 
candidosis earlier in the course of their disease could be those who 
are non-secretors.
If we accept that Candida must colonise the host surface to 
be able to produce its pathogenic effect (Howlett & Squier, 1980), 
then studies on candidal adhesion to epithelial cells from diabetic 
patients may be helpful to clarify differences in susceptibility to 
candidal carriage or infection between diabetics and non-diabetics. 
If, in future, this type of study has proved useful, more meticulous 
investigations may be designed to study interindividual variations in 
susceptibility among diabetic patients with different states of 
diabetic control.
This study and others (Lamey et al., 1988) have shown that 
diabetic patients with poor glycaemic control may not be more 
predisposed to oral candidosis than those with good control. Moreover 
neither type or duration of diabetes appeared to affect this 
predisposition. Therefore, since candidal adhesion to epithelial 
cells was a prerequisite for colonisation (Kimura & Pearsall, 1978) 
and predisposition to infection (Kennedy, 1988), additional studies 
were undertaken to compare candidal adhesion to epithelial cells from 
diabetic patients and control subjects.
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CHAPTIR POUR
ADHESION OF CANDIDA ALBICANS TO BUCCAL EPITHELIAL CRT.T.S OF DIABETIC 
PATIENTS AND NON-DIABETIC INDIVIDUALS
4.1 IOTBCCUCTTON AND AIMS OF THE STODY
The adhesion of microorganisms to host mucosal surfaces is a 
necessary prerequesite for successful microbial colonisation and 
infection (Gibbons & van Houte, 1975), and the role of adhesion in the 
pathogenesis of many fungal infections is widely appreciated (Kennedy, 
1988). Various animal studies have provided evidence for a 
relationship between the ability of Candida species to adhere to a 
host surface and their propensity for initiating infection (McGourtie 
& Douglas, 1984; Calderone et al., 1985).
The predisposition of diabetic patients to cutaneous 
(Kandhari et al., 1969) and vaginal candidosis (Sonck & Somersalo, 
1963) as well as to oral candidosis (Lamey et al., 1988) has been 
recognised but the reasons, as yet, not fully identified. However, as 
has been shown in Chapter Three, factors indicative of glycaemic 
control in diabetic patients, such as blood glucose concentration, 
glycosylated haemoglobin, and type and duration of diabetes seemed to 
bear no relation to the higher predisposition of diabetic patients to 
oral candidal infection. However, one study has shown female patients 
with diabetes mellitus to have higher rates of adhesion of Cm_ albicans 
to their vaginal epithelial cells in vitro (Segal et al., 1984) which 
may explain, in part, the increased predisposition of these patients 
to vaginal candidosis.
118
In view of the reported correlation between candidal adhesion 
in vitro and the ability to initiate candidal infection in vivo 
(McCourtie & Douglas, 1984; Ray et al., 1984; Ghannoum & Abu Elteen, 
1986), the present study aimed to compare the adhesion of 0_ albicans 
strain CDS 88 to buccal epithelial cells (BEC) from patients with 
diabetes mellitus and a group of age, sex and denture status matched 
non-diabetic control subjects in an attempt to explore whether a 
relationship exists between the higher predisposition of such patients 
to oral candidal infection and increased candidal adhesion in vitro. 
The opportunity was also taken to investigate the effect of parameters 
such as oral candidal colonisation, secretor status, blood glucose 
level and haematological status, as well as quality of diabetic 
control as factors which might influence candidal adhesion to oral 
epithelial cells.
4.2 MATBOMS AND METHODS
4.2.1 Patients Selection
The subjects of this study (the same groups investigated in 
Chapter Three) comprised 50 randomly selected outpatients with 
diagnosed diabetes mellitus and 50 age, sex and denture status matched 
non-diabetic control subjects. Diabetic patients were recruited from 
the Diabetic Clinic at Glasgow Royal Infirmary while control subjects 
were recruited from either the Oral Medicine Unit at their first 
attendence to a Migraine Clinic or from patients routinely attending 
the Department of Prosthodontics, Glasgow Dental Hospital for denture 
assessment. All participants gave informed consent to participate in 
the study which was approved in full by the local Ethics Committee.
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4.2.2 Clinical History and Oral Eram-inai-ira
The clinical history of each participant was recorded on a 
special proforma (see Figure 3.1). The type of diabetes mellitus, 
diabetic treatment and duration of the disease were recorded for the 
diabetic patients. For each participant, the possession of a dental 
prosthesis and whether the prosthesis was worn continuously was also 
recorded.
The medical and drug history (other than that used for 
glycaemic control) was matched in both groups as closely as possible. 
No individual in either group was, or had in the previous three 
months, received antibiotic or steroid therapy or used an antiseptic 
mouth wash and no female subject was known to be a pregnant. Tobacco 
smoking and alcohol consumption were also matched as closely as 
possible between subjects of both groups.
Each participant underwent a routine oral clinical 
examination and the presence of oral candidosis was recorded. 
Subjects with chronic atrophic candidosis had their disease extent 
described according to the classification of Newton (Newton, 1962).
4.2.3 Routine Blood Investigations
These investigations were described in Section 3.2.3. 
Briefly, a venous blood sample was obtained from the subjects for 
estimation of corrected whole blood folate, ferritin, haemoglobin 
(Hb), vitamin B12 and (biochemically) random blood glucose 
concentration. Glycosylated haemoglobin (HbA.1) was also estimated for 
the diabetic patients.
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4.2.4 Microbiological Investigations
The microbiological investigations were described in detail 
in Section 3.2.4. Briefly, The concentrated oral rinse technique 
described by Samaranayake et al. (1986b) was used for oral yeast 
isolation. Swabs and smears were obtained from areas of clinically 
infected mucosa and from the angles of the mouth if appropriate. The 
swabs and oral rinses were inoculated onto Sabouraud's dextrose agar 
(Gibco, Paisley, Scotland) and incubated aerobically at 37°C for 48 
hours. The smears were taken using plastic instruments and samples 
applied to glass microscope slides and stained by Gram technique.
4.2.5 Yeast Identification and Quantification
C. albicans and other Candida species were identified by 
serum germ tube formation technique (MacKenzie, 1962) and using the 
identification system API 20 C AUX (API Products Ltd., Basingstoke, 
Hampshire, England). Details of yeast identification and 
quantification were given in Sections 3.2.5 and 3.2.6 respectively.
4.2.6 Secretor Status Determination
Secretor status was determined by agglutination inhibition 
technique described by Periera et al. (1969). Details of saliva 
collection, the agglutination inhibition technique itself and defining 
the secretor status were described in Sections 3.2.7 to 3.2.9.
4.2.7 (hllflnHm of Buonal Tfoifhellal Cells
Buccal epithelial cells (BEC) for the adhesion assay were 
obtained from each subject by gently scraping the right and left 
buccal mucosa separately with a sterile cotton swab (Exogen Ltd.,
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Clydebank, Scotland). BEC from each subject were pooled by agitating 
the swabs in 10ml PBS (0.1 M pH 7.2) in a universal container (Sterilin 
Ltd., Feltham, England) which was kept on crushed ice till the time of 
processing. PBS of the same osmolarity and pH was used throughout the 
study. All clinical examinations and samplings took place between 
1400 and 1700 hours.
4.2.8 Preparation of Buocal Epithelial Gell Suspension
BEC were washed twice in 10ml PBS by centrifugation at 200g 
for ten minutes (MSE Centaur 2 Centrifuge. Fisson's Ltd., Crawley, 
England) to remove loosely attached microorganisms and debris. The 
cells were then suspended in PBS to give a final BEC concentration of 
105 per ml determined by haemocytometer counting (Hawksley and Sons 
Ltd., Lancing, England).
4.2.9 Source, Identification and Maintenance of Candida Albicans 
Strain CDS 88
C. albicans strain CDS 88 used throughout this study was 
originally isolated from the oral cavity of an asymptomatic carrier in 
Glasgow Dental Hospital. The species was identified by serum germ 
tube formation technique (MacKenzie, 1962) and using the yeast 
identification system API 20 C AUX and subsequently freeze-dried. The 
strain was maintained on slopes of Sabouraud's dextrose agar at 4 C 
and the culture was replaced monthly by a new one freshly grown from 
freeze-dried stock. The strain used has never been subcultured 
throughout the study.
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4.2.10 Preparation of Candida Albicans Suspension
To prepare the candidal cells for the adhesion assay, a 
loopful of the stock culture was inoculated into 10ml of Sabouraud's 
broth (Gibco, Paisley, Scotland) containing 500mM sucrose in a 
universal container, and incubated overnight (18-24 hours) at 37°C in 
an orbital shaker incubator (Gallenkamp, Loughborough, England) 
operating at 100 revolutions per minute. A growth medium containing 
500mM sucrose was known to enhance candidal adhesion (McCourtie & 
Douglas, 1984) and albicans in the stationary phase of growth 
adhere to a higher degree than when in the logarithmic growth phase 
(King et al., 1980). The culture was then harvested by centrifugation 
at 400g for five minutes and the deposit washed twice in aliquots of 
10ml PBS by centrifugation at 400g for five minutes. A final yeast
7
cells suspension of 10 per ml was prepared by appropriate dilution of 
the deposit in PBS followed by haemocytometer counting.
4.2.11 Hie Candidal Adhesion Assay
The in vitro adhesion of the C;_ albicans strain CDS 88 to BEC
from each diabetic patient and control subject was studied as
described by Kimura and Pearsall (1978) with minor modifications.
For the adhesion assay, equal volumes (0.5ml) of BEC
suspension and C. albicans suspension were mixed in a sterile bijou
container (Sterilin Ltd., Feltham, England) and incubated on an
o
orbital shaker operating at 80 revolutions per minute at 37 C for one 
hour. In each experiment, a control container was included that 
contained 0.5ml BEC suspension and 0.5ml PBS to determine the 
background count of possible indigenous yeasts. Following incubation, 
the BEC were harvested on a polycarbonate filter of 25mm diameter and
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12j^tin pore size (Nuclepore Gmbh, Germany) mounted on a DEFT (direct 
epifluorescent filter technique) manifold (Micromeasurements Ltd., 
Saffron Waden, Essex, England) shown in Figure 4.1. A negative 
pressure of 5mm Hg was applied to the manifold, and the filter with 
retained EEC were washed gently with 30ml of PBS in aliquots of 5ml to 
remove unattached yeast cells. The pore size of 12jum was small enough 
to retain the EEC without gross distortion but large enough to allow 
unattached yeast cells to be washed through the filter unit, leaving 
only the BEC with adherent yeast on the filter. The filter with 
washed BEC was then removed from the filter unit, mounted on a 1.0mm 
thick, 26 X 76mm glass microscope slide (Chance Proper Ltd., 
Smethwick, Warley, England) and left for one hour to air-dry then 
Gram-stained. The filter and the stained BEC, on the glass slide, 
were left overnight to air-dry then a 22 X 22mm glass cover slip 
(Chance Proper Ltd., Smethwick, Warley, England) was fixed on the 
filter with Harleco resin (Kodak Chemicals, England).
The DEBT manifold (Figure 4.1) consists of a stainless steel 
housing on which up to five filters can be mounted in filter units 
consisting of a sintered glass base beneath a filter tower, between 
which the filters are sandwiched. The weight of the filter tower 
forms a seal against the filter and the negative pressure is applied 
to the manifold from a Venturi pump drawing the suspension in the 
filter tower through the filter. The BEC are thus deposited evenly 
over the exposed area of the filter, determined by the internal 
diameter of the filter tower.
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Figure 4.1 DEPT manifold filter unit showing (a) the sintered glass 
base and (b) the filter tower.
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4.2.12 Oounting of .Adherent Yeast HpIIc;
The glass slides holding the filters were coded and read 
"blindly". The number of Ct albicans blastospores attached to one 
hundred individual BEC were counted under a x40 objective. To ensure 
consistent counting of fields, on each occasion the count was started 
at the top left hand side of the filter and consecutive fields counted 
till 1 00 BEC were obtained. Only morphologically normal epithelial 
cells with a round entire edge and cells that were flat, but not 
folded, were counted in the field. Clumps of BEC were excluded and 
pseudohyphae, if present, were not counted. To obtain the correct 
final count of the adherent yeast cells the background count of the 
control assay, if present, was subtracted from the total count.
4.2.13 Statistical Analysis
Maan candidal adhesion (MCA) together with the standard 
deviation of the mean (SD) to BEC from the groups was compared by 
Student's t test for unpaired data. Pearson's correlation test was 
used to correlate MCA to various parameters. Probabilities of less 
than five per cent were taken to be statistically significant.
4.3 RESULTS
4.3.1 Subjects of the Study
The diabetic patients and control subjects were closely 
matched for age, sex, denture status and denture wearing patterns 
(Table 4.1).
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Diabetics (n= 50) Controls (n= 50)
Male 27 (54%) 23 (46%)
Female 23 (46%) 27 (54%)
Mean age (years) 53.7 SD 14.9 56.3 SD 17.3
Age range (years) 17 - 81 20 - 84
Denture wearers 36 (72%) 36 (72%)
Dentate 14 (28%) 14 (28%)
Smokers 16 (32%) 14 (28%)
Alcohol drinkers 7 (14%) 2 ( 4%)
TTaKlft 4.1 Clinical status of the study subjects.
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Study Tbtal yeast counted Bac^ oground count Adherent Candida
no. Yeast / 100 BEC Yeast / 100 BEC Yeast / 100 BEC
1 26 406 308 0 0 406 308
2 27 210 235 0 0 210 235
3 28 806 310 0 8 806 302
4 29 144 368 0 0 144 368
5 30 400 350 0 2 400 348
6 31 443 352 0 0 443 352
7 32 857 431 0 0 857 431
8 33 549 491 4 0 545 491
9 34 645 519 0 0 645 519
10 35 637 418 0 1 637 417
11 36 367 305 0 0 367 305
12 37 566 271 0 0 566 271
13 38 535 423 0 0 535 423
14 39 330 376 0 0 330 376
15 40 530 333 0 0 530 333
16 41 1053 234 28 0 1025 234
17 42 691 284 2 0 689 284
18 43 469 256 1 0 468 256
19 44 472 256 1 0 471 256
20 45 262 183 0 0 262 183
21 46 261 250 0 0 261 250
22 47 229 169 0 0 229 169
23 48 480 156 0 0 480 156
24 49 257 287 10 0 247 287
25 50 560 461 0 0 560 461
•Cable 4.2 Raw data for candidal adhesion to BEC from diabetic 
patients.
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Study Total yeast aounted Background count Adherent Candida
no- Yeast / 100 BBC Yeast / 100 BBC Yeast / 100 BBC
1 26 253 375 0 37 253 338
2 27 228 503 0 0 228 503
3 28 421 359 0 0 421 359
4 29 317 380 0 0 317 380
5 30 428 330 0 0 428 330
6 31 211 395 0 0 211 395
7 32 417 339 0 0 417 339
8 33 295 267 0 0 295 267
9 34 369 213 0 0 369 213
10 35 484 440 11 0 473 440
11 36 231 483 0 0 231 483
12 37 190 408 0 0 190 408
13 38 153 245 0 0 153 245
14 39 173 131 0 0 173 131
15 40 220 107 0 0 220 107
16 41 125 78 0 0 125 78
17 42 200 43 0 0 200 43
18 43 220 77 0 0 220 77
19 44 371 61 0 0 371 61
20 45 393 156 0 0 393 156
21 46 244 157 0 0 244 157
22 47 282 201 0 0 282 201
23 48 134 212 0 0 134 212
24 49 149 218 0 0 149 218
25 50 143 106 0 0 143 106
ivihio 4.3 Haw data for candidal adhesion to BBC from control 
subjects.
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4.3.2 Adhesion of Candida Alhicans to Buccal Epithelial f^lls from
Diabetic Patients and Non-diabetic Control Subjects
The number of albicans blastospores of the strain used 
(CDS 88) adherent to 100 BEC of 50 diabetic patients and 50 control 
subjects was counted. Then the mean candidal adhesion (MCA) to a 
single BEC together, with the standard deviation from the mean (SD) 
for each group, was calculated. The value derived was 4.02 (SD 1.85) 
yeast / BEC for the diabetic patients and 2.6 (SD 1.2) yeast / BEC for 
the control subjects (Figure 4.2). Statistical analysis showed that 
MCA in the diabetic patients was significantly higher than in control 
subjects (p<0.001 ). As shown in Figure 4.3, there was increased 
frequency of candidal adhesion values over 300 yeast / 100 BEC in 
diabetic patients compared to the control subjects.
The study also attempted to determine whether a qualitative 
difference existed in affinity of BEC to the C. albicans strain used 
between diabetic patients and control subjects. The number of BEC 
with one or more adherent C^ albicans blastospores (Candida +ve cells) 
and the number of BEC with no adherent blastospores (Candida -ve 
cells) (Figure 4.4) was counted, and the mean number of Candida +ve 
and Candida -ve cells per 100 BEC from each group then calculated.
The affinity of BEC from diabetic patients to the 0_ albicans 
strain used was higher than that of the control subjects. The mean 
number of Candida +ve cells in diabetic patients (63.2 SD 11.2) was 
significantly higher (p<0.001) than in control subjects (54.4 SD 
13.8). The mean number of Candida -ve cells in diabetic patients (37 
SD 11.2) was significantly decreased (p<0.001) compared to control 
subjects (45.7 SD 13.7).
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Figure 4.2 Mean candidal adhesion to buccal epithelial cells from 
the diabetic patients and the control subjects. The 
vertical bars present the standard deviation of the 
mean.
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Figure 4,3 Relative frequency of subjects with different candidal 
adhesion values to 100 buccal epithelial cells.
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Figure 4.4
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s
Candida albicans blastospores adhering to buccal 
epithelial cells, (a) Candida +ve cell, (b) Candida -ve 
cell.
133
As shown in Tables 4.2 and 4.3, there was considerable 
interindividual variations in candidal adhesion to BEC among subjects 
of both groups. In the diabetic patients, candidal adhesion ranged 
from 144 to 1025 yeast / 100 BEC. The range in the control group was 
43 to 503 yeast / 100 BEC.
4.3.3 Relationship of Candidal Adhesion to Age
Ths diabetic patients and control subjects were divided into 
two subgroups according to age (Table 4.4). The diabetic patients who 
were below 60 years of age had significantly increased candidal 
adhesion than those aged 60 years or over 0.004).
In the diabetic patients, a significant inverse correlation 
between MCA and age was detected (r= -0.3; p<0.05). However, this was 
not significant in control subjects (r= -0.04; p>0.05) as shown in 
Tables 4.5 and 4.6 respectively.
Group
Age group 
(Years) No. (%)
Moan candidal adhesion 
Yeast / BBC (SD)
Diabetics < 60 33 (66) 4.6 (1.9)
> 60 17 (34) 3.1 (1.4)
Controls < 60 22 (44) 2.8 (1.4)
> 60 28 (56) 2.4 (1.1)
Tahle 4.4 Mean candidal adhesion in different age groups.
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4.3.4 Rftlatnxiiship of Ccffriidfll, ASiosion to Gender
In the diabetic patients, MCA was not statistically different 
between males and females (Table 4.7), whereas in non-diabetic 
subjects MCA was significantly higher in females (p<0.02) compared to 
males (Table 4.8).
4.3.5 Relationship of Candidal Adhesion to Denture Status and 
Denture Wearing Patterns
Statistical analysis showed no significant difference in MCA 
between dentate and denture wearers in either diabetic patients (Table 
4.7) or control subjects (Table 4.8). Nevertheless, continuous 
denture wearing (day and night) in the control subjects, but not in 
the diabetic patients, was associated with a significantly increased 
MCA compared to day denture wearing (p<0.02; Table 4.8). However, in 
the control subjects, 71.4% of those who wore dentures continuously 
were females.
4.3.6 Relationship of Candida! Adhesion to Tobacco Smoking
The subjects of the study were subdivided into smokers and
non-smokers according to the subject's social history. Any subject 
who smoked daily was considered as a smoker. MCA was not 
significantly different between smokers and non-smokers either in the 
diabetic patients (Table 4.7) or control subjects (Table 4.8).
4.3.7 Relationship of Candidal Adhesion to Alcohol Consumption
The subjects of the study were subdivided into alcohol 
users and non-drinkers according to the subject's social history.
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Mean candidal adhesion 
Group No- Yeast / BBC (SD) p
Male 27 4.2 (1.8) 0.5 NS
Female 23 3.8 (1.9)
Dentate 14 4.7 (2.0) 0.1 NS
Denture 36 3.7 (1.7)
D and N 13 3.5 (1.0) 0.5 NS
D 23 3.9 (2.0)
Smokers 16 3.5 (1.3) 0.1 NS
Non-smokers 34 4.3 (2.0)
Drinkers 7 3.8 (1.2) 0.6 NS
Non-drinkers 43 4.0 (1.9)
Dry mouth 15 4.3 (2.1) 0.5 NS
Not dry 35 3.9 (1.7)
D and N : Day and night denture wearing.
D : Day only denture wearing.
NS : Not significant.
'fahip 4.7 Mean candidal adhesion in subgroups of diabetic patients.
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Group No.
iram canmnm aonesicn 
Yeast / BBC (SD) P
Male 23 2.1 (1.1) 0.01 s
Female 27 3.0 (1.2)
Dentate 14 2.7 (1.5) 0.7 NS
Denture 36 2.5 (1.1)
D and N 14 3.1 (1.1) 0.01 S
D 22 2.2 (1.0)
Smokers 14 2.6 (1.3) 1.00 NS
Non-smokers 36 2.6 (1.2)
Drinkers 2 2.4 (1.1) 0.9 NS
Non-drinkers 48 2.6 (1.2)
Dry mouth 8 2.7 (1.4) 0.7 NS
Not dry 42 2.5 (1.2)
D and N: Day and night denture wearing.
D : Day only denture wearing.
S : Significant.
NS : Not significant.
4.8 Mean candidal adhesion in subgroups of control subjects,
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Any subject who drank alcohol daily was considered as a 
drinker, MCA was not significantly different between alcohol drinkers 
and non—drinkers either in the diabetic patients (Table 4,7) or 
control subjects (Table 4.8).
4.3*8 Relationship of Candidal Adhesion to Symptomatic Xerostomia
Statistical analysis showed no significant difference in MCA 
between those who reported symptomatic mouth dryness and those who did 
not report this symptom either in the diabetic patients (Table 4.7) or 
control subjects (Table 4.8).
4.3.9 Relationship of Candidal Adhesion to EEaematological Status 
Relationship to Haemoglobin Concentration
In the diabetic patients, the correlation was not significant 
between MCA and blood haemoglobin level (r= 0.2; p= 0.2; Table 4.5). 
Ihree diabetic patients had low haemoglobin levels (<12g/dl for 
females and <12.5g/dl for males) with MCA 4.7 (SD 0.9) while 39 
patients had normal haemoglobin levels with MCA 3.9 (SD 1.8). The 
difference between the two groups was not significant (p= 0.3). 
Haemoglobin estimation could not be determined in eight patients.
In the control subjects, a significant inverse correlation 
was detected between haemoglobin levels and MCA (r= - 0.3; p= 0.03; 
Table 4.6). Three control subjects had low haemoglobin levels with 
MCA 3.2 (SD 1.3) while 43 had normal blood haemoglobin levels with MCA
2.5 (SD 1.1). The difference in MCA between the two groups was not 
significant (p= 0.5). However, due to the small sample size, 
statistical analysis was inappropriate.__________________ __
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Relationship to Ferritin Concentration
No significant correlation was detected between MCA and 
ferritin concentration in either diabetic (r= 0.14) or control group 
subjects (r= -0.16) as shown in Tables 4.5 and 4.6 respectively.
In the diabetic patients, 16 patients were iron-deficient 
(ferritin <12ng/ml) with MCA 4.0 (SD 1.7) while 26 patients had normal 
blood ferritin concentrations with MCA 3.9 (SD 1.8). The difference 
in MCA between the two groups was not significant (p= 0.9). Ferritin 
concentration could not be determined in eight patients.
In the control group, four subjects were iron-deficient with 
MCA 3.4 (SD 1.1) while 42 subjects had normal blood iron 
concentrations with MCA 2.5 (SD 1.1). The difference in MCA between 
the two groups was not significant (p= 0.2). However, ferritin 
concentration could not be determined in four subjects.
Relationship to Cbrrected Whole Blood Folate Concentration
No significant correlation was detected between MCA and 
corrected whole blood folate concentration in either the diabetic 
patients (r= -0.09) or control group subjects (r= 0.3) as shown in 
Tables 4.5 and 4.6 respectively. Subjects of both groups had normal 
folate levels.
lteiafimshlp to Blfnd Vitamin B12 levels
No significant correlation was detected between MCA and 
vitamin B12 concentration in either diabetic patients (r= 0.16) or 
control group subjects (r= 0.1) as shown in Tables 4.5 and 4.6 
respectively.
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Vitamin B1 2 concentration was normal in diabetic patients. 
However, four control subjects were vitamin B12-deficient (<175pg/ml) 
with MCA 2.8 (SD 1.1) while 42 had normal concentrations with MCA 2.5 
(SD 1.1). The difference between the two groups was not significant 
(p= 0.7). Vitamin B12 concentration could not be determined in four 
control subjects.
4.3.10 Relationship of Candidal Adhesion to Type of Diabetes
The diabetic patients group comprised 19 patients with 
insulin-dependent diabetes mellitus (MCA 4.1, SD 2.0) and 31 patients 
with non-insulin dependent diabetes mellitus (MCA 4.0, SD 1.8). The 
difference in MCA between patients of either type of diabetes was not 
significant (p= 0.8).
4.3.11 Relationship of Candidal Adhesion to Duration of Diabetes
No significant correlation was detected between MCA and 
duration of diabetes mellitus (r= -0.18; Table 4.5). Diabetic 
patients were divided according to the duration of the disease into 
groups of five year intervals (Table 4.9). Patients with diabetes of 
less than five years duration had a significantly increased MCA over 
those who had the disease for more than 14 years (p= 0.03).
4.3.12 Relationship of Candidal Adhesion to Blood Glucose
Concentration
No significant correlation was detected between MCA and blood 
glucose concentration in either diabetic (r= 0.25) or control group 
subjects (r= -0.19) as shown in Tables 4.5 and 4.6 respectively.
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Duration of diabetes 
(Years)
Mean candidal adhesion
Yeast / BBC (SD)
< 5 26 4.2 (2.1)
5 - 9 11 3.7 (1.3)
10 - 14 7 4.4 (2.0)
>14 5 3.0 (0.7)
Table 4.9 Relationship of mean candidal adhesion to duration of 
diabetes mellitus.
% HhA1 No.
Mean candidal adhesion 
Yeast / BBC (S» P
< 10 25 3.8 (1.5)a 0.9
10 - 12 13 3.8 (1.7)b
> 12 4 6.0 (2.8)c 0.05
< 12 38 3.8 (1.5)
a vs c (P= 0.2). 
b vs c (P= 0.2).
4.10 Relationship of mean candidal
glycosylated haemoglobin per cent (%HhA1).
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The diabetic patients were further subdivided into two groups 
according to blood glucose concentration and MCA was compared between 
those who had a random blood glucose concentration of 10mmol/dl or 
less (25 patients; MCA 3,9, SD 1.7), and those who had a blood glucose 
concentration above 10mmol/dl (25 patients; MCA 4.1, SD 2.0). The 
difference was not significant between the two subgroups (p= 0.8).
4.3.13 Halaticnship of Candidal. Adhesion to Glycosylated Tfa*=wmglnh>in
No significant correlation was detected between MCA and 
percentage of glycosylated haemoglobin in diabetic patients (r= 0.2; 
Table 4.5).
The diabetic patients were further subdivided into three 
subgroups according to the percentage of glycosylated haemoglobin 
concentration as shown in Table 4.10. A Mann-Whitney U test showed 
diabetic patients with a glycosylated haemoglobin of 12 per cent or 
higher had a marginally significant increased MCA compared with those 
who had a glycosylated haemoglobin below 12 per cent.
4.3.14 Relationship of Candida! Adhesion to Oral Yeast Colonisation
The data relating to oral candidal colonisation aspects of 
this study were presented fully in Chapter Three. Briefly, oral 
candidal carriage was detected in 21 (42%) of diabetic patients while 
another six (12%) patients had clinical and microbiological evidence 
of oral candidosis. In the control group, 20 (40%) of subjects were 
Candida carriers while oral candidosis was not detected clinically in 
any of the control subjects. Oral candidal carriage rate was not 
significantly different between the diabetic patients and control 
subjects, whereas oral candidosis was significantly increased in the
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diabetic patient group (p<0.02). C. albicans was the most commonly 
isolated species from both diabetic patients (75%) and control 
subjects (67%).
No significant correlation was detected between MCA and 
quantity of oral candidal isolation either in the diabetic patients 
(r= -0.08) or control subjects (r= 0.08) as shown in Tables 4.5 and
4.6 respectively.
Finally, in diabetic patients, no significant difference was 
detected in MCA between patients who were Candida carriers, non­
carriers or those with oral candidal infection (Table 4.11). 
Similarly, in control subjects, the difference in MCA between Candida 
carriers and non-carriers was also not significant (Table 4.12).
4.3.15 Relationship of Candida Adhesion to Secrebar Status
The secretor status of the diabetic patients and control 
subjects were described in details in Chapter Three.
In the diabetic group, 31 (64.6%) patients were secretors of 
blood group substances in saliva with MCA 3.8 (SD 1.8) and 17 (33.4%) 
patients were non-secretors with MCA 4.5 (SD 2.0). Although MCA in 
the diabetic patients who were non-secretors was higher than in 
secretors, nevertheless, the difference was not statistically
significant (p= 0.2).
In the control group, 31 (62%) subjects were secretors with 
MCA 2.5 (SD 1.3) and 19 (38%) subjects were non-secretors with MCA 2.6 
(SD 1.1). The difference in MCA between secretors and non-secretors 
was also not statistically significant (p= 0.9).
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Oral candidal status No.
Mean candidal adhesion 
Yeast / BBC (SD) P
Carriers 21 4.1 (2.0 )a 0.9
Non-carriers 23 4.1 (1.9)b 0.8
Carriers + Infected 27 3.9 (1.9)
Infected 6 3.3 (1.0)c
a vs c (P= 0.16). 
b vs c (P= 0.15).
'Cable 4.11 Relationship of mean candidal adhesion to oral candidal 
colonisation in diabetic patients.
Mean candidal adhesion 
Oral candidal status No. Yeast / BBC (S3) p
Carriers 20 2.5 (1.3) 0.9
Non-carriers 30 2.6 (1.2)
fiv>hio 4.12 Relationship of mean candidal adhesion to oral candidal 
colonisation in control subjects.
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4.4 DISCDBS3EN AND CONCLUSIONS
The majority of the studies in the field of candidal adhesion 
have focussed on the adhesion process itself. Although the mechanisms 
involved were repeatedly studied they were, however, often not fully 
identified. In addition, the biological attributes of the yeast cells 
or the significance of their growth environment which might influence 
adhesion were also investigated extensively (Kennedy, 1988). Some 
studies have described variations in the adhesion capability of 
different Candida species and strains (Kearns et al., 1983; McCourtie 
& Douglas, 1984). However, there have been few investigations 
examining variations in the ability of epithelial cells from 
different sources to bind yeast cells (Sandin et al., 1987a) which was 
the main aim of the present study.
Accumulating evidence has indicated a relationship between 
microbial adhesion to the host surfaces and propensity to cause 
infection (Gibbons & van Boute, 1975). The experimental studies have 
shown a good correlation between candidal adhesion to epithelial cells 
in vitro and pathogenicity. C*_ albicans strains which had higher 
adhesion rates to epithelial cells were more virulent in animal models 
of disseminated candidosis (McCourtie & Douglas, 1984; Barrett-Bee et 
al., 1985; Ghannoum & Abu Elteen, 1 986). albicans and C^ 
stellatoidea which adhered markedly to comeocytes were particularly 
pathogenic in a rodent model of cutaneous candidosis in contrast to 
nan-pathogenic species which showed little or no adherence (Ray et 
al., 1984). Moreover, a rabbit Candida endocarditis model (Calderone 
et al., 1985) and a murine model of vaginal candidosis (Lehrere et 
al., 1986) were established by using a C. albicans strain which was 
able to adhere well in vitro to fibrin platelet clots and vaginal
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epithelial cells respectively/ while a mutant of the same strain which 
showed a reduced ability to adhere was not pathogenic.
§j:j?^-cans. an opportunistic yeast known to reside 
ccmnensally in the oral cavity, gastrointestinal tract and urogenital 
system of many individuals (Odds, 1988). Although the pathogenesis of 
clinical fungal infection involves a complex series of interactions 
which may not be fully reproduced during in vitro experiments, 
nevertheless, candidal adhesion to host surfaces still appears to be 
of prime importance. Adherence of albicans to oral epithelial 
cells might not be neccessary either for yeasts survival or growth, it 
is an important first step in surface colonisation by counteracting 
the influence of dislodging forces like the continuous secretion of 
saliva, food movement and muscular contraction in the oral cavity. 
This "adherability" enables the yeast to proceed to colonisation and 
subsequent infection. In that regard, Howlett and Squier (1980) have 
shown that candidal adhesion to the epithelial cells was necessary for 
the invasion to occur while yeasts which did not adhere were unable to 
invade the epithelium.
Comparing results of adhesion of the present investigation 
with those of other workers can be problematical due to differences in 
methods used to study candidal adhesion in vitro. These variations 
include differences in strains of C«_ albicans used (or concentration), 
epithelial cell source, candidal growth media and culture environment 
(Kennedy & Sandin, 1988) all of which indicate the need for a 
universal standardised adhesion assay.
T^v-y»ai epithelial cells were used in this study as a 
substratum for candidal adhesion for the following reasons : (I) The
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ease of collection of a reasonable number of cells. (II) Cell size 
and morphology which is suitable for counting procedures. (Ill) 
Comparatively few indigenously attached bacteria. (IV) Buccal mucosa 
is a site for candidal infection in vivo. C. albicans was chosen as 
the test organism because it adheres to buccal epithelial cells to a 
greater degree than other Candida species (King et al., 1980) and is 
the most commonly species isolated from cases of oral candidosis 
(Odds, 1988).
Adhesion of albicans to epithelial cells is generally the 
result of interaction between Candida adhesion site(s) and 
complementary epithelial cell receptor(s). Critchley and Douglas 
(1987b) have shown that epithelial receptors are composed of 
glycosides containing a protein and carbohydrate moiety which may be 
particularly required for Cj_ albicans adhesion. Since all adhesion 
assays in the present study were conducted under the same 
environmental conditions, using the same growth medium, the same 
thorough washing technique and a single candidal strain, any 
quantitative differences in candidal adhesion between the groups 
studied should reflect true differences in the number and / or nature 
of the available receptors on the epithelial cell membrane.
The finding that albicans was the most commonly isolated 
species in both diabetic and control subjects is consistent with the 
generally accepted idea that albicans is recovered more commonly 
from mucosal surfaces than other species (Odds, 1988). This may be 
due to the ability of this particular species to adhere to buccal and 
vaginal epithelial cells in vitro to a much higher degree than other 
candidal species (King et al., 1980).
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The increased susceptibility of women with diabetes mellitus 
to vaginal candidosis has been previously linked with an increased in 
yitro- adhesion of C. albicans to vaginal epithelial cells collected 
from these patients (Segal et al., 1984). The present study is the 
first to report a significantly increased candidal adhesion to buccal 
epithelial cells of diabetic patients compared with non-diabetic 
individuals. Theoretically, this may mean the presence of higher 
number of receptors for Candida on epithelial cells from diabetic 
patients. In addition, the possible qualitative difference in 
receptors on epithelial cell surface between diabetic patients and 
non-diabetic subjects should be taken into consideration. 
Interestingly, the number of cells that had no adherent Candida was 
considerably less in the diabetic patients. This suggests that the 
proportion of epithelial cells having receptors for Candida is greater 
in diabetic patients when compared with non-diabetics. These 
observations may partly explain the increased predisposition of 
diabetic patients to oral candidal infection. However, the additional 
finding of considerable inter individual variations in candidal 
adhesion between subjects in either group is consistent with that 
reported in other studies of normal individuals (Sobel et al., 1981; 
Sandin et al., 1987a). If other studies confirmed the increased 
candidal adhesion to epithelial cells from diabetic patients, this 
will open the way for further research to explain this phenomenon. 
Although the present study has not identified specific reason for the 
increased candidal adhesion in diabetic patients, multiple mechanisms 
are possible.
Long standing diabetes is frequently associated with 
permanent and irreversible functional and structural changes in the
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cells of the body (Baird, 1987). Glucose in blood is known to form 
glycosylation products with proteins at a rate proportional to the 
glucose concentration. Hence the amount of glycosylation products, 
whether on haemoglobin, basement membranes or endothelial cells are 
much increased in diabetic patients (Brownlee, Cerami, Vlassara, 
1988). It would therefore be interesting to investigate the 
possibility of alterations in the glycosylation process in diabetic 
patients, which may affect carbohydrate moieties on the epithelial 
cells in a way that might modify their receptivity to yeast cells. A 
phenomenon such as this may account for the significant increase in 
Candida "positive" cells observed in the diabetics when compared with 
the controls. It is also worth noting that candidal cells adhered in 
greater numbers to epithelial cells from those diabetic patients with 
high percentages of glycosylated haemoglobin (over 12 per cent - 
indicating poor glycaemic control) than to diabetics with lower 
glycosylated haemoglobin levels and thus better glycaemic control. 
Segal et al. (1984) explained the increased candidal adhesion to 
vaginal epithelial cells from diabetic women as being due to the 
increased glycogen content of these cells and the higher proportion of 
intermediate epithelial cells with larger surface area.
C. albicans grown in media supplemented with glucose 
exhibited changes in the cell wall structure resulting in enhanced 
adhesion to epithelial cells (McCourtie & Douglas, 1981; Samaranayake 
& MacFarlane, 1982b). Therefore it is tempting to speculate that a 
higher glucose concentration in the saliva of diabetic patients 
(Thors tens son et al., 1989), may modify the surface of oral epithelial 
cell in a way which increases their receptivity to Candida.
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Oral commensal microflora has been shown to affect candidal 
adhesion to oral epithelium (Liljemark & Gibbons, 1973). Strep. 
salivar ius, Strep, mitior (Samaranayake & MacFarlane, 1982a) and 
lactobacilli (Sobel et al., 1981 ) all have been shown to reduce 
candidal adhesion to epithelial cells. In addition, Cox (1983) 
noticed reduced candidal adhesion to buccal epithelial cells already 
colonised with bacteria.
Bacterial competition for receptors on epithelial cells or 
production of bacterial metabolites affecting these receptors are 
possible mechanisms (Samaranayake & MacFarlane, 1982a). However, 
certain piliated bacteria such as coli can enhance, rather than 
reduce, candidal adhesion to epithelial cells (Makrides & MacFarlane, 
1983). Probably the mannose-sensitive pili from attached bacteria 
could recognise mannan-containing moities on the surface of C. 
albicans, bind to them and facilitate candidal adhesion to epithelial 
cells. There is, therefore, a need for subsequent studies quantifying 
oral bacterial flora and investigating its influence on candidal 
adhesion to epithelial cells from diabetic patients and control 
subjects. However, neither type of diabetes mellitus, duration of 
disease, or blood glucose concentration seems to affect candidal 
adhesion in diabetic patients. Perhaps the metabolic effect of 
diabetes on epithelial cells therefore occurs early in the course of 
the disease and may be irreversable. In addition, the measurement of 
a single blood glucose level at one point in time is too crude to be 
expected to correlate with candidal adhesion.
Salivary pH has been reported frequently to be lower in 
diabetic patients than that in non-diabetic individuals (Banoczy et 
al., 1987). A culture medium of low pH has also been shown to enhance
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candidal adhesion to epithelial cells (Samaranayake & MacFarlane, 
1982a). Mammalian cells and yeast cells, are both endowed with a net 
negative surface potential. Therefore, prior to candidal adhesion to 
epithelial cells, each must overcome the electrostatic barrier of 
their negatively-charged functional groups (Kennedy, 1988). It is 
tempting to speculate that the low pH in the oral cavity of diabetic 
patients acts to reduce surface electronegativity on the epithelial 
cell surface due to protonation of the exposed cell surface functional 
groups and, theoretically, may facilitate candidal adhesion in 
diabetic patients.
Since lysozyme, the potent fungicidal salivary factor, is 
known to have a highly cationic charge, it may avidly bind either to 
the yeast or the epithelial cell surface (or both) and thereby, 
interfere with yeast adhesion to the epithelial cell surface (Tobgi 
et al., 1988). However, lysozyme in saliva of diabetic patients may 
not be as inf luencial in retarding candidal adhesion, as it is in non­
diabetic individuals, since it has been shown to have significantly 
reduced activity in saliva of diabetic patients (Velikov et al., 1985) 
and in hamsters rendered diabetic by alloxan (Muratsu & Morioka, 
1985).
Previous studies of yeast adhesion to buccal cells of healthy 
adnl t~ct have shown that age of the donors does not have an influence on 
yeast adhesion (Cox, 1983). The present results in the non-diabetic 
subjects tend to agree with this conclusion. However, why diabetics 
aged below 60 years had a higher mean candidal adhesion than older 
patients is not at present explicable, and the clinical importance is 
uncertain. Whether functional or quantitative differences exist in
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epithelial cell receptors for Candida in diabetics of different ages 
warrants study.
In health, gender does not affect candidal adhesion to buccal 
epithelial cells (Cox, 1983; Sandin et al., 1987b) which agrees with 
the present results in the diabetic patients. Quite why candidal 
adhesion was found to be higher in non-diabetic females compared to 
males is uncertain, although a possible hormonal influence cannot be 
excluded. However, it is noteworthy that more than 70 per cent of 
control female subjects wore their dentures continuously and 
continuous denture wearing in the non-diabetic subjects was associated 
with a significant increase in candidal adhesion compared with those 
who wore dentures during the day only. Although this latter finding 
is an observation rather than an explanation, it could be relevant to 
the results presented in Chapter Three since clinical oral candidosis 
was diagnosed only in continuous denture wearers, which is in 
accordance with that reported in denture wearers generally (Budtz- 
Jorgensen, 1974). In addition to the multiple factors predisposing 
denture wearers to oral candidal infection (Budtz-Jorgensen, 1974), 
the present observation of effect of denture wearing pattern suggests 
that the continuous wearing of dentures, in some way, has an influence 
on oral epithelial cells integrity rendering them more receptive to 
yeast cells.
There is little information in the literature on the effect 
of saliva on candidal adhesion to oral epithelial cells. Samaranayake 
and MacFarlane (1982a) reported that pretreatment of HeLa cell 
monolayers with mixed saliva enhanced adherence of C. albicans. The 
present study could not detect any difference in candidal adhesion 
between those patients who reported symptomatic xerostomia and those
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who did not report this symptom. However, the present in vitro 
finding is difficult to interpret since only the outer surface of 
buccal cells would be directly coated with saliva leaving the deeper 
cell surface saliva-free. In addition, subsequent washing of the 
buccal epithelial cells may dilute or remove some of the salivary 
components cn the cell surface.
The relationship of haematological status including levels of 
haemoglobin, ferritin, folate and vitamin B12 on in vitro candidal 
adhesion has not as yet been reported. These factors were shown to 
have no apparent influence on candidal adhesion in diabetic patients. 
The observed significant positive correlation between reduced 
haemoglobin level and in  vitro candidal adhesion in the diabetic 
patients is far from explained. However, this finding may be 
reasonable considering the reported increased incidence of oral 
candidosis in patients with iron deficiency (Fletcher et al., 1975; 
Challaccmbe, 1986). This warrants further study to include patients 
with selected haematological deficiencies.
Hie present study did not demonstrate a difference in mean 
candidal adhesion between carriers of Candida species and non-carriers 
or patients with oral candidosis. This finding is in contrast to the 
results of Cox (1983) who found a significantly increased candidal 
adhesion to epithelial cells both from Candida colonised subjects and 
from patients with oral candidosis compared with controls. However, 
95 per cent of the colonised and 80 per cent of diseased subjects in 
that study were receiving antibiotic therapy at the time of testing. 
Other recent research in this field has shown antibiotic therapy to 
increase candidal adhesion to oral epithelial cells (Velichko &
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Karaev, 1988). Hus is probably because antibiotic therapy suppresses 
indigenous oral bacteria competing with yeasts for nutrients (Knight & 
Fletcher, 1 971) and adhesion sites on the epithelial cell surface 
(Centeno et al., 1983).
Hie lack of correlation between yeast carriage and in vitro 
candidal adhesion implies that other factors in addition to candidal 
adhesion such as presence of dental prostheses or denture wearing 
patterns (Arendorf & Walker, 1979) or high carbohydrate intake 
(Samaranayake, 1986) may promote carriage of candidal species in the 
oral cavity. Although carbohydrate intake was not quantified in 
diabetic subjects, it would be expected to be low since most of the 
diabetic patients had good glycaemic control as measured by 
glycosylated haemoglobin level.
Considering subjects with proven oral candidal colonisation, 
the present study has shown that candidal adhesion to buccal 
epithelial cells was comparable both in infected and non-infected 
individuals. Thus factors such as host immune status and other 
environmental determinants, including saliva composition, may be more 
important in determining why adherence was achieved and resulted in 
clinical infection in some individuals. In other words, the 
propensity for the adhered yeast cells to behave as commensal 
organisms or proceed to clinical infection could depend on a dynamic 
balance of various parameters acting either in favour or against the 
host. This is in line with oral candidosis being described by the
epithet "disease of the diseased".
Hie result of comparing candidal adhesion to buccal 
epithelial cells isolated from secretors and non-seeretors, was not 
significant and, therefore, not in agreement with the finding reported
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by May et al. (1986) that epithelial cells from secretors bind Candid 
in fewer number than those epithelial cells derived from non— 
secretors.
In the saliva of non-secretors, Lewis3 antigen (a blood group 
antigen found predominantly on the cells of non-secretors) may adsorb 
to epithelial cells and function as a receptor for some strains of C. 
albicans (Blackwell, 1989). Recently May, Blackwell and Weir (1989) 
have shown that not all C. albicans blastospores have the ability to 
recognise Lewis3 antigen on epithelial cells from non-secretors as a 
receptor, which was probably the case with the strain used in the 
present study.
If future studies confirm the present finding of increased 
candidal adhesion to buccal epithelial cells in diabetic patients, the 
precise additional factors responsible could be clearly identified and 
their importance in  vivo established. This may clear the way for a 
greater understanding of the mechanisms of mucosal candidal infection 
in patients with systemic disease such as diabetes, and the 
information thus gained could be translated to a clinical setting.
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CHAPTER FIVE
T86 *N Vl'-PtO AND ESI VIVO EFFECT OF 0.2% CHLORHEXIDINE GLUCONATE ON 
AEHESXQN OF CMP3DA AU3ICANS TO BUX3VL HTEHELIAL CFTJ-c; 5ROM DIABETIC 
PATltHES AND NCN-DIABEnC INDIVIDOAIS
5,1 EWHCDUCTICN AND AIMS CF THE STUDY
Chlorhexidine gluconate in a concentration of 0.2 per cent is 
used widely in clinical practice as an antiseptic oral rinse. It has 
proven to be effective against a broad spectrum of oral microorganisms 
and therefore, has been shown to be useful in the control of 
supragingival plaque and gingivitis (Salem et al., 1 987). The 
antifungal effect of chlorhexidine has been demonstrated in several 
clinical trials where it was used successfully in a regimen for the 
treatment of chronic atrophic candidosis in otherwise healthy 
individuals (Budtz- Jorgensen & Loe, 1972; Olsen, 1975a). Indeed, the 
therapeutic effect of chlorhexidine in cases of chronic atrophic 
candidosis was comparable to that of the specific antifungal agent 
amphotericin B (Olsen, 1975b). The application of 0.2% chlorhexidine 
to the fitting surface of upper denture and palatal mucosa four times 
daily has also proved useful in reducing candidal colonisation to 
these surfaces (Olsen, 1975a).
In addition to its fungicidal properties (Bobichon & Bouchet, 
1987), chlorhexidine, when used as a mouth rinse, has been reported to 
render the host surfaces less receptive to candidal colonisation. 
Pretreating acrylic surfaces in vitro with 2% chlorhexidine reduced 
the adherence of Candida species (Samaranayake et al., 1980; 
McCourtie et al., 1986a). A recent study, albeit on a limited number
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of healthy individuals, has shown a significant reduction in the 
adhesion of albicans to buccal epithelial cells exposed to 0.2% 
chlorhexidine (Tobgi et al., 1987). It is conceivable that, diabetic 
patients who as a disease group are predisposed to oral candidosis and 
have higher rates of candidal adhesion to their epithelial cells 
(described in Chapters Three and Four), may benefit from the use of a 
0.2% chlorhexidine mouth rinse. This benefit could be derived by both 
reducing candidal adhesion to their oral mucosa and the direct 
fungicidal activity of the agent. However, this hypothesis has to 
date not been investigated.
Since the inherited inability to secrete blood group antigens 
in saliva has been linked with susceptibility to oral candidosis (Thom 
et al., 1989) and diabetic patients who are non-secretors may have an 
increased propensity to harbour yeast intraorally, the aims of the 
present in vitro and in vivo investigations were to answer several 
specific questions. Firstly, would exposure of buccal epithelial 
cells (BEC) from healthy adult individuals to 0.2% chlorhexidine 
gluconate, for one minute reduce candidal adhesion ? Secondly, if so, 
whether similar treatment of BEC from diabetic patients results in a 
comparable reduction in candidal adhesion and finally, whether such a 
treatment results in an equivalent reduction in candidal adhesion to 
BEC from non-secretors and secretors.
5.2 MATERIALS AND METHODS
5.2.1 Patients Selection
Twelve patients with diabetes mellitus and 12 non-diabetic
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subjects gave informed consent to participate in the study which was 
approved by the local Ethics Committee. All subjects from both 
patient and control group participated jointly in both in vitro and in 
vivo experiments.
The diabetic patients were recruited from the outpatient 
Diabetic Clinic at Glasgow Royal Infirmary to the Oral Medicine Unit 
at Glasgow Dental Hospital where the clinical sampling was performed. 
The non-diabetic subjects were postgraduate students or staff at 
Glasgow Dental Hospital and School who volunteered to participate in 
the study.
5.2.2 Clinical History and Oral Bcam-inai-tra
A verbal medical history was taken from each subject. The 
type of diabetes mellitus and duration of the disease were recorded 
for the diabetic patients. For each subject, the wearing of a dental 
prosthesis was recorded as was whether the prosthesis was worn 
continuously (day and night). Subjects who either consumed alcohol 
regularly or who smoked cigarettes daily were considered as smokers 
and drinkers respectively.
Each subject underwent a routine oral clinical examination to 
detect the presence of clinical oral candidal infection.
5.2.3 Sdcxebor Status Determination
Secretor status was determined by the agglutination 
inhibition technique described by Periera et al. (1969) using 
unstimulated mixed saliva. Details of saliva collection, the 
agglutination inhibition technique itself and criteria for defining 
secretor status were described in Sections 3.2.7 to 3.2.9.
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5.2.4 Collection and Preparation of Buccal Epithelial Cells to 
Study the Effect of Exposure to 0.2% Chlorhexidine Tn vitro 
on Candida! Adhesion In Vitro
For the in vitro experiment, BEC were collected from each 
subject by gently rubbing both the right and left buccal mucosa each 
with a sterile cotton swab (Exogen Ltd., Clydebank, Scotland). Each 
swab was then agitated in 10ml phosphate buffered saline (PBS 0.1 M, pH 
7.2) in a universal container (Steriiin Ltd., Feltham, England) which 
was retained cn crushed ice till the time of processing. Throughout 
the study, PBS of the same osmolarity and pH was used. Buccal 
epithelial cells obtained from the right buccal mucosa were used as 
the control for the experiment (control cells), while those obtained 
from the left mucosa were allocated for the in vitro experiment (test 
cells)•
BEC were pelleted by centrifugation (MSE Centaur 2 
Centrifuge. Fisson's Ltd., Crawley, Sussex, England) at 400g for five 
minutes. Subsequently, the BEC pellet from the left buccal mucosa was 
exposed to 10ml 0.2% chlorhexidine gluconate ("Corsodyl", ICI 
Pharmaceuticals, Macclefield, England) while BEC from the right buccal 
mucosa were treated similarly with 10ml PBS. After one minute 
incubation at room temperature, BEC were harvested on polycarbonate 
filters of 25mm diameter and 12/xm pore-size (Nuclepore Gmbh, Germany) 
mounted on a DEFT (direct epifluorescent filter technique) manifold 
(Mi.crqreas*itpnyants Ltd., Saffron Walden, Essex, England) as shown in 
Figure 4.1. This method provided rapid separation of BEC from 
chlorhexidine and thus attempted to simulate the in vivo conditions.
Ihe filter and the retained BEC were then agitated gently in 
10ml PBS in a universal container to detach the BEC from the filter
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which therefore became suspended in PBS, Subsequently, the filter was 
discarded and the BEC washed twice in 10ml PBS by centrifugation at 
400g for five minutes. Microscopic examination has shown none of the 
BEC had naturally attached yeasts after the PBS wash. A final BEC 
suspension of 10  ^cell per ml was prepared by appropriate dilution of 
the deposit in PBS following haemocytometer counting (Hawksley and 
Sons Ltd., Lancing, England).
5.2.5 Collection and Preparation of Buccal Epithelial Cells to 
Study the Effect of 0.2% Chlorhexidine Rinse In Vivo on 
Qmdidal Adhesion In Vitro
In the assay in vivo, BEC were collected from each subject by 
gently rubbing the right buccal mucosa with a sterile cotton swab, 
which was then agitated in 10ml PBS in a universal container retained 
on crushed ice. These cells acted as the control BEC for the 
experiment. Subsequently, each subject was asked to rinse the mouth 
thoroughly (after denture removal if appropriate) with 10ml 0.2% 
chlorhexidine gluconate. After one minute, the subject expectorated 
the rinse and BEC were immediately obtained by gently rubbing the left 
buccal mucosa with a sterile cotton swab which was then suspended in 
10ml PBS in a universal container, and was placed on crushed ice 
until processing.
BEC washed twice in 10ml PBS by centrifugation at 400g for
c
five minutes were then resuspended in PBS at a concentration of 10 
cell per ml as determined by haemocytometer counting. Microscopic 
examination showed that none of the BEC had indigenously adherent 
yeasts after the PBS wash. All sampling was carried out between 1400
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and 1700 hours. The in vitro and in vivo experiments were repeated 
twice for each subject with a two weeks interval between sampling to 
avoid any possible carry-over effect of the chlorhexidine mouth wash. 
Also, as further standardisation, BEC were collected at the same hour 
of the day to exclude any possible influence of diurnal variations.
5.2.6 Source, Identification and Maintenance of Candida AJJbicans
Strain CDS 88
Gj_ albicans strain CDS 88 used throughout the study was 
originally isolated from the oral cavity of an asymptomatic carrier of 
C. albicans from the Oral Medicine Unit at Glasgow Dental Hospital. 
The species was identified by the serum germ tube formation technique 
(MacKenzie, 1962) and using the identification system API 20 C AUX 
(API Products Ltd., Basingstoke, Hampshire, England), and then freeze- 
dried. The strain was maintained on slopes of Sabouraud's dextrose 
agar (Gibco, Paisley, Scotland) at 4° C and the culture was replaced 
monthly by a new one freshly-grown from freeze-dried stock.
5.2.7 Preparation of Candida Albicans Suspension
To prepare the yeast cells for the adhesion assay, a loopful 
of the stock culture was inoculated into 10ml Sabouraud's broth 
(Gibco, Paisley, Scotland) containing 500mM sucrose in a universal 
container, and incubated overnight (18-24 hours) at 37 C in an orbital 
shaker incubator (Gallenkamp, Loughborough, England) operating at 100 
revolutions per minute. Sabouraud's broth containing 500mM sucrose is 
known to enhance candidal adhesion (McCourtie & Douglas, 1981) and 
yeast cells in the stationary phase of growth have been shown to 
adhere more readily to epithelial cells than yeast cells in the
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logarithmic phase (King et al., 1980). Hie culture was then harvested 
by centrifugation at 400g for five minutes and the pellet washed twice 
in 10ml PBS by centrifugation at 400g for five minutes. A final yeast 
cells suspension of 107 per ml was prepared by appropriate dilution of 
the deposit in PBS followed by haemocytometer counting.
5.2.8 The Candidal Adhesion Assay
The in vitro candidal adhesion assay described by Kimura and 
Pearsall (1978) was used in this study with few modifications.
For the adhesion assay, equal volumes (0.5ml) of BEC 
suspension and C. albicans suspension were mixed in a sterile bijou 
container (Sterilin Ltd., Feltham, England) and incubated on an 
orbital shaker operating at 80 revolutions per minute at 37° C for one 
hour. The BEC were then harvested on polycarbonate filters of 25mm 
dimater and *\2fm pore-size mounted on a DEFT manifold. A negative 
pressure of 5mm Hg was applied to the manifold from a Venturi pump 
drawing the suspension in the filter tower through the filter, and the 
filter with the retained BEC were washed gently with 30ml PBS in 
aliquots of 5ml to eliminate unattached yeast cells. Hie pore size of 
12/Am was small enough to retain the BEC without gross distortion but 
large enough to allow unattached yeast cells to be washed through the 
filter unit, leaving only the BEC with the adherent yeast cells on the 
filter. The filter with the washed BEC were then removed from the 
filter unit, mounted on a 1mm thick, 26 X 76mm glass microscope slide 
(Chance Proper Ltd., Smethwick, England) and left for one hour to air- 
dry and then Gram-stained. The filter and the stained BEC on each 
glass slide were left overnight to air-dry then a 22 X 22mm glass
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cover slip (Chance Proper Ltd., Smethwick, England) was fixed on the 
filter with Harleco resin (Kodak Chemicals, England).
5.2.9 Counting of Adherent Yeast Cells
The glass slides holding the filters were coded and counting 
was undertaken in a "blind" manner. The number of CL albicans 
blastospores which adhered to 100 individual BEC in randomly selected 
fields were counted microscopically under x40 objective (Olympus Ltd., 
London, England). Only morphologically normal epithelial cells were 
counted. These were flat cells, with an intact surface membrane which 
was not folded. Clumps of BEC were excluded and pseudohyphae, if 
present, were not counted.
5.2.10 Statistical Analysis
Hie percentage reduction in candidal adherence for each 
subject was calculated as follows:
Ac - At
% reduction in adherence =-------x 100
Ac
Ac = Yeast adhered to 100 BEC of control cells.
At = Yeast adhered to 100 BEC of test cells.
Student's t test for paired data was used to evaluate 
differences in candidal adherence between subjects of a group, whereas 
Student's t test for unpaired data was used to evaluate differences in 
candidal adhesion between different groups as well as between 
different experiments. Probabilities of less than five per cent were 
taken to be statistically significant.
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5.3 RESOLES
5.3.1 Subjects of the Study
The clinical status of study subjects is presented in Table 
5.1. The diabetic group comprised of eight patients (66.7%) with 
insulin-dependent diabetes mellitus and four patients (33.3%) with 
non-insulin dependent diabetes mellitus. The mean duration of the 
disease was 8.98 (SD 8) years, ranging from three months to 22 years.
None of the subjects had received antibiotic or steroid 
therapy, or had used a mouth wash or tooth paste containing 
chlorhexidine for at least three months before commencing the study. 
None of the subjects had either signs or symptoms suggestive of oral 
candidal infection.
5.3.2 The Effect of Exposure of BEC to 0.2% Chlorhexidine Gluconate
In Vitro on Candidal Adhesion
Pretreating BEC for one minute with 0.2% chlorhexidine 
gluconate in vitro resulted in a significant reduction in candidal 
adhesion in both non-diabetic subjects (Table 5.2; p<0.0001 ) and 
diabetic patients (Table 5.3; p< 0.0001). However, BEC from one 
control subject showed an overall increase in candidal adhesion after 
0.2% chlorhexidine treatment.
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Diabetics (n= 12) Non-diabetics (n= 12)
Male 6 (50%) 8 (67%)
Female 6 (50%) 4 (33%)
Mean age (years) 37.3 SD 13.8 31.9 SD 4.9
Age range (years) 15 - 57 22 - 39
Denture wearers 3 (25%) 1 (8%)
D and N 3 (100%) 1 (100%)
Dentate 9 (75%) 11 (92%)
Symptomatic xerostomia 4 (33%) 0 (0%)
Smokers 3 (25%) 2 (17%)
Alcohol drinkers 0 ( 0%) 0 ( 0%)
D and N : Day and night denture wearing.
SD : Standard deviation of the mean.
qy»Kip 5.1 Clinical status of the chlorhexidine study subjects.
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In diabetic patients and non-diabetic subjects, variations 
were observed in mean percentage reduction in candidal adhesion 
between individuals. The overall mean percentage reduction in 
candidal adhesion in non-diabetic subjects was 33.1 per cent (95% 
confidence intervals 21,6 , 46.9) ranged from 6.5 per cent to 62.6 per 
cent. The mean percentage reduction in candidal adhesion in diabetic 
patients as a whole was 21.6 per cent (95% confidence intervals 15.6 , 
27.6) ranged from 8.9 per cent to 36.8 per cent. However, when the 
test was repeated in two separate occasions, intr a individual 
variations were also observed in percentage reduction in candidal 
adhesion to BEC in both groups. Although the mean percentage 
reduction in candidal adhesion was higher in non-diabetic subjects 
than in diabetic patients, the difference was not statistically 
significant (p>0.05).
5.3.3 Hie Effect of 0.2% Chlorhexidine Gluconate Rinse In Vivo on
Candidal Adhesion
Rinsing the mouth for one minute with 0.2% chlorhexidine 
gluconate resulted in a significant reduction in candidal adhesion to 
BEC in non-diabetic subjects (Table 5.4; p<0.05) and diabetic patients 
(Table 5.5; p<0.002). However, BEC obtained from one non-diabetic 
subjects and two diabetic patients showed overall increased candidal 
adhesion after chlorhexidine rinsing. In agreement with the results 
of the in vitro experiments, in the in vivo experiment both inter and 
intrainH-i virlna 1 variations were observed in the percentage reduction 
in candidal adhesion in individuals of both groups. The mean 
percentage reduction in candidal adhesion in non-diabetic subjects was
20.1 per cent with a range from 6.4 per cent to 51.2 per cent (95%
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confidence intervals 7.5, 32.8). In the diabetic patients, the mean 
percentage reduction in candidal adhesion to BEC was 1 4.8 per cent 
(95% confidence intervals -1.5 , 31) with overall results ranging from 
0.2 per cent to 42.8 per cent. Although the mean percentage 
reduction in candidal adhesion was higher in non-diabetic subjects 
than in diabetic patients, the difference was not statistically 
significant (p>0.5).
5.3.4 Comparison Between In Vitro and In Vivo Results
One minute exposure of BEC to 0.2% chlorhexidine in vitro 
resulted in a higher mean percentage reduction in candidal adhesion to 
BEC than in vivo one minute mouth rinsing with 0.2% chlorhexidine 
(Figure 5.1). Nevertheless, statistical analysis showed no 
significant difference between in vitro and in vivo experiments either 
in diabetic patients or non-diabetic subjects (p>0.05).
5.3.5 Relationship Between Percentage Reduction in Candidal
Adhesion to BEC and Secretor Status
No significant difference was detected in mean percentage 
reduction in candidal adhesion to BEC between secretors and non- 
secretors. This finding held true for both the diabetic patients 
(Table 5.6) and non-diabetic subjects (Table 5.7) and also for the 
results of both the in vitro and in vivo experiments.
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Case MCA: Yeast / 100 BBC (SD) % Reduction
no. Control Test in adhesion
1 254 150 40.9
173 97 43.9
- - - Mean 213.5 (57.3) 123.5 (37.5) 42.4 (2.1)
2 206 186 9.7
303 203 33.0--Mean 254.5 (68.6) 194.5 (12.0) 21.4 (16.5)
3 141 136 3.5
241 108 55.2
—  _ 191.0 (70.7) 122.0 (19.8) 29.4 (36.6)
4 103 47 54.4
241 108 55.2
-------ncsm 172.0 (97.6) 77.5 (43.1) 54.8 (0.6)
5 107 77 28.0
317 204 35.6
Mean 212. (103.9) 140.5 (89.8) 45.1 (13.5)
6 67 100 +49.2
281 160 43.0
Mean 174.0 (151.0) 130 (42.4) + 3.1 (65.2)
7 317 148 53.3
330 171 48.2
- - Mean 323.5 (9.2) 159.5 (16.3) 50.7 (3.6)
8 177 87 50.8
247 218 11.7
mm------HB9K1 212.0 (49.5) 152.5 (92.5) 31.2 (27.6)
9 153 133 13.0
150 150 0.0
mm-----nean 151.5 (2.1) 141.5 (12.5) 6.5 (9.2)
10 182 88 51.6
249 139 44.2
- - nean 215.5 (47.4) 113.5 (36.1) 47.9 (3.7)
11 112 87 22.3
228 177 22.4
Mean 170.0 (82.0) 132.0 (63.6) 22.3 (0.1)
12 296 99 66.5
211 87 58.8
mm-----nean 253.5 (60.1) 93.0 (8.5) 62.6 (5.4)
Mean 214.5 131.6 33.1
SD 48.4 30.5 19.9
+ : % increase in candidal adhesion.
TaKlo 5.2 The effect of exposure to 0.2% chlorhexidine gluconate in
vitro cn adhesion of C^_ albicans to buccal epithelial
cells from non-diabetic subjects.
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Case MCA: Yeast / 100 BBC (SD) % Reduction
no. Obntrol Test in adhesion
1 169 128 24.3
280 151 46.0—- — naan 224.5 (78.5) 139.5 (16.3) 35.1 (15.3)
2 156 109 30.1
244 239 2.0
-------Mean 200.0 (62.2) 174.0 (91.9) 19.9 (2.5)
3 274 248 9.5
203 168 17.2
----nean 238.5 (50.2) 208.0 (56.6) 13.3 (5.4)
4 316 271 14.2
275 235 14.5
if, i .naan 295.5 (29.0) 253.0 (25.5) 14.4 (0.2)
5 240 142 40.8
247 239 3.2
nean 243.5 (4.9) 190.5 (86.6) 22.0 (26.6)
6 345 209 39.4
295 194 34.2
»» - - nean 320.0 (35.4) 201.5 (10.6) 36.8 (3.7)
7 311 219 29.6
370 295 20.3
naan 340.5 (41.7) 257.0 (53.7) 24.5 (6.6)
8 300 260 13.3
173 165 4.6
**------nean 236.5 (89.8) 212.5 (67.2) 8.9 (6.1)
9 553 432 21.9
310 253 18.4
------nean 432.0 (172.0) 342.5 (126.5) 20.1 (2.5)
10 272 252 7.3
247 213 13.8
Mean 259.5 (17.7) 232.5 (27.6) 10.5 (4.6)
11 416 191 54.0
430 389 9.5
Mean 423.0 (9.9) 290.0 (140.0) 31.7 (31.5)
12 368 246 33.1
438 352 19.6_._.HBBffl 403.0 (49.0) 299.0 (75.0) 26.3 (9.5)
Mean 301.3 233.3 21.6
SD 81.7 57.7 9.5
■fahio 5.3 Hie effect of exposure to 0.2% chlorhexidine gluconate in
vitro on adhesion of albicans to buccal epithelial
cells from diabetic patients.
173
Case MCA: Yeast / 100 BBC (SD) % Reduction
no. Cbntrol Test in adhesion
1 216 146 32.3
138 100 27.5
Mean 177.0 (55.2) 123.0 (32.5) 29.9 (3.5)
2 167 153 8.4
132 175 32.6--HB9H 149.5 (24.7) 164.0 (15.6) 12.1 (28.9)
3 71 86 +21.1
182 120 34.0--nean 126.5 (78.5) 103.0 (24.0) 6.4 (38.9)
4 156 216 +38.5
206 184 10.4
Mean 181.0 (35.4) 200.0 (22.6) +13.9 (34.8)
5 184 118 35.9
185 120 35.1--nean 184.5 (0.7) 119.0 (1.4) 35.5 (0.6)
6 67 69 + 2.9
251 148 41.0» » -MBan 159.0 (130.0) 108.5 (55.9) 19.0 (31.0)
7 144 101 29.9
538 321 40.3»»--nean 341.0 (279.0) 211.0 (156.0) 35.1 (1.5)
8 240 134 44.2
235 98 58.3--nean 237.5 (3.5) 116.0 (25.5) 51.2 (9.9)
9 193 193 0.0
170 149 12.3
_ _ ~ nean 181.5 (16.3) 171.0 (31.1) 6.9 (8.7)
10 164 92 43.9
179 136 24.0--nean 171.5 (10.6) 114.0 (31.1) 33.9 (14.1)
11 160 106 33.7
238 183 23.1
Mean 199.0 (55.2) 144.5 (54.4) 28.4 (7.5)
12 286 198 30.8
129 111 13.9-nean 207.5 (111.0) 154.5 (61.5) 22.3 (11.9)
Mean 192.9 139.8 20.1
SD 54.5 35.9 19.9
+ : % increase in candidal adhesion.
TViMg 5.4 The effect of 0.2% chlorhexidine gluconate rinse in vivo on
adhesion of albicans to buccal epithelial cells from
non-diabetic subjects.
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Case
no.
MCA: Yeast / 100 BBC (SD) 
Control Test
% Reduction 
in adhesion
1 468 328 29.9
233 202 13.3
Mean 351.5 (166.0) 265 (89.1) 21.6 (11.7)
2 297 269 9.4
606 385 36.5- - nean 452.5 (218.0) 327 (82.0) 23.0 (19.2)
3 370 223 39.7
191 103 46.0
Mean 280.5 (126.6) 163 (84.9) 42.8 (4.4)
4 350 280 20.0
621 743 +19.6* ~ - - Mean 485.0 (192.0) 512 (327.0) 0.2 (28.2)
5 336 473 +40.8
367 379 + 3.3--nean 351.5 (21.9) 426 (66.5) +22.0 (26.5)
6 300 210 30.0
171 126 26.3~ - - Moan 235.5 (91.2) 168 (59.4) 28.1 (2.6)
7 300 188 37.3
296 139 34.8
--nean 298.0 (2.8) 163.5 (34.5) 36.0 (1.7)
8 402 301 25.1
393 215 45.3
nean 397.5 (6.4) 258 (60.8) 35.2 (14.4)
9 178 130 27.0
336 252 25.0
nean 257.0 (111.7) 191 (86.3) 26.7 (1.4)
10 84 132 +57.1
105 138 +31.4
_ - nean 94.5 (14.8) 135 (4.2) +44.2 (18.2)
11 365 265 27.4
362 306 15.5- _ _ nean 363.5 (2.1) 285.5 (29.0) 21.4 (8.4)
12 132 76 42.4
145 182 +25.5--nean 138.5 (9.2) 129 (75.0) 8.5 (48.0)
Mean 308.9 251.9 14.8
SD 116.8 120.8 25.6
+ : % increase in candidal adhesion.
Table 5.5 The effect of 0.2% chlorhexidine gluconate rinse in vivo on
adhesion of C^_ albicans to buccal epithelial cells from
diabetic patients.
175
Mean % reduction in 
candidal adhesion 
40 -| H I  Non-Diabetics 
|  Diabetics
30 -
20
10 -
0 -1
Figure 5.1
In vitro In vivo
Comparison between in vitro and in vivo effect of 0.2% 
chlorhexidine gluconate on candidal adhesion to buccal 
epithelial cells.
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Mean % reduction in randlrial arJhpqim + 5TJ
Experiment Secretors (rt= 9) Non-secretars (n= 3) P
In vitro 18.5± 8.3 31.0 ± 6.2 0.05
In vivo 10.2 ±28.2 28.5 ± 7.3 0.1
Table 5,6 Relationship between mean percentage reduction in candidal 
adhesion and secretor status in the diabetic patients.
Mean % TQr¥'ir+",^ri rsmdidal adheslm + 3)
Experiment Secretors (n= 8 ) Nbnr-secrebors (n= 4) P
In vitro 38.3 ± 21.0 26.3 ± 17.2 0.2
In vivo 25.9 ± 18.8 8.6 ± 19.0 0.3
ibiKio 5.7 Relationship between mean percentage reduction in candidal 
adhesion and secretor status in the non-diabetic subjects.
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5.4 DISC05SICN AID CONCLUSIONS
The results of the present investigations have demonstrated 
that the adhesion of the strain of C^_ albicans tested was 
substantially reduced by pretreatment of the buccal epithelial cells 
^  vitro, or rinsing the mouth, with 0.2% chlorhexidine gluconate for 
one minute.
Olsen (1975a; b) showed that 0.2% chlorhexidine gluconate 
mouth rinsing reduced the number of yeast cells on the palatal 
epithelium and also reduced palatal inflammation in a group of 
patients with chronic atrophic candidosis. Lamb and Martin (1983) 
have shown that when chlorhexidine is incorporated into acrylic dental 
appliances, it diffuses in saliva and can both eliminate and prevent 
palatal candidosis in rats. Also, Langslet et al. (1974) reported 
that 0.2% chlorhexidine gluconate was effective in treatment of 
children with oral candidosis when it was used either as a mouth wash 
or painted directly onto the lesions. This regimen of mouth rinsing 
was also able to resolve oral candidal infections in immunocompromised 
patients (Ferretti et al., 1987). In addition to the previously 
documented fungicidal effect of chlorhexidine (Bobichon & Bouchet, 
1987; Salem et al., 1987), the results of the present investigation 
suggest that part of the clinical improvement reported by the use of 
chlorhexidine in earlier studies could be the result of reduced 
adhesion of candidal species to the epithelial cell surfaces. 
Therefore, the present data provides evidence that mouth rinsing with 
0.2% chlorhexidine gluconate for one minute may have a role in the 
management of oral candidosis. The regular use of chlorhexidine could 
be nspfnT in preventing or reducing the incidence of oral candidosis 
in patients with diabetes mellitus but clearly this would need to be
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proven in clinical trials.
Due to the highly cationic property of chlorhexidine, it 
binds avidly to the negatively charged surfaces including epithelial 
cslls. addition, it has been shown to adsorb to hydroxyapatite 
(Moran & Addy, 1985) and salivary proteins (Hjeljord, Rolla, 
Bonesvoll, 1973). Several studies have concluded that about 30 per 
cent of the total chlorhexidine dose is retained in the mouth for 24 
hours after one minute rinsing (Hjeljord et al., 1973; Bonesvoll et 
al., 1974).
The adsorption of chlorhexidine to the epithelial cell 
surface may be a factor in the reduced candidal adhesion observed in 
the present study. Previously, the reduced adherence of Candida 
species to acrylic surfaces pretreated with chlorhexidine has been 
reported (McCourtie et al., 1985; McCourtie et al., 1986a; b) but, 
the mechanisms have never been fully explained. However, it is 
conceivable that the binding of chlorhexidine gluconate to the 
epithelial cell surface is a process which, in some way, alters 
candidal adhesion.
Previous research has shown rapid release of chlorhexidine 
adsorbed in the oral cavity in the first hour after mouth rinsing 
(Bonesvoll et al., 1974). When C. albicans cells were exposed to a 
subminimal inhibitory concentration of chlorhexidine gluconate for a 
short time, alterations in the cell wall occurred (Bobichon & Bouchet, 
1987) and reduced adhesion to acrylic surfaces was observed (McCourtie 
et al., 1986a; b). It could be that the chlorhexidine released from 
the buccal epithelial cells in the assay medium of the present study 
was sufficient to induce surface changes on C«_ albicans cells 
responsible for the observed reduced adherence to epithelial cells,
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and similar mechanisms may also pertain in vivo.
It is possible that chlorhexidine released from the buccal 
epithelial cells into the adhesion assay medium affected the viability 
of candidal cells and thus reduced candidal adhesion. Kimura and 
Pearsall (1978) have shown viable candidal cells to adhere in higher 
number than non-viable ones (Kimura & Pearsall, 1978). However, due 
to the low concentration of chlorhexidine expected in the assay medium 
and the short incubation time, this assumption should be considered 
with caution. Nevertheless, testing the viability of candidal cells, 
before and after the adhesion assay, is recommended in further 
studies. In the present study, a single mouth rinse with 0.2% 
chlorhexidine produced a significant inhibitory effect on candidal 
adherence to buccal epithelial cells. This raises the question of 
whether daily mouth rinsing with 0.2% chlorhexidine gluconate would 
produce comparable or additive inhibitory effects on candidal 
adhesion.
As to why chlorhexidine showed less of an adherence 
inhibitory effect in diabetic patients compared with non-diabetic 
subjects is presently not clear and, therefore, the clinical 
importance of this observation is uncertain. The lower salivary pH 
reported frequently in diabetic patients (Banoczy et al., 1987) may 
partially explain the present findings since the adsorption of 
chlorhexidine to surfaces is less under acidic conditions (Hjeljord et 
al., 1973; Morran & Addy, 1985), probably due to a reduction in 
anionic influence of the recipient surface (Morran & Addy, 1985). 
However, additional possible explanations include differences in 
epithelial cell surface properties in diabetics or alterations in 
salivary composition.
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It is also unclear why the adherence inhibitory effect of 
chlorhexidine was more pronounced in vitro than in vivof although 
again there are several theoretical possibilities. Chlorhexidine in 
the oral cavity has been shown to bind to a variety of structures 
including salivary proteins (Hjeljord et al., 1973), teeth (Park, 
Katz, Stookey, 1984), the oral microbial flora (Davies, 1973) in 
addition to epithelial cells surfaces. Clearly, apart from the 
epithelial cells, the other aforementioned variables were not included 
in the in vitro study. As a consequence, probably less chlorhexidine 
was available to interact with epithelial cells in vivo than in vitro. 
In addition, chlorhexidine bound to the salivary film on epithelial 
cells in vivo is likely to have been partly removed by post treatment 
washing. Relevent to that possibility is the observation of Moran and 
Addy (1985) who exposed saliva-treated and saliva-untreated 
polymethylmethacrylate to chlorhexidine. After washing the 
polymethylmethacrylate, they noticed a relatively reduced uptake of 
chlorhexidine to saliva-treated samples than to untreated samples. In 
addition, the ability of chlorhexidine to inhibit candidal adhesion 
has been shown to be dependent on concentration (McCourtie et al., 
1985). Almost certainly any 0.2% chlorhexidine gluconate held 
intraorally becomes diluted by saliva and consequently exhibits less 
of an adherence inhibitory effect.
The present investigation has shown considerable inter and 
intra-individual variations in reduction of candidal adhesion to 
epithelial cells after exposure to chlorhexidine both in vitro and in 
vivo. This may be explained partly by a differing ability of 
epithelial cells to bind chlorhexidine. Ihe magnitude of this ability
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seems to change from day to day. In that regard, Bonesvoll et al. 
(1974) studied 12 subjects and found the oral retention of 0.2% 
chlorhexidine to range between 32 per cent and 47 per cent after a one 
minute rinse. The same experiment was repeated at weekly intervals on 
seme of the individuals on five seperate occasions and considerable 
interindividual variations in chlorhexidine retention were noted 
between experiments. However, this does not explain why epithelial 
cells from some subjects showed increased, rather than decreased, 
candidal adhesion after exposure to chlorhexidine. Whether this has 
any clinical significance is not certain, but it is tempting to 
speculate that in those individuals in whom chlorhexidine was adsorbed 
to the epithelial surfaces in small amounts it was therefore 
insufficient to inhibit candidal adhesion although it may have 
decreased the net negative charge on epithelial cell surfaces. A 
mechanism such as this could theoretically reduce the electrostatic 
repulsion forces between negatively charged yeast cells and epithelial 
cells and subsequently enhance candidal adhesion.
Although candidal adhesion to epithelial cells has been shown 
to be increased in non-secretors of blood group antigens in saliva 
compared with secretors (Blackwell, 1989), the present results 
indicated that exposure to chlorhexidine gluconate reduces candidal 
adhesion to epithelial cells irrespective of the secretor status.
CHAPTER SIX
THE IN V-LTHQ AND IN VIVO EFFECT OF THE ANTTFUNGAL AGENT NYSTATIN ON 
AEBESIGN CF CANDIDA ALBICANS TO BUCCAL EPITHELIAL fCTJ.fi PROM DIABETIC 
PATIENTS AMD NON-DIABETIC INDIVIDUALS
6.1 INTRODUCTION AMD AIMS CF THE STUDY
The polyene nystatin was the first specific antifungal agent 
to be developed and hence is the drug most commonly used clinically to 
treat cases of oral candidosis (Odds, 1988). However, even when drug 
treatment has been effective clinically, recurrence of candidosis 
ccmmonly occurs after cessation of medication.
Although nystatin is a potent fungicidal agent (Barkvoll & 
Attramadal, 1 989), its possible other actions, for example on 
adherence mechanisms of C. albicans# have rarely been investigated 
but may be important therapeutically.
Inhibition of candidal adhesion to oral epithelial cells 
could be advantageous in reducing candidal colonisation and hence oral 
candidosis, particularly in susceptible patients such those with 
diabetes mellitus. Recent research has indicated that exposure of 
acrylic denture base materials to therapeutic concentrations of 
nystatin, in vitro, effectively inhibits adherence of Candida species 
(McCourtie et al., 1986b).
The purposes of the present study were firstly to investigate 
whether exposure of buccal epithelial cells (BEC) to therapeutic doses 
of nystatin, in vitro and in vivo, would result in inhibition of 
adhesion of C^ albicans. The second aim was to establish whether 
inhibition of adhesion was comparable in diabetic patients and non­
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diabetic subjects. Finally, since the inherited inability to secrete 
ABO(H) blood group antigens in saliva has been linked with relatively 
increased candidal adhesion to epithelial cells (Blackwell, 1989), 
this study was also designed to investigate whether nystatin therapy 
would reduce candidal adhesion to epithelial cells from non-secretors 
as well as from secretors.
6 .2  MA3KUA££ PM) METHODS
6 .2 .1  P atients S election
TWelve randomly selected patients with diagnosed diabetes 
mellitus and 12 non-diabetic subjects gave informed consent to 
participate in the study which was approved by the local Ethics 
Ccnmittee. All subjects from both patients and control groups 
participated jointly both in the in vitro and in vivo experiments.
The diabetic patients were recruited from the outpatient 
Diabetic Clinic at Glasgow Royal Infirmary and refered to the Oral 
Medicine Unit at Glasgow Dental Hospital where the clinical sampling 
was performed. The non-diabetic subjects were postgraduate students 
or staff at Glasgow Dental Hospital and School who willingly 
volunteered to participate in the study.
6.2.2 minimal History and Oral Examination
A verbal clinical and medical history was taken from each 
subject. In the patients group, the type of diabetes mellitus and 
duration of the disease were recorded. For each subject, the wearing 
of a, dental prosthesis was recorded as was whether the prosthesis was
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worn continuously (day and night). Subjects who either consumed 
alcohol or who smoked cigarettes daily were considered as drinkers and 
smokers respectively. Each subject underwent a routine oral clinical 
examination to detect the presence of clinical oral candidal 
infection.
6 .2 .3  S ecreto r Status Determ ination
Secretor status was determined by the agglutination 
inhibition technique described by Periera et al. (1969) using 
unstimulated mixed saliva. Details of saliva collection, the 
agglutination inhibition technique itself and criteria for defining 
secretor status were as described in Sections 3.2.7 to 3.2.9.
6 .2 .4  Preparation o f N ystatin  Solution
Pilot studies showed that the solubility of nystatin 
pastilles in distilled water was poor. Therefore, nystatin powder 
(E.R. Squibb and Sons Ltd., Hounslow, Middlesex, England) was used. 
Nystatin powder was obtained in sterile vials each containing 500,000 
international units (iu) and was dissolved in propylene glycol (The 
British Drug House Ltd., BDH Laboratory Chemical Devision, Poole, 
Etogland) as recommended by the manufacturer. Five ml of propylene 
glycol was injected by a sterile syringe into the vial which was then 
vibrated until dissolution of the powder occurred thus producing a 
final drug concentration of 100,000iu / ml. Throughout the period of 
the experiment a new solution was prepared weekly and stored at 
temperature of 4°C when not in use and the old solution discarded.
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6 .2 .5  C o lle c tio n  and P re p a ra tio n  o f B uccal E p ith e lia l C e lls  to
Study th e  E ffe c t o f Exposure to  N ys ta tin  In  V itro  on Candidal
Adhesion In  V itro
EEC for the in vitro experiment were collected from each 
subject by gently rubbing the right and left buccal mucosa 
individually with a sterile cotton swab (Exogen Ltd., Clydebank, 
Scotland). Each swab was then agitated in 10ml phosphate buffered 
saline (PBS 0.1 M, pH 7.2) in a universal container (Sterilin Ltd., 
Feltham, England) which was kept on crushed ice until the time of 
processing. Throughout the study, PBS of the same osmolarity and pH 
m s  used. EEC obtained from the right buccal mucosa were used as the 
control for the experiment (control cells), while cells obtained from 
the left buccal mucosa were allocated for the in vitro experiment 
(test cells).
BBC were pelleted by centrifugation (MSE Centaur 2 
Centrifuge. Fisson's Ltd., Crawley, Sussex, England) at 400g for five 
minutes. Subsequently, the BEC from the left buccal mucosa were 
exposed to 1ml nystatin solution (100,000iu) at room temperature while 
cells from the right buccal mucosa were treated similarly with 1 ml 
propylene glycol. After ten minutes exposure time (the average time 
needed by a subject to suck completely one nystatin pastille), BEC 
were harvested cm a polycarbonate filter of 25mm diameter and of 12^m 
pore-size (Nuclepore Gmbh, Germany) mounted on a DEFT (direct 
epifluorescent filter technique) manifold (Micromeasurement Ltd., 
Saffron Walden, Essex, England) as shown in Figure 4.1. This method 
provided rapid and complete separation of BEC from the nystatin 
solution.
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filter and the retained BEC were then agitated gently in 
10ml PBS in a universal container to detach the BEC from the filter 
and thus become suspended in the PBS. Subsequently, the filter was 
discarded and the BEC washed twice in 10ml PBS by centrifugation at 
400g for five minutes. Microscopic examination demonstrated that none 
of the BEC had indigenously adherent commensal yeast organisms after 
the PBS wash. A final BEC suspension of 10^  cell per ml was prepared 
by appropriate dilution of the deposit in PBS following haemocytometer 
counting (Hawksley and Sons Ltd., Lancing, England).
6 .2 .6  Studying the E ffe c t o f Propylene G lycol on Candidal Adhesion
to Buocal QritheHal Cells
A pilot experiment was undertaken on BEC obtained from six 
apparently healthy non-diabetic males to detect if propylene glycol, 
used in the dissolving of the nystatin powder, had any effect on 
candidal adhesion. BEC were collected from each subject by gently 
scraping the right and left buccal mucosae each with a sterile cotton 
swab followed by agitation of the swabs in 10ml PBS in a universal 
container. BEC were washed twice in 10ml PBS by centrifugation at 
400g for five minutes. After the second wash the supernatant was 
discarded and BEC from the left buccal mucosa (test cells) were 
exposed to 1 ml propylene glycol while those from the right mucosa 
(control cells) were treated similarly with PBS. After ten minutes at 
room temperature, BEC were washed twice in PBS by centrifugation at 
400g for five minutes and a final BEC suspension of 105 per ml was 
prepared by dilution in PBS follwed by haemocytometer counting. The 
adhesion assay was then conducted as described in Section 6.2.10.
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6 .2 .7  C o llectio n  and P rep ara tio n  o f Buccal E p ith e lia l C e lls  to  
Study the E ffe c t o f N ystatin  la Vivo on Chndidal Adhesion In 
V itro
BEC for the assay in vivo were collected from each subject by 
gently rubbing the right buccal mucosa with a sterile cotton swab 
which was then agitated in 10ml PBS in a universal container placed on 
crushed ice. These cells acted as the control BEC for the experiment 
(control cells). Subsequently, each subject was asked to suck one 
nystatin pastille (100,000iu, E.R. Squibb and Sons Ltd., Hounslow, 
Middlesex, England) slowly in the mouth, after denture removal if 
appropriate. Each subject was specifically asked to allow pastille 
dissolution to occur as near the buccal mucosae as possible. After 
the subject had dissolved the pastille completely (approximately ten 
minutes), BEC were immediately obtained from the left buccal mucosa 
(test cells) by gentle scraping with a sterile cotton swab and 
suspended in 10ml PBS in a universal container placed on crushed ice.
BEC were washed twice in 10ml PBS by centrifugation at 400g
c
for five minutes and then suspended in PBS at a concentration of 10J 
cell per ml as determined by haemocytometer counting. Microscopic 
examination showed that none of the BEC had attached yeast cells after 
the PBS wash. All samplings were carried out between 1400 and 1700 
hours. The in vivo and in vitro experiments were repeated twice for 
each subject with a two weeks lapse to avoid any possible carry-over 
effect of nystatin, and the BEC were collected at the same hour of the 
day to minimise any possible diurnal variations.
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6.2.8 Source, Identification and Maintenance of Cand-Ma ^ ihjnans
S tra in  CDS 88
Cj_ albicans strain CDS 88 used throughout the study was 
originally isolated from the oral cavity of an asymptomatic carrier in 
Glasgow Dental Hospital. Species identification and maintenance were 
described in details in Section 5.2.6.
6 .2 .9  Preparation o f Candida. A lh ira rs  Suspension
C. albicans suspension for the adhesion assay was prepared as 
described in detail in Section 5.2.7. Briefly, a loopful of the stock 
culture was inoculated into 10ml Sabouraud's broth (Gibco, Paisley, 
Scotland) containing 500mM sucrose in a universal container, and
O
incubated overnight (18-24 hours) at 37 C in an orbital shaker 
incubator (Gallenkamp, Loughborough, England) operating at 100 
revolutions per minute. The culture was then harvested by 
centrifugation at 400g for five minutes and the deposit washed twice 
in 10ml PBS by centrifugation at 400g for five minutes. A final yeast 
cells suspension of 107 per ml was prepared by appropriate dilution of 
the deposit in PBS followed by haemocytometer counting.
6 .2 .1 0  The Candidal  Adhesion Assay
The in vitro C. albicans adhesion assay described by Kimura 
and Pearsall (1978) with minor modification was used throughout as 
decrlbed in detail in Section 5.2.8. Briefly, equal volumes (0.5ml) 
of pet? suspension and C*_ albicans suspension were mixed in a sterile 
bijou container (Sterilin Ltd., Feltham, England), and incubated on an 
orbital shaker operating at 80 revolutions per minute at a temperature 
of 37° C for one hour. Subsequently, BEC were harvested on 25mm
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diameter 12/xm pore-size polycarbonate filters mounted on a DEFT 
manifold. The BEC were then washed gently in 30ml PBS in aliquots of 
five ml to remove unattached yeast cells. Each filter with the washed 
BEC was then removed and mounted on a 1mm thick, 26 X 76mm glass 
microscope slide (Chance Proper Ltd., Smethwick, England) and left for 
one hour to dry at room temperature before being Gram-stained. The 
filter and the stained BEC on the glass slide were left overnight to 
air-dry and then a 22 X 22mm glass cover slip (Chance Proper Ltd., 
Smethwick, England) was fixed on the filter with Harleco resin (Kodak 
Chemicals, England).
6.2.11 Cbunting of Adherent Yeast Cells
The glass slides holding the filters were coded and "blind" 
conditions were used in counting. The number of CL_ albicans 
blastospores adherent to 100 individual BEC in randomly selected 
fields were counted microscopically under x40 objective (Olympus Ltd., 
London, England). Only morphologically normal epithelial cells, with 
an intact surface membrane which was not folded, were counted in the 
selected fields. Clumps of BEC were excluded and pseudohyphae, if 
present, were not counted.
6.2.12 Statistical Analysis
The percentage reduction in candidal adhesion was calculated 
as follows:
Ac - At
% reduction in adhesion = -------x 100
Ac
Ac = Yeast adhered to 100 BEC of control cells.
At = Yeast adhered to 100 BEC of test cells.
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Student's t test for paired data was used to evaluate 
differences in candidal adherence in either experiment between control 
and test BEC in the same group. Student's t test for unpaired data 
was used to evaluate differences in candidal adhesion between 
different groups as well as between in vitro and in vivo experiments. 
Since data of candidal adhesion obtained from secretors and non- 
secretors were known not to be normally distributed, data were 
analysed by a Mann-Whitney U test. A probability of less than five 
per cent was taken to be statistically significant.
6.3 RESCUES
6.3.1 Subjects of the Study
The clinical status of the study subjects is presented in 
Table 6.1. The diabetic group comprised nine patients (75%) with 
insulin-dependent diabetes mellitus and three patients (25%) with non­
insulin dependent diabetes mellitus. The mean duration of the disease 
was 10.3 (SD 7.8) years, with a range of three months and 22 years.
None of the subjects was receiving antibiotic or steroid
therapy, or had used a mouth wash for at least three months before
commencing the study. None of the subjects had either signs or 
symptoms suggestive of oral candidal infection or had previously 
received antifungal therapy.
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Diabetics (rt= 12) NoPr-diabetics (n= 12)
Male 7 (58.3%) 9 ( 75.0%)
Female 5 (41.7%) 3 ( 25.0%)
Mean age (years) 37.5 SD 14.5 33.5 SD 4.5
Age range (years) 15 - 56.5 26 - 40
Denture wearers 3 (25.0%) 2 ( 16.7%)
D and N 2 (66.7%) 2 (100.0%)
Symptomatic xerostomia 3 (25.0%) 0 (00.0%)
Smokers 2 (16.7%) 2 (16.7%)
Alcohol drinkers 0 (00.0%) 0 (00.0%)
D and N : Day and night denture wearing.
TViKlg* 6.1 Clinical status of nystatin study subjects.
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6.3.2 Effect of Propylene Glycol on CandiHai Adhesion to Buccal 
Epithelial Cells
Pretreating BEC with propylene glycol did not result in a 
significant effect on candidal adhesion to BEC (p= 0.5; Table 6.2).
Subject
no.
Candidal adhesion 
(Yeast / 100 BBC)
Control Test
1 60 46
2 242 234
3 77 117
4 210 198
5 147 169
6 214 223
Ifn -» -iMean
SD
158.3
76.4
164.5
71.7
nviKio 6.2 Effect of propylene glycol on candidal adhesion to buccal 
epithelial cells.
6.3.3 The Effect of Exposure of Buccal Epithelial flails to Nystatin
In Vitro on Candidal Adhesion
Pretreating BEC for ten minutes with nystatin (100,000iu) in 
vitro resulted in a significant reduction in candidal adhesion in both 
non-diabetic subjects (Table 6.3; p<0.002) and diabetic patients 
(Table 6.4; p<0.002). However, BEC from one non-diabetic subject 
shewed an overall increased candidal adhesion after the nystatin 
treatment.
The overall mean percentage reduction in candidal adhesion 
was not statistically different between the two groups (p>0.05). It 
was 25.2 per cent in non-diabetic subjects compared to 29.6 per cent 
in diabetic patients.
6.3.4 The Effect of Nystatin Pastille Dissolution on Candidal
Adhesion
Dissolving a nystatin pastille (100,000iu) in the oral cavity 
produced an inconsistent and fluctuating effect on candidal adhesion 
to BEC in subjects of both groups (Tables 6.5 and 6.6). Overall 
results showed no significant difference in candidal adhesion to BEC 
before and after a nystatin pastille intake both in non-diabetic 
subjects (Table 6.5; p= 0.6) and diabetic patients (Table 6.6; p= 
0.1).
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Case MCA: Yeast / 100 BEC (SD) % reduction
no. Control Test in adhesion
1 159 140 11.9
88 88 0.0
Mean 123.5 (50.2) 114.0 (36.8) 5.9 (8.4)
2 147 64 56.5
89 49 44.9
Mean 118.0 (41.0) 56.5 (10.6) 50.7 (8.2)
3 136 96 29.4
274 92 66.4
Mean 205.0 (92.6) 94.0 (2.8) 47.9 (26.2)
4 784 419 46.5
504 499 1.0
Mean 644.0 (198.0) 459.0 (56.6) 23.7 (32.2)
5 375 325 13.3
234 236 + 0.8
mgr, ,Mean 295.5 (87.0) 280.5 (62.9) 6.2 (9.9)
6 180 142 21.1
508 323 36.4
Hr,Mean 344.0 (231.9) 232.5 (128.0) 28.7 (10.8)
7 152 103 32.3
694 479 31.0
Mean 423.0 (383.2) 291.0 (265.9) 31.6 (0.9)
8 394 218 44.7
363 335 7.7
lfn .Mean 378.5 (21.9) 276.5 (82.7) 26.2 (26.2)
9 154 123 20.1
312 190 39.1
Hn i-i nMean 233.0 (111.7) 156.5 (47.4) 29.6 (13.4)
10 519 302 41.8
324 203 37.3
Mean 421.5 (137.9) 252.5 (70.0) 39.5 (3.2)
11 420 249 40.7
237 212 10.5
^» - - HBEB1 328.5 (129.4) 230.5 (26.2) 25.6 (21.3)
12 158 128 19.0
325 476 +46.5
mgr, , ,Mean 241.5 (118.1) 302.0 (246.1) +13.7 (46.3)
MEAN 313.0 228.8 25.2
SD 146.6 110.4 18.3
+ : % increase in candidal adhesion.
6.3  The effect of exposure to nystatin in vitro on adhesion of 
C. albicans to buccal epithelial cells frcm nan-diabetic 
subjects.
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Case
no.
MCA: Yeast / 100 
Control
BBC (SD) 
Test
% reduction 
in adhesion
1 250 104 58.4
337 215 36.2
mgr-, , M ,Mcym 293.5 (61.5) 159.5 (78.5) 47.3 (15.7)
2 184 149 19.0
420 253 41.0
Mean 306.5 (173.2) 201 .0 (73.5) 30.0 (15.5)
3 137 88 35.8
172 212 +23.2
Mean 154.5 (24.7) 150.0 (87.7) 6.3 (41.7)
4 402 172 57.2
386 180 53.4
Mean 394.0 (11.3) 176.0 (5.6) 55.3 (2.7)
5 177 80 54.8
177 130 26.5
Hr, - .Mean 177.0 (0.0) 105.0 (35.3) 40.6 (20.0)
6 171 162 2.3
156 158 + 1.3
Mean 163.5 (10.6) 162.5 (6.4) 0.5 (2.5)
7 150 139 7.3
240 172 28.3
Mean 195.0 (63.6) 155.5 (23.3) 17.8 (14.8)
8 448 167 62.7
273 221 19.0
»gnMean 360.5 (123.7) 194.0 (38.2) 40.8 (30.9)
9 254 142 44.0
431 495 +14.8
------Mean 342.5 (125.1) 318.5 (249.6) 14.6 (41.6)
10 257 113 56.0
264 156 40.9
mg_——-Moan 260.5 (4.9) 134.5 (30.4) 48.4 (10.7)
11 361 344 4.7
237 193 18.6
m*------MSQH 299.0 (87.7) 258.5 (106.8) 11.6 (9.8)
12 472 270 42.8
329 192 41.6
Hbbti 400.5 (101.1) 231.0 (55.1) 42.2 (0.8)
MEAN 278.9 188.0 29.6
SD 88.8 59.9 18.6
+ : % increase in candidal adhesion.
Table 6.4 The effect of exposure to nystatin in vitro 
C. a 1 hi nans to buccal epithelial cells
patients.
on adhesion of 
fran diabetic
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Case
no.
MCA: Yeast / 100 BBC (SD) 
Control Test
% reduction 
in adhesion
1 220 193 12.3
344 178 48.2
Mean 282.0 (87.7) 185.5 (10.6) 30.2 (25.4)
2 232 169 27.1
224 168 25.0
Hr,nean 228.0 (5.6) 168.5 (0.7) 26.0 (1.5)
3 388 489 +26.0
172 330 +91.9
Mean 280.0 (152.7) 409.5 (112.4) +58.9 (46.6)
4 296 368 +24.3
477 348 27.0
Mean 368.5 (128.0) 358.0 (14.1) 1.3 (36.3)
5 418 467 +11.7
392 430 + 9.7
Mean 405.0 (18.4) 448.5 (26.2) +10.7 (1.4)
6 311 290 6.7
357 402 +12.6
Moan 334.0 (32.5) 346.0 (79.2) + 2.9 (13.6)
7 588 860 +46.2
686 835 +24.3
------Mean 637.0 (69.3) 847.5 (17.7) +35.2 (15.5)
8 327 317 3.0
256 251 1.9
Mean 291.5 (50.2) 284.0 (46.7) 2.4 (0.8)
9 510 387 24.1
441 424 3.8
»fn , - .Mean 475.5 (48.8) 405.5 (26.2) 13.9 (14.3)
10 513 244 52.4
174 241 +38.5
- -Mean 343.5 (239.7) 242.5 (2.1) 6.9 (46.3)
11 259 304 +17.4
380 353 7.1
»^ ~ - Moan 319.5 (85.5) 328.5 (34.6) + 5.1 (17.3)
12 693 436 37.0
603 366 39.3
 ^- - - Mean 648.0 (63.6) 401.0 (49.5) 38.1 (1.6)
MEAN 358.9 368.7 0.5
SD 136.5 175.5 27.2
+ : % increase in candidal adhesion.
«i»aKip 6.5 The effect of nystatin pastille dissolution on adhesion of 
C. a 1 hi nans to buccal epithelial cells from non-diabetic 
subjects.
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Case MCA: Yeast / 100 BBC (SD) % reduction
no. Cbntrol Test in adhesion
1 289 156 46.0
217 254 +17.0
Mean 253.0 (50.9) 205.0 (69.3) 14.5 (44.5)
2 141 184 +30.5
214 198 7.5
Mean 177.5 (51.6) 191.0 (9.9) 11.5 (26.9)
3 108 165 +52.8
349 259 25.8
Mean 228.5 (170.4) 212.0 (66.5) +13.5 (55.6)
4 283 166 41.3
298 170 42.9
||n m~*Mean 290.5 (10.6) 168.0 (2.8) 42.1 (1.1)
5 157 85 45.8
275 106 61.4
lfr, ,Mean 216.0 (88.4) 95.5 (14.8) 53.6 (11.8)
6 148 134 9.4
296 179 39.5
Mean 222.0 (104.6) 156.5 (31.8) 24.4 (21.3)
7 234 308 +31.6
157 242 +45.1
Mean 195.5 (54.4) 275.0 (46.7) +42.8 (15.9)
8 164 256 +56.0
256 194 24.2
Ifean 210.0 (65.0) 225.0 (43.8) +15.9 (56.7)
9 394 498 +26.4
790 788 0.2
Mean 592.0 (280.0) 643.0 (205.0) +13.1 (18.8)
10 220 203 7.7
243 211 13.2
Mean 231.5 (16.3) 207.5 (5.6) 10.4 (3.9)
11 241 230 4.6
467 413 11.6
n ,.Mean 354.0 (159.8) 321.5 (129.4) 8.1 (4.9)
12 475 305 35.8
402 406 + 1.0
ig, I, .Mram 438.5 (51.6) 355.5 (71.4) 17.4 (26.0)
MEAN 284.1 254.6 6.1
SD 122.0 141.4 27.0
+ : % increase in candidal adhesion.
'PaKi<* 6.6 The effect of nystatin pastille dissolution on adhesion of 
C. albicans to buccal epithelial cells frcm diabetic
patients.
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6*3*5 Relationship Between the Effect of Nystatin PrpfrT^ t-mpni- m  
Candidal Adhesion and Secretar Status
The effect of nystatin pretreatment on candidal adhesion was 
not statistically different between seeretors and non-seeretors. This 
finding held true for non-diabetic subjects (Table 6.7) and diabetic 
patients (Table 6.8) and both in the in vitro and in vivo experiments.
Moan % reduction in candidal adhesion. ± SD
Experiment Secretars (n= 10) Non—secretars (l*= 2) P
In vitro 23.0 ± 19.4 35.5 ± 5.6 0.1
In vivo 3.4 ± 27.3 +14.1 ±29.8 0.5
+ : % increase in candidal adhesion.
*Eah1e 6.7 The relationship between the effect of nystatin pretreatment 
on randidal adhesion and secretor status in non-diabetic 
subjects.
199
Mean % reduction in candidal adhesion ± SD
Experiment Secretars (n= 9) Nan-secretars (n= 3) p
In vitro 28.8 ± 20.3 32.0 ± 15.4 0.7
In vivo 13.0 ± 24.7 +14.6 ±26.7 0.3
+ : % increase in candidal adhesion.
TfrKle 6.8 The relationship between the effect of nystatin pretreatment 
on candidal adhesion and secretor status in diabetic 
patients.
In spite of the considerable array of antifungal agents 
developed in recent years, nystatin remains the mainstay of 
chemotherapy for superficial candidosis due to its potent and specific 
antifungal activity. The fact that nystatin absorption from the 
gastrointestinal tract is negligible makes oral ingestion of this drug 
a safe procedure in the treatment of oral candidosis (Odds, 1988). 
This treatment usually involves sucking nystatin pastilles containing 
100,000iu and/or applying suspension or cream formulation of this drug 
containing 100,000iu / ml on the lesion and to the fitting surface of
the denture if relevant (Cawson, 1963).
Nystatin is known to cause membrane damaging effects to 
CariHida cells by binding to sterols in the cell membrane (Hamilton- 
MiHer^ 1973). Recent studies have shown pretreatment of albicans 
with nystatin resulted in inhibition of adhesion to buccal epithelial 
cells (Brenciaglia et al., 1986; Macura, 1988) as well as to denture
6.4 DISCUSSION AND OONCUDSICNS
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acrylic materials (McCourtie et al., 1986b) and plastic surfaces 
(Vuddhakul et al., 1988). On the other hand, when candidal adhesion 
was investigated after treatment of the host (rather than the yeast 
cells) with nystatin, candidal adhesion was considerably reduced to 
acrylic pretreated with nystatin (McCourtie et al., 1986b). However, 
the present study is the first to report the ability of nystatin to 
inhibit adherence to pretreated buccal epithelial cells.
Candidal adhesion to epithelial cells surfaces is recognised 
as an essential first step in the process of candidal colonisation and 
subsequent infection (Kennedy, 1 988). The present study has 
demonstrated that exposure of buccal epithelial cells to therapeutic 
doses of nystatin in vitro, effectively reduced adhesion of C. 
albicans although the mechanism(s) involved remains to be determined. 
However, when the in vitro study was simulated by in vivo 
experimentation by dissolving a single nystatin pastille in the oral 
cavity of the subjects, no difference in candidal adhesion to buccal 
epithelial cells was noted before and after nystatin intake. These 
results were, however, obtained in subjects free of an oral candidal 
infection. Whether nystatin treatment would lead to reduction in 
candidal adhesion to epithelial cells from patients with oral 
candidosis is worthy of farther study.
As to why nystatin treatment in vitro inhibited candidal 
adhesion is not clear as yet. Nystatin has a preferential binding to 
ergosterol in the fungal cell membrane (Hamilton-Miller, 1973), which 
is not a component of mammalian cells. However, nystatin can bind to 
cholesterol that is present in membranes of human cells (Epstein, 
1990). It is tempting to speculate that nystatin binding to 
cholesterol in the buccal epithelial cell wall may have led to
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structural changes and thus induced inhibition of candidal adhesion.
McCourtie et al. (1986b) have shown the inhibitory effect of 
nystatin on adhesion to pretreated acrylic surfaces to be dose- 
dependent. The lack of an inhibitory effect of nystatin on adherence 
in vivo in the present study may be due to the diluting and flushing 
action of saliva in the oral cavity. Thus, intraoral nystatin would 
probably not have been bathing the buccal mucosa continuously as 
opposed to the conditions existed in vitro. Moreover, due to the 
intraoral dissolution of the nystatin pastille and the continuous 
swallowing of saliva, the buccal mucosa may have been exposed to a 
reduced concentration of nystatin than that was available to buccal 
epithelial cells in vitro. Due to these reasons, it may be worth 
studying the effect of saliva alone on nystatin-mediated inhibition of 
candidal adherence. Conventionally, nystatin pastilles (100,000iu) 
are taken four time daily for four to six weeks to control oral 
candidosis (Cawson, 1963). In view of the in vitro results of the 
present study, it is tempting to speculate that the frequent and 
regular usage of nystatin pastilles topically may have an additive 
effect on reducing adherence of Candida species.
On reviewing the literature, it would appear that the 
influence of antifungal agents on candidal adhesion to host surfaces, 
has not been conclusively studied (Odds & Webster, 1988). 
Methodological differences between researchers in addition to 
variations in the concentration of the drugs used makes comparisons 
between different studies difficult and, highlights the need for the 
adoption of standardised methods to study the effect of antifungal 
drugs on microbial adhesion.
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The inherited inability to secrete blood group antigens in 
saliva has been described in association with increased candidal 
adhesion to epithelial cells and a predisposition to candidosis 
(Blackwell, 1989). The results of the present study suggested that 
nystatin treatment in vitro reduced candidal adhesion comparably in 
both secretors and non-secretors. Nevertheless, this study has 
indicated that after oral dissolution of a single nystatin pastille, 
the non-secretors tend to show increased, rather than decreased, 
candidal adherence. This finding held true for both non-diabetic 
subjects and diabetic patients. However, the difference was not 
statistically significant between secretors and non-secretors and one 
reason for this may be due to the relatively small number of non- 
secretors used in the present study. More studies with larger groups 
of secretors and non-secretors are required to identify differences 
between the two groups.
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